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Abstract 
The specification of the pancreas into lineages has been extensively studied 
In particular, the focus has lied on molecular cues guiding the differentiation of 
cells into the endocrine lineage, because of the prevalence of diabetes 
mellitus. However, the mechanisms of 3D tissue growth and the interaction 
between the lineages in order to reach an organ of right size and composition 
are not understood.  
In this project, I aim to characterise the dynamics and interaction of three 
pancreatic compartments, i.e. acinar, ductal, and islet lineage. I carry out 
clonal lineage tracing, followed by extensive quantitative analysis of clone 
sizes and tissue parameters. I combine this analysis with whole-mount EdU 
proliferative assay to study the kinetics during development, as well as single-
cell RNA sequencing in order to gain molecular insight of the observed 
lineage tracing outcomes.  
Firstly, I identify a rapid cell fate restriction of the tissue, starting already 
around E9.5 after the appearance of the pancreatic bud, with the bulk of cells 
being fully committed by E12.5 with persisting rare tripotent cells, followed by 
complete replenishment of tripotency beyond E15.5. 
I then propose a mechanism explaining a coordinated morphogenesis of 
acinar, ductal and islet lineage. I identify ductal-ends as a niche proliferative 
environment carrying acinar-committed, ductal-committed together with rare 
multipotent precursors. With time, the multipotent precursors replenish. The 
mechanism of tissue growth involves ductal-end driven morphogenesis with 
stochastic decision between bifurcation and termination of a branch. Based on 
clonal data from various timepoints, I find that the most intense branching 
morphogenesis is taking place until E15.5 after which only a few rounds of 
branching are taking place. 
Lastly, the analysis of islet associated clones and islet parameters enable me 
to determine some of the cellular mechanisms regulating islet size.  
 
 
xx 
Altogether, I propose a novel model for coordinated lineage growth and 
development during pancreatic morphogenesis, which complements previous 
literature.
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Chapter 1 
Introduction 
1.1 The Pancreas: structure and function 
The pancreas, located behind the stomach and attached to the duodenum, is 
an organ essential for controlling nutrient metabolism. It possesses two 
functionally and morphologically different cell populations – the exocrine and 
endocrine tissue. The exocrine acinar cells amount to 90% of tissue mass 
(Benitez et al. 2012) and produce the pancreatic juice with enzymes 
necessary for the breakdown of proteins, carbohydrates and lipids. This 
secretion is transported via a system of ductal cells, known as pancreatic 
ducts, to be released into the duodenum. In addition to performing a digestive 
enzyme draining function, the mature duct cells produce bicarbonate (which 
neutralises acidic chyme entering the duodenum from the stomach) and 
mucins (components of mucus). The endocrine cells, in turn, are located in 
the Islets of Langerhans, which are embedded within the pancreatic exocrine 
tissue. The islets are associated with a network of blood vessels, neurons, 
and stromal components of mesodermal origin. The interaction between 
endocrine and vascular cells enables hormone release, therefore ensuring the 
regulation of blood glucose levels. The predominant two endocrine cell types 
are glucagon-producing α-cells and insulin-producing β-cells, responsible for 
increasing and decreasing blood glucose levels, respectively. The rarer three 
endocrine cell types are δ, ε and PP cells producing somatostatin, ghrelin and 
pancreatic polypeptide respectively – all associated with the control of diet 
and digestion. The structure and composition of the pancreas is presented in 
Figure 1.  
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Figure 1. Pancreatic structure. The pancreas is composed of exocrine and 
endocrine tissue. Exocrine acinar cells produce pancreatic juice containing 
enzymes for digestion of proteins, carbohydrates and lipids. The juice is 
transported via a system of ductal cells into duodenum. Endocrine cells 
producing hormones are located within the islets of Langerhans, which are 
embedded in the exocrine tissue. 
 
 
Figure 2. Pancreas development is composed of two main phases: primary 
and secondary transition. Primary transition is characterised by rapid 
proliferation of cells leading to microlumen formation, and eventually 
specification of tip and trunk domains. Secondary transition is a phase of 
extensive tissue specification and remodelling, although proliferation 
continues. Endocrine, ductal and acinar tissues are specified.  
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1.2 Pancreatic specification: phases 
Pancreas specification is composed of a phase of pancreatic pre-patterning 
followed by the main developmental phases. Pre-patterning is an essential 
phase starting at around E8.5, which prepares the local environment for 
subsequent switching on of the pancreatic specification programmes and 
emergence of dorsal and ventral pancreas. Pancreatic development itself is 
composed of 3 phases, as distinguished by morphological and cell 
specification changes: primary transition between E9.5 and E12.5, secondary 
transition between E12.5 and birth, as well as maturation between birth and 
weaning (Fig. 2). Primary transition is characterised by extensive progenitor 
proliferation leading to microlumen formation. Towards the end of primary 
transition, the tip and trunk domain begin to appear (details in subsequent 
sections). Secondary transition is characterised by intense tissue specification 
and remodelling, concomitant with continued cell proliferation. In this phase 
the three pancreatic compartments – ductal, acinar and islet – are formed 
(Fig. 2, reviewed in Shih et al. 2013; Benitez et al. 2012; Pan & Wright 2011).  
The growth and development continues in the neonatal pancreas, during the 
maturation phase in two waves. The first wave lasts until 2 weeks after birth 
(P15) and is characterised by proliferation of endocrine cells. The second 
phase, in turn, spans between P15 and P30 and is dominated by the 
proliferation of exocrine cells (Dore et al. 1981).  
1.2.1 Pancreatic pre-patterning 
Prior to the outgrowth of ventral and dorsal pancreatic buds, the pre-
pancreatic region is specified around E8.5. Even though the two regions arise 
independently in two distinct locations, similar molecular programmes govern 
them. They both require Shh signalling exclusion, as well as retanoic acid and 
VEGF signalling (reviewed in Pan & Wright 2011) 
The dorsal pre-pancreatic region formation is promoted firstly by signalling 
from the adjacent mesoderm during gastrulation, and later on by the signalling 
from the nearby notochord, dorsal aorta as well as the proliferative signals 
from the pancreatic mesenchyme. The ventral bud region, in turn, is 
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established in response to signals from the lateral plate mesoderm, cardiac 
mesoderm and septum transversum (details of signalling between the tissues 
in the next Chapter 1.2.1.1) (reviewed in Pan & Wright 2011). 
1.2.1.1 Pancreatic pre-patterning: signalling in dorsal region 
The notochord is an extrinsic factor absolutely essential for dorsal pancreatic 
endoderm specification and the two tissues are in close association around 
E8. The removal of the notochord perturbs dorsal pancreatic development 
(Apelqvist et al. 1997; Kim et al. 1997; Hebrok et al. 1998). The signals sent 
from the notochord seem to be permissive rather than instructive, as the 
tissue is incapable of inducing pancreatic gene expression in non-pancreatic 
regions (Kim et al. 1997). The notochord is thought to act on the endoderm 
via the repression of Shh pathway by the release of Activin-β and Tgf2 
molecules (Hebrok et al. 1998). It has been shown that Shh is selectively 
excluded from pancreatic endoderm during normal specification, while 
removal of the notochord causes ectopic Shh expression (Apelqvist et al. 
1997; Kim et al. 1997; Hebrok et al. 1998; reviewed in Pan & Wright 2011). 
The influence of notochord is complemented by paraxial mesoderm, which 
induces retinoic acid (RA) signalling. RA signalling is necessary for proper 
pancreatic induction, as the absence of RA leads to pancreas agenesis in 
zebrafish as well as the lack of dorsal pancreas in Xenopus and mice (Martin 
et al. 2005; Molotkov et al. 2005; Stafford & Prince 2002). RA seems to act via 
Shh independent mechanisms, because loss of RA does not cause ectopic 
Shh expression in the pre-pancreatic region of mice (Martin et al. 2005).  
At E8.5, the fusion of two dorsal aortae displaces the notochord away from 
the dorsal endoderm. At this stage, the dorsal pre-pancreatic region is in 
contact with vascular endothelium, which is absolutely necessary for the 
establishment of the pancreatic domain (Lammert et al. 2001; see Section 
1.5.11 for more about the role of blood vessels in pancreas morphogenesis) 
and may promote the survival of dorsal mesenchyme, which produces Fgf10 
and maintains Ptf1a expression and progenitor pool expansion (Jacquemin et 
al. 2006) 
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By E10, the mesenchyme has accumulated around dorsal pancreatic region, 
and the Fgf10 expression is very high, which stimulates the bud outgrowth 
and proliferation of pancreatic progenitor cells (reviewed in Shih et al. 2013 
and Pan & Wright 2011).  
1.2.1.2 Pancreatic pre-patterning: signalling in ventral region 
The ventral pre-pancreatic endoderm initially receives instructive signals from 
the adjacent lateral plate mesoderm, which include BMP, RA, or activin 
(Kumar & Melton 2003). Later, around E8, the region is under inhibitory 
influence of cardiac mesoderm and septum transversum mesenchyme 
(reviewed in Pan & Wright 2011).  
The cardiac mesoderm induces hepatic differentiation via Fgf signalling 
(reviewed in Pan & Wright 2011). Indeed, in the absence of the cardiac 
mesoderm Fgf signalling alone is capable of hepatic differentiation induction 
in endodermal explants. The prevention of Fgf signalling from the cardiac 
mesoderm renders the ventral region unable to acquire the hepatic fate, whilst 
acquiring the pancreatic fate (Jung et al. 1999). Similarly, the septum 
transversum produces BMP, an inhibitory signal, which then enhances the 
Gata-4 expression and acts in parallel with Fgf signal from the cardiac 
mesoderm to induce the liver cell fate (Rossi et al. 2001). Altogether, this 
suggests that the default fate of cells in that region is to become pancreatic 
cells, and only active signalling from the cardiac mesoderm can redirect the 
cells towards the hepatic differentiation pathway.  
The important question is then how the pancreas can be formed in the 
presence of such inhibitory signals. It has been suggested that the 
proliferation of Hhex positive cells at the leading edge of endoderm promotes 
the movement away from the cardiac mesoderm (Bort et al. 2004). Indeed, 
blocking the movement of the lateral ventral endoderm prevents the 
specification of the ventral pancreas (Bort et al. 2004). Hence, tissue 
migration might be a mechanism in which cells avoid inhibitory signals.  
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Additionally, RA and Sonic Hedgehog (Shh) may also play an important role, 
since differentiation protocols using RA and the inhibitor of Shh and BMP are 
able to induce pancreatic identity in vitro (D’Amour et al. 2006).  
Two other factors that may be responsible for decision between pancreatic 
and hepatic cell fate determination are Sox17 and Hes1. Sox17 is responsible 
for establishing the boundary between liver, extrahepatobiliary (EHB, 
including gall bladder primordium, bile and cystic duct) system and ventral 
pancreas region. Loss of Sox17 causes biliary abnormalities and ectopic 
pancreas formation, while Sox17 miss-expression supresses pancreatic 
development by promoting the biliary-like tissue formation (Kanai-Azuma et al. 
2002). Hence, it appears that Sox17 acts as a pancreas inhibitory and biliary 
promoting factor. How then can the pancreas be formed from endoderm 
exposed to Sox17? It has been suggested that Sox17 may up-regulate 
expression of the key player, Hes1, in Pdx1-expressing endoderm. Hes1 then 
restricts formation of Sox17+ biliary progenitors in a negative feedback loop to 
the ventral foregut, in this way creating the boundary between EHB and the 
ventral pancreas (reviewed in Pan & Wright 2011; Spence et al. 2009). 
At E8.5, the gut tube is already formed and the ventral region of prospective 
pancreas comes in proximity to vitelline veins. The vitelline vascular cells 
produce VEGF, which induces Pdx1 and Ptf1a expression - transcription 
factors necessary for acquiring the pancreatic cell fate (reviewed in Pan & 
Wright 2011)  
1.2.2 Primary transition: main developmental events 
The primary transition starts with the emergence of ventral and dorsal 
epithelial buds on two sides of the foregut endoderm – around E9.5 and E10 
respectively. It is a phase characterised by huge morphogenic changes – 
caused by high proliferation of progenitor cells, followed by microlumen 
formation and their subsequent coalescence (Villasenor et al. 2010; Kesavan 
et al. 2009). The morphological changes are accompanied by the 
compartmentalisation of the organ into tip and trunk domain at the end of 
primary transition. 
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The tip domain contains the multipotent pancreatic cells (MPCs) that have the 
potential to differentiate into acinar, ductal or endocrine cells. The trunk 
epithelium, in turn, is composed of endocrine-duct bipotent progenitors. In this 
phase already the first differentiated endocrine cells of the dorsal pancreatic 
bud start to appear and they are mainly the glucagon-producing α-cells 
(Johansson et al. 2007). 
The dorsal and ventral buds elongate along the presumptive duodenum and 
stomach, and eventually fuse into a single organ by the end of the phase at 
E12.5 as a result of the coiling of the intestine. At this stage the 
undifferentiated epithelium is tightly surrounded by mesenchymal tissue 
(reviewed in Shih et al. 2013). 
1.2.2.1 Signalling events in primary transition: establishing and 
maintaining pancreatic identity 
After the ventral and dorsal domains have emerged, several transcription 
factors specific for the pancreatic region start being expressed. The earliest 
include Pdx1, Ptf1a and Sox9. Transcription factors Gata 4/6, Foxa1/2, Elf2, 
Onecut 1/2, Hes1, Prx1, Mnx1 are also expressed, but their expression is 
broader and present throughout the foregut endoderm (reviewed in Pan & 
Wright 2011). Each individual factor from this group is not essential for the 
initiation of pancreatic development, i.e. budding still occurs when one of them 
is not expressed (reviewed in Pan & Wright 2011). However, they play a very 
important role in determining and maintaining pancreatic cell fate. For 
example, Ptf1a deficient cells reallocate to duodenal and bile duct endoderm 
fate according to lineage tracing studies (Burlison et al. 2008; Kawaguchi et 
al. 2002). The gain of function experiments, in turn, reveal an instructive role 
of Pdx1 and Ptf1a, since their constitutively active expression in the liver 
redirected these cells to a pancreatic fate (Afelik et al. 2006). The extent to 
which these factors expression in adult non-pancreatic cells could shift them 
towards the pancreatic fate should be studied.  
Importantly, the transcription factors, mentioned above, function in networks. 
Even though the deletion might not affect the initial budding of the tissue, it 
very often affects the general development of the organ. For instance, cross-
Introduction 
 
 
9 
talk between Sox9, Pdx1, Hes1 and Ptf1a, as well as the effect of deletion of 
any of these, has been described (Hale et al. 2005; Seymour et al. 2007; 
Thompson et al. 2012). 
The requirement for specific transcription factors for establishment and 
maintenance of pancreatic identity is relatively well studied; however less is 
understood about the control of their expression. Notch signalling is 
considered a key regulator, as it has been shown to influence Hes1 and Sox9 
levels (Kageyama et al. 2007; Shih et al. 2012). Embryos deficient in the 
Notch effector RBP-jk showed pancreatic growth arrest, with the phenotype 
similar to Hes1 or Sox9 deletion (Apelqvist et al. 1999; Fujikura et al. 2006; 
Jensen et al. 2000). Hes1 deletion caused up-regulation of cell cycle inhibitor 
p57 in pancreatic progenitors (Georgia et al. 2006), which suggests a link 
between Notch signalling and pancreatic-specific transcription factors as well 
as the cell cycle control. 
Another signalling cue playing an important role in the initial stages of 
pancreatic development is Fgf signalling. Fgf10 is highly expressed in 
mesenchyme, while the respective receptor Fgfr2 is present throughout the 
pancreatic epithelium (Bhushan et al. 2001; Dichmann et al. 2003; Seymour 
et al. 2012). Gain and loss of function experiments have shown that Fgf10 is 
required for cell proliferation and thus the growth of the pancreatic bud 
(Bhushan et al. 2001). Fgf10 regulates Ptf1a and Sox9 expression 
(Jacquemin et al. 2006; Seymour et al. 2012) and therefore its deletion shows 
the same phenotype as Ptf1a and Sox9 knockout pancreatic buds (Bhushan 
et al. 2001; Seymour et al. 2007). In general there is a feed forward loop 
between Sox9, Fgfr2 and Fgf10. Mesenchymal Fgf10 maintains epithelial 
Sox9 expression. Sox9, in turn, cell-autonomously controls Fgfr2 levels and 
hence the receptivity of the cells to Fgf10 (Seymour et al. 2012). If the loop is 
disrupted at any point during pancreatic development, the cells fail to maintain 
their identity and liver genes are activated (Seymour et al. 2012; reviewed in 
Shih et al. 2013).  
Lastly, EGF, Wnt and BMP pathways also regulate pancreatic progenitor 
maintenance. The Wnt and the BMP signalling seem to take place between 
Introduction 
 
 
10 
pancreatic epithelium and the surrounding mesenchymal tissue (Jonckheere 
et al. 2008; Ahnfelt-Rønne et al. 2010), but it is not understood if the ligands 
are secreted by epithelium or the mesenchyme. The importance of 
mesenchyme has been demonstrated in a study, whereby pancreatic explants 
in vitro do not persist in the absence of mesenchyme, while co-culture of 
pancreatic cells with mesenchymal tissue leads to progenitor expansion 
(Bhushan et al. 2001). It appears that multiple factors are involved and work in 
loops, as co-culture of pancreatic lineage intermediates grown with single 
factors or combinations of them does not succeed in effective progenitor 
expansion (Sneddon et al. 2012). 
1.2.2.2 Signalling events in primary transition: tip-trunk specification 
Before the onset of secondary transition, the epithelial cells of the developing 
pancreas are multipotent precursor cells (MPCs). At about E12.5 tip-trunk 
segregation is taking place. The organ grows rapidly, which is accompanied 
by structural changes, and protrusions from the edges arise. These 
protrusions are the tips and are Ptf1a+, c-Myc+, Cpa+. The inner cells are 
referred to as the trunk cells and express Nkx6.1/6.2, Sox9, Tcf2, Onecut-1, 
Prox1 and Hes1 (see Fig. 3; reviewed in Shih et al. 2013). Lineage tracing 
has shown that the trunk cells become endocrine and ductal cells 
predominantly, while the tips will contribute to acinar lineage later on in 
secondary transition (see Fig. 3; Kopinke et al. 2011; Kopp et al. 2011).  
The cell fate decision between becoming a tip or a trunk cell is a process 
regulated by co-repression of NKx6.1/6.2 and Ptf1a – two transcription factors 
initially co-expressed in MPCs. Nkx6.1/6.2 promote trunk identity, while Ptf1a 
directs the cells towards the tip fate (Schaffer et al. 2010) (See Fig. 3). 
Importantly, what is the mechanism that makes one master regulator 
overcome another in a cross-repression and therefore cause the cells to gain 
either tip or trunk identity? Notch signalling is a candidate pathway for the 
control of this decision. Repression of Notch causes excessive tip formation at 
a cost of trunk cells (Afelik et al. 2012). The constitutive activation of Notch, in 
turn, prevents tip formation and causes the expansion of trunk cells partly by 
activating trunk marker Nkx6.1 (Afelik et al. 2012; Esni et al. 2004). Hence it 
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appears that Notch plays a very important role in the tip-trunk decision 
process. Factors controlling Notch activity, however, are not well understood. 
1.2.3 Secondary transition: main developmental events 
The secondary transition phase takes place between E12.5 and birth, and is 
characterised by continued morphogenesis and expansion of pancreatic 
epithelium as well as endocrine, acinar and ductal specification and tissue 
remodelling. The potential of the tip compartment is now limited to the 
production of acinar cells. The trunk domain gives rise to ductal cells and 
endocrine-committed cells – endocrine precursors delaminate from the 
emerging ductal structures following Ngn3 expression, while the left-behind 
cells mature to become functional ductal cells. The process of delamination is 
poorly understood, but is considered to involve an epithelial-to-mesenchymal 
transition (Rukstalis & Habener 2007). By the end of secondary transition, the 
pancreas has acquired the organisation of the adult tissue to a significant 
extent. The acinar cells are clustered at the ends of the ductal network, while 
the endocrine cells are located within the Islets of Langerhans and distributed 
throughout the exocrine tissue. 
1.2.4 Signalling events in secondary transition: acinar specification 
Tip cells of the secondary transition become unipotent precursors of acinar 
cells. Acinar differentiation is driven by transcription factors Ptf1a, Rbp-jl and 
Nr5a2 (reviewed in Shih et al. 2013). Ptf1a interacts with Rbp-jl and this 
complex establishes the acinar phenotype by activating essential acinar 
genes, such as those encoding digestive enzymes, proteins required for 
exocytosis and zymogen granules production, as well as Ptf1a and Rbp-jl 
themselves as a part of an auto-activation loop (reviewed in Shih et al. 2013).  
Nr5a2, on the other hand, is a direct target of Ptf1a. It binds to and activates a 
similar set of genes as the Nr5a2-Rbp-jl complex. Even though Ptf1a plays a 
very important role in acinar specification, its forced expression is insufficient 
to induce acinar cell differentiation (Schaffer et al. 2010). This suggests that 
other factors acting in parallel may be required. Candidates include Mist1, 
which is highly expressed in acinar cells but independent of PTF1-L 
transcriptional activation (Masui et al. 2010). Mist1 deficient mice show loss of 
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cell polarity and defective exocytosis in acini (Pin et al. 2001). Genome wide 
analysis of Mist1 target genes should reveal if there are any overlapping 
targets between Mist1 and PTF1-L complex and hence whether the two could 
work in conjunction (Reviewed in Shih et al. 2013).  
By E15.5 most tip cells have undergone acinar differentiation and their 
expansion is mainly driven by proliferation (reviewed in Shih et al. 2013). The 
molecular mechanisms behind specification of progenitors into the acinar 
lineage has been studied extensively, however, the factors responsible for 
rapid divisions of specified cells until birth are not well understood. Mist1 and 
Ptf1a are considered negative regulators of proliferation. Nr5a2 has been 
shown to promote divisions (Benod et al. 2011; Botrugno et al. 2004). Other 
candidates include c-myc ad β-catenin, the inactivation of which in early 
pancreatic progenitor stage results in acinar cell hypoplasia (Bonal et al. 
2009; Murtaugh et al. 2005; Nakhai et al. 2008; Wells et al. 2007; reviewed in 
Shih et al. 2013).  
1.2.5 Signalling events in secondary transition: ductal-islet cell fate 
choice 
Ductal and islet lineages derive from the pancreatic trunk. The key driver of 
cell fate choice between ductal and islet fate choice is Ngn3, a basic helix-
loop helix transcription factor and a master regulator of endocrine 
differentiation. Only a small fraction of trunk cells express Ngn3. Trunk cells 
that do not activate Ngn3 stay behind and become ductal tree. Therefore, the 
control of Ngn3 is critical in the decision between endocrine and ductal cell 
fate.  
It is not fully understood how Ngn3 is repressed in the majority of the trunk 
cells. One possible mechanism might be via repression by Hes1. One study 
suggested that Hes1 accelerates the degradation of Ngn3 (Qu et al. 2013). 
This is in line with the finding of Villasenor et al., whereby Ngn3 mRNA 
displays a much broader expression than the protein, suggesting post-
transcriptional/translational regulation (Villasenor et al. 2008). 
 
Introduction 
 
 
13 
 
Figure 3. Signalling events leading to specification of endocrine and exocrine 
pancreatic lineages are accompanied by morphological changes (adapted 
from Shih et al. 2013, see Fig. 2). Pdx1+ Ptf1a+ Sox9+ Hes1+ progenitors 
gradually specify into either tip or trunk domain, regulated by Notch signalling 
and Ptf1a – Nkx6.1 cross-repression. The Ptf1a+ Cpa+ c-Myc+ cells will later 
specify into acinar lineage. The Nkx6.1+ Sox9+ cells will later specify into 
endocrine or ductal cells as regulated by Notch signalling, as well as Ngn3-
Sox9 cross-repression. The right side of the schematic presents 
morphological events accompanying the specification of the pancreas. 
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An alternative control mechanism may occur via Notch signalling.  
Constitutively active Notch signalling prevents Ngn3 gene activation and 
enhances ductal differentiation (Greenwood et al. 2007; Murtaugh et al. 
2003). This suggests that Notch signalling is switched off in order for 
endocrine differentiation to occur, however, a set of studies have shown that 
Notch activates both positive and negative regulators of Ngn3 (Fig. 3; Shih et 
al. 2012). The solution to this apparent inconsistency may lie in the intensity of 
Notch signalling. High Notch levels activate Hes1 and Sox9, which inhibit 
Ngn3. Lower Notch signalling levels, however, activate Sox9 exclusively, 
which then activates Ngn3 (see schematic in Fig. 3; Shih et al. 2012). How the 
variable intensity of Notch signalling is regulated during development is not 
understood.  
When the progenitor cells become hormone producing endocrine cells, their 
gene expression profile changes. Ngn3 dependent factors are expressed, 
such as Pax4, Arx, Rfx6, NeuroD1, Pax6, Isl1 and IA2, together with the 
expression of cell specific hormone genes (Shih et al. 2013). For instance, 
Ngn3 binds directly to promoters of β-cell specific transcription factors 
B2/NeuroD and Pax4 to promote differentiation into β-cells (Shih et al. 2013). 
Ngn3 expression ceases or becomes very low as the hormones start being 
produced (reviewed in Rukstalis & Habener 2009). 
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1.3 Lineage tracing in the pancreas: establishment of lineage 
hierarchy and search for multipotent progenitors 
1.3.1 Lineage tracing and its contribution to pancreatic developmental 
biology 
Genetic lineage tracing is a novel tool used to follow the progeny of cells 
during development and tissue maintenance. Lineage tracing provides 
dynamic information about the fate and the number of cells that descend from 
the mother cell and their localisation within a tissue. The temporal 
understanding of cell fate cannot be achieved with the aid of “traditional 
techniques” such as transcriptional profiling of cell populations or the use of 
fixed samples to quantify gene and protein expression levels. Importantly, 
lineage tracing has shed light on some aspects of pancreatic developmental 
biology, prominently the fate of Pdx1 and Ngn3 expressing cells, the role of 
Ptf1a transcription factor in progenitor cell contribution to exocrine and 
endocrine lineages, the role of Notch signalling in pancreatic development, 
the origin and maintenance of β-cells, as well as the search for multipotent 
progenitors. The contribution of lineage tracing studies to each of these areas 
is outlined below. 
1.3.2 All pancreatic cells differentiate from Pdx1 expressing precursors, 
while endocrine islet cells arise from Ngn3 expressing precursor cells 
Gu et al. used Pdx1-Cre-based and Ngn3-Cre-based lineage tracing to prove 
that Pdx1 expressing cells give rise to all pancreatic cell types, while the Ngn3 
expression restricts the cells to the endocrine lineage (α, β, δ, ε and PP cells) 
(Gu et al. 2002). 
Desgraz and Herrera investigated the potential of individual Ngn3+ cells 
(Desgraz & Herrera 2009) as opposed to the previous studies, which treated 
Ngn3+ cells as a population of cells capable of differentiation into all 
endocrine cell types (Gu et al. 2002). They used the MADM system (mosaic 
analyses with double markers) to label Ngn3+ cells at a low mosaic 
frequency. The authors found that in newborn mice the labelled islets 
frequently contain a single marked Ngn3+ cell, suggesting that one Ngn3+ cell 
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gives rise to one type of endocrine cell by differentiation without division. In 
adult mice, clusters of marked cells within an islet were found, suggesting that 
the single endocrine cell originating from a single Ngn3+ cell re-enters the cell 
cycle after birth. According to this data, Ngn3+ cells are committed to a 
specific endocrine subtype and can be considered unipotent precursors 
(Desgraz & Herrera 2009). 
Although it has been shown that all endocrine cells arise from Ngn3+ cells, it 
does not mean that all Ngn3 expressing cells eventually differentiate into 
endocrine islet cells. In fact, some studies found that different amounts of 
Ngn3 transcription factor may result in different cell fates. Wang et al. 
postulated the existence of a threshold of Ngn3 (Wang et al. 2010). The lower 
Ngn3 levels shift the cells towards the exocrine lineage, while higher Ngn3 
expression results in endocrine differentiation. They lineage traced Ngn3+ 
cells in the pancreases of 3 genetically engineered mice: a) Ngn3TGBAC-Cre; 
R26REYFP wild type pancreas expressing normal amounts of Ngn3, b) Ngn3+/-; 
Ngn3TGBAC-Cre; R26REYFP pancreas of lower Ngn3 expression, and c) Ngn3F/-; 
Ngn3TGBAC-Cre; R26REYFP pancreas whereby Ngn3 is immediately inactivated 
when its own transcription is activated. Analysis performed at E14.5 revealed 
that only 15% of the labelled cells developed into exocrine cells in the wild 
type pancreas, 45% in the pancreas with decreased expression of Ngn3, 
while almost all EYFP reporter label was located in the exocrine tissue in the 
pancreas of mice with inactivated Ngn3. This suggests that pancreatic 
progenitors, in which Ngn3 levels are decreased, maintain a degree of 
plasticity to revert to the exocrine progenitor state. 
Beucher et al. went further on to investigate the fate of those “failed” 
endocrine progenitors. They lineage traced the failed endocrine progenitors in 
Ngn3 deficient mice at different stages and found that their ability to become 
duct or acinar cells depended on a particular stage these cells were in 
(Beucher et al. 2012). At an early bud stage, before E12.5, the failed 
endocrine cells are capable of differentiation into acinar or duct cells, 
however, after E12.5 in the branching pancreas they are limited to 
differentiation only into duct cells. This indicates a higher degree of plasticity 
at early developmental stages. 
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1.3.3 Ptf1a (AKA PTF1-p48) transcription factor switches on the 
differentiation of pancreatic cells from endodermal epithelium 
Kawaguchi et al. showed that Ptf1a-inactivated cells differentiated to the 
duodenal and bile duct cell lineages, whereas the Ptf1a expressing cells were 
capable of differentiation into all pancreatic cell types (Kawaguchi et al. 2002). 
This suggests that Ptf1a plays an important role in the switching on of the 
pancreatic cell fate in the undifferentiated endodermal epithelium. 
Similarly to what has been showed for Ngn3, the study by Fukuda et al. 
revealed that the level of Ptf1a expression influences cell fate determination 
(Fukuda et al. 2008). The authors traced the cells and their progeny with 
diminished Ptf1a expression and they managed to show that there was a 
threshold above which the cells would differentiated into pancreatic cells and 
below which only the bile duct or the duodenal cell fates could be achieved. 
1.3.4 Notch signalling plays an important role in pancreatic development 
Notch signalling is known to regulate various developmental processes. Its 
role in the pancreas is not well understood. Generally, it is thought to inhibit 
exocrine and endocrine specification, but it is not clear how exactly Notch 
signalling regulates pancreatic progenitors at different stages of development.  
A study by Fukuda et al. showed that Notch signalling is necessary for region 
appropriate specification of pancreas in the foregut (Fukuda et al. 2006). They 
used Hes1 knockout mice, Hes1 being a downstream target of Notch 
signalling, and carried out Ptf1a-Cre lineage tracing. They found that Ptf1a, a 
pancreatic determinant, was misallocated to distinct regions of the primitive 
stomach and duodenum as well as the bile duct. These mislocalised Ptf1a+ 
cells were able to differentiate into endocrine, exocrine or duct pancreatic 
cells, resulting in ectopic pancreas development. This shows that Notch 
signalling is required for correct pancreas development by spatial regulation of 
Ptf1a expression. 
Kopinke et al. aimed at finding out the differentiation potential of pancreatic 
progenitors in response to Hes1-mediated Notch signalling at different 
developmental stages (Kopinke et al. 2011). They used Hes1-CreERT2 knock-
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in allele, whereby Hes1 expression was induced and Hes1+ cells traced. The 
authors found that in embryonic pancreas, Hes1+ cells are multipotent 
progenitors, the differentiation of which seems to be inhibited by Notch 
signalling. Late Hes1+ cells are exocrine restricted and respond to elevated 
Notch signalling by becoming ductal cells. In adults, in turn, Hes1 expression 
is restricted to differentiated cells, mainly the presumptive centroacinar 
population at the interface of ductal ends and acini. These Hes1+ cells in 
adults do not normally serve as progenitors for β-cells, even after pancreatic 
duct ligation injury. Hence, the results of this group reveal a shift in the 
differentiation potential of Notch-responsive cells from multipotent progenitors 
to exocrine restricted progenitor cells. 
1.3.5 β-cell maintenance and the possible existence of multipotent 
progenitor compartments have been studied by lineage tracing 
Much interest has been given to the study of the origin and maintenance of β-
cells, as understanding the natural mechanisms of these cells’ derivation 
would be a huge step forward in the creation of potential replacement 
therapies for diabetic patients. Opinions concerning the regeneration of β and 
other pancreatic cells from duct or duct associated progenitor populations 
have been divided, with studies supporting and contradicting this hypothesis. 
Although the matter remains unresolved, lineage tracing has helped elucidate 
this challenging aspect of pancreatic biology by providing a new type of 
evidence. 
Dor et al. suggested that adult β-cells are maintained by self-duplication 
rather than differentiation from progenitor cells (Dor et al. 2004). In their 
experiment, the fraction of insulin-Cre labelled cells stayed constant over time. 
The authors of the article reasoned that the proportion should decrease, if the 
insulin-positive β-cells were to be maintained by endocrine neogenesis from 
insulin-negative progenitors. On the contrary, the constant proportion of 
insulin+ cells observed suggests the maintenance of islet mass in adults by 
duplication of pre-existing endocrine precursors specified during development. 
This conclusion, however, is based on the premise that all the insulin+ cells 
are mature β-cells. It is possible that the insulin+ cells could retain the 
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multipotency despite expression of differentiation-associated marker, as it is 
the case for the expression of differentiated astrocyte marker GFAP in a 
neural stem cell population in the brain (Doetsch et al. 1999). 
Contradictory evidence was provided by Xu et al., whereby they proposed that 
β-cell neogenesis from the pancreatic ducts after recovery from pancreatic 
duct ligation (pancreatic injury model) was taking place (Xu et al. 2008). 
However, the authors of this paper did not provide the evidence of lineage 
tracing in vivo. 
The hypothesis, whereby duct cells might be a source of progenitors in the 
adult and developing pancreas capable of the generation of β cells and other 
cells (usually of lesser interest), has been supported by some lineage tracing 
studies. Inada et al. performed Carbonic anhydrase II-Cre transgene lineage 
tracing (using a human promoter that marks only duct cells), and they 
observed that cells positive for this duct cell marker were able to give rise to 
β-cells and acinar cells (Inada et al. 2008). Furthermore, their results suggest 
that duct progenitors may play a role in pancreatic tissue regeneration, as a 
quarter of β-cells were labelled after pancreatic duct ligation. However, the 
quantification of the reporter-labelled β-cells in the non-injected control was 
not well characterised, leading to potential error in the assessment of the 
quantity of newly arising β-cells. 
Furthermore, the results of Solar et al., Kopp et al., and Furuyama et al. 
question the conclusion of Inada et al. about the possibility of β-cell 
regeneration in adults. By lineage tracing Sox9+ (Kopp et al. 2011; Furuyama 
et al. 2011) and Hnf1β+ duct cells (Solar et al. 2009) the groups showed that 
endocrine cells can be differentiated from ductal cells during embryogenesis 
but not after birth. Only one study shows a minor production of endocrine cells 
within the first three weeks post-birth (Kopp et al. 2011). Furthermore, 
pancreatic duct ligation suggests that β-cell regeneration from ductal cells is 
not taking place in the adult (Solar et al. 2009).  
The existence of multipotent progenitors, that can give rise to all pancreatic 
lineages, has been proposed by Zhou and colleagues. The authors identified 
another multipotent compartment in the early tip domain based on expression 
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analysis and lineage tracing (Zhou et al. 2007). This population of cells co-
expresses Pdx1, Ptf1a, c-Myc (high), and Carboxypeptidase A1 (Cpa1) and 
was shown to be capable of differentiation into exocrine, endocrine and duct 
cells. However, the switch from multipotent cells into exocrine-fated cells 
occurs at E14, during secondary transition, consistent with the differentiation 
of the tip domain. Hence, no multipotent domain persisting beyond E14 has 
been identified in this study. 
Furthermore, one group has suggested a hypothetical multipotent domain 
based on transcription factor expression (Kopp et al. 2011). The early 
pancreatic bud expresses a set of transcription factors such as Pdx1, Sox9, 
Ptf1a, Hnf1b, Hes1 and Nkx6.1 (Seymour et al. 2007; Hald et al. 2008; 
Haumaitre et al. 2005), the domains of which separate at later stages 
(Schaffer et al. 2010). Kopp et al. identified a rare area of tissue at the 
interface of ducts and acini at later embryonic stages, where these 
transcription factors are still co-expressed (Kopp et al. 2011). This could be 
the potential site of multipotent progenitors. Interestingly, the location of these 
cells highly resembles that of centroacinar cells, previously reported to be 
multipotent ex vivo (Rovira et al. 2010). Unfortunately, the question of 
multipotency of the cells expressing this specific combination of factors cannot 
be assessed functionally with lineage tracing experiment due to current 
technological limitations. It should be the focus of future studies, when more 
refined cell-fate mapping of cells expressing multiple markers has been 
developed. 
Finally, the question of the acinar compartment hosting the potential 
multipotent progenitor domain has been debated. The acinar tissue cells 
seem to contribute to acinar tissue maintenance, with a possibility of acinar to 
ductal trans-differentiation, however, it has not been reported as a potential 
source of progenitors for the endocrine lineage cell regeneration (Desai et al. 
2007; Strobel et al. 2007).  
Overall, the existing literature outlined above studies the behaviour of cells 
which may include the specific subset of Pdx1+ Sox9+ Ptf1a+ Hnf1b+ Hes1+ 
and Nkx6.1+ cells, however, the observed tripotency in embryos may be 
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associated with merging of multiple lineage-restricted progenitors due to non-
clonal levels of reporter induction in these studies (Zhou et al. 2007; Kopinke 
et al. 2011; Kopp et al. 2011; Inada et al. 2008; Solar et al. 2009). 
1.3.6 It is not clear if β-cells may originate from α-cells during 
development 
It has been postulated that the insulin producing β-cells may derive from α-
cells. The reasoning behind this was that the early primordial epithelial cells 
express more than one pancreatic hormone, hence the idea of a common 
precursor for all five islet cell types (α, β, δ, ε, PP). Since the glucagon-
containing cells are the first to differentiate in early buds and because cells 
that co-express insulin and glucagon exist (Johansson et al. 2007), this 
encouraged the hypothesis that β cells may be derived from α-cells. Several 
experiments have focused on determining whether such conversion is 
possible, including the lineage tracing studies.  
By lineage tracing, Herrera showed that adult glucagon producing α-cells and 
insulin producing β-cells derive from cells that never transcribed insulin or 
glucagon respectively (Herrera 2000). In their genetic construct, they placed a 
reporter under the control of insulin-2 or glucagon promoter, so that cells 
expressing these hormones could be traced. They found no cells expressing 
the two hormones at any time during the time-course of analysis. This 
suggests that neither of the two cell types descend from another.  
On the other hand, Thorel et al. reported that the conversion of α to β-cells 
was possible after extreme β-cell loss (Thorel et al. 2010). Targeted β-cell 
destruction together with the tracing of α-cells was performed, and a very low 
conversion rate was observed. 
1.3.7 Summary of lineage tracing studies in the developing mouse 
pancreas 
In summary, genetic lineage tracing enables the study of gene function in a 
novel way – the role of genes in cell differentiation, proliferation and migration 
can be investigated. This has helped to identify the role of certain transcription 
factors in pancreatic development, as summarised in Figure 4. It needs to be 
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emphasised, however, that the studies outlined in this part were all based on 
high induction levels of lineage tracing. This may lead to inaccuracy in the 
apparent potency outcome, as multiple independent labelled cells could 
merge together. Hence, while the studies discussed here have helped to 
elucidate the role of various transcription factors in pancreatic development, 
the lineage hierarchy model and potency assessment based on them is 
hypothetical and needs to be confirmed with clonal density lineage tracing. 
Furthermore, only specific cell lineages have been traced, therefore, a more 
unbiased approach in the search of multipotent precursors and in the 
inference of lineage hierarchy should be undertaken in the future. 
 
 
Figure 4. Role of different transcription factors as revealed by genetic lineage 
tracing (adapted from Herrera et al. 2002). Ptf1a switches on the 
differentiation of pancreatic cells from endodermal epithelium. All pancreatic 
cells arise from Pdx1 expressing precursors, while endocrine islet cells arise 
from Ngn3-expressing precursor cells. It is not clear if β-cells may originate 
from α-cells during development, and until what stages the Sox9+ domain 
retains tripotent precursors.  
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1.4 Non-lineage tracing based search for evidence of multipotent 
progenitors 
Besides the lineage tracing approach, a key role in understanding the potency 
of pancreatic progenitors has been played by experiments involving 
fluorescently activated cell sorting (FACS) followed by seeding of cells in vitro 
to study their potential. The premise behind these ex vivo studies has been 
the reasoning that even though certain lineages might not give rise to 
endocrine cells in the tracing studies in vivo under physiological conditions, 
they may retain the potential to do so when they are provided with sufficient 
signals.  
For instance, Rovira and colleagues FACS-sorted a centroacinar population 
of cells based on their stem cell-associated aldehyde-dehydrogenase-1 
(ALDH-1) activity and E-cadherin expression (Rovira et al. 2010). These cells 
were capable of sphere formation in vitro – the phenomenon that has been 
associated with progenitor cell activity in the nervous system and other organs 
(Lawson et al. 2007; Dontu et al. 2003). The expression of endocrine markers 
in the spheres was initiated, while the expression of the ductal Sox9 was 
retained throughout. These cells differentiated into endocrine and acinar cells 
upon transplantation into embryonic pancreatic explants (Rovira et al. 2010).  
Another study by Seaberg et al. identified the so called pancreas-derived 
multipotent precursors (PMPs) in the adult pancreas (Seaberg et al. 2004). 
They showed that a single PMP is capable of in vitro proliferation to form a 
clonally-derived sphere, which expresses neural and pancreatic precursor 
genes. After differentiation, these spheres contain differentiated cells coming 
from both the nervous and pancreatic lineages. Functional β-cells were 
generated, which were capable of a glucose stimulated Ca2+ response, and 
insulin secretion.  
A follow up study was then carried out by Smukler et al., whereby they 
showed that transplanted PMP cells express insulin and those insulin+ cells 
are capable of producing pancreatic and neural cells in normal adult pancreas 
(Smukler et al. 2011). To confirm the pancreatic origin of PMPs and exclude 
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their neural crest derivation, pancreatic Pdx1 and neural crest labelling were 
performed.  
Altogether, these studies have been useful in identifying facultative 
progenitors, which show multipotency in ex vivo conditions. However, FACS 
isolation does not always result in pure populations of cells, and it is possible 
that the colonies described above contain cells of non-ductal or even of non-
epithelial origin. Furthermore, the ex vivo behaviour does not necessarily 
recapitulate the in vivo cell fate potency. 
Interestingly, a study by Stanger et al. has shown that the persistence of 
multipotent progenitors in the developing pancreas may indeed be very 
limited. Deletion of cells until E12.5 for various periods of time results in a 
significantly reduced pancreatic mass (Stanger et al. 2007), indicative of pre-
determination of pancreas size by the early progenitor pool. This could mean 
that the cells have an autonomous restriction of the amount of tissue they are 
capable of generating, suggesting that there are no ‘stem cell-like’ progenitors 
present which can compensate the tissue loss by proliferation. 
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1.5 Link between pancreas morphogenesis, specification and 
molecular signalling 
Specification of cells during pancreatic development has been extensively 
studied, and the understanding of molecular pathways guiding the lineage 
differentiation and maturation is becoming progressively more complete. In 
particular, β-cell differentiation protocols in vitro have been developed to a 
great extent due to an increasing understanding of molecular cues guiding 
their specification in vivo (D’Amour et al. 2006; Pagliuca & Melton 2013; 
Pagliuca et al. 2014). However, these signalling events are accompanied by 
morphological changes leading to the formation of adult topology of tubular 
ductal structures with acini at ductal ends and islets in between them by the 
end of secondary transition. The understanding of how the morphological 
events are linked to cell signalling and specification is very limited at present. 
The key unanswered question in the field of pancreatic biology regards the 
way in which the pancreas reaches its final size and composition.  
In this section, I focus on the main morphological processes such as cells 
acquiring early polarity, primordial central tube formation, plexus remodelling, 
branching morphogenesis and islet formation, detailing the cellular 
mechanism and the influence of molecular signals on the tissue 3-dimensional 
development.  
1.5.1 Establishment of early tissue polarity 
The pancreas emerges at E9.5 as a morphologically homogenous bud 
(reviewed in Shih et al. 2013) composed of multipotent precursors (Shih et al. 
2013; Pan & Wright 2011; Zhou et al. 2007; Solar et al. 2009; Gu et al. 2002; 
Kopp et al. 2011; Pan et al. 2013).  
First distinguished pancreatic polarity arises due to the presence of a central 
lumen following stratification of cells during bud emergence from pre-
pancreatic endoderm between E7.5 and E10.0 (Villasenor et al. 2010). Even 
though the placode is originally 1 layer thick, it stratifies into 6-8 layers 
surrounding the primary central lumen (PLC) between E8.75 and E11.5 
(Villasenor et al. 2010).  
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Initially, the epithelium is highly polarised with cells in the lumen displaying 
apical polarity and cells in contact with basement membrane displaying 
basement polarity. Around E10.5, when the bud becomes more stratified, the 
inner cells, which constitute the majority of cells, are not in contact, directly 
nor via thin extensions, with either the PLC nor the basement membrane 
encasing the pancreatic bud (Villasenor et al. 2010). Once the pancreas is 
fully stratified (around E10.5), the cells organise into 3 main layers, with an 
outer layer of ‘cap’ cells, internal ‘body’ cells and the lumen-lining cells. The 
cap cells maintain their polarity by being in direct contact with basement 
membrane and by receiving signals such as laminin and collagen. However, 
they show no apical polarity as evident by the lack of aPKC, Par3 or ezrin 
expression (Villasenor et al. 2010). The body cells show no polarity as they 
are not in contact with either apical or basal membrane. The lumen-lining 
cells, unlike the cap cells, show only apical polarisation, as they are in direct 
contact with the lumen, and accumulate apical markers such as Par3, aPKC, 
ezrin, ZO (Villasenor et al. 2010).  
Even though the cap progenitors are highly motile and rearrange frequently 
during mitotic divisions in the cap compartment (Shih et al. 2016), the cap and 
inner body cells tend to stay within their compartment and not intermingle at 
E10.5 (Shih et al. 2016). This suggests that the initial axis for pancreas growth 
and development may already be established by this stage. Even though the 
progenitors are considered to be multipotent at this stage (Shih et al. 2013; 
Pan & Wright 2011; Zhou et al. 2007; Solar et al. 2009; Gu et al. 2002; Kopp 
et al. 2011; Pan et al. 2013) there may be some morphological and 
mechanical differences related to positional effects. This could possibly have 
an effect on the future fate potential of cells in these distinct regions. 
Specifically, cap cells are likely to receive pro-proliferative signals from the 
ECM and mesenchyme and may therefore contribute to the formation of tip 
protrusions during the tip-trunk specification (see Chapter 4.3). Additionally, 
mechanical cues arising from the mesenchyme exerting local pressure on the 
pancreatic bud may also play a role in regulating the local proliferation and 
movement of cells and hence the emergence of tips.  
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Around E11.5, the dorsal and ventral pancreatic buds come in contact and 
fuse due to the rotation of the gut. The mechanism of fusion and how the 
process affects the global pancreatic polarity are not understood. 
1.5.2 Plexus formation and remodelling 
Around E11, the first pancreatic ductal plexus starts to appear and remodel. 
The origin and mechanism of its formation is not fully understood (Iber & 
Menshykau 2013). The central lumen formation, described in the previous 
section, appears to serve as the origin of the ductal plexus. The PCL, which is 
initially a prominent central cavity, is progressively and very quickly thinned as 
the bud elongates. In parallel, new lumen emerge in the pancreatic 
epithelium. At E10.75, the pancreatic bud consists mainly of the forming 
lumen and links and networks established between those lumens (Villasenor 
et al. 2010). Even though at E10.5 the body cells were shown to lack polarity 
(see previous section), by E10.75 they regain this polarity as assessed by the 
expression of ZO-1 protein (Villasenor et al. 2010). The reason for the re-
appearance of polarity in body cells, associated with ZO-1 expression, is not 
clear. It could be due to cells receiving a different concentration of signals 
from the mesenchyme such as Fgf10 from that of cap cells.  
Villasenor et al. show that individual body cells express aggregates of ZO-1 
expression, and in some cells the expression pattern is distinguishable by an 
O-ring pattern forming a collar on the apical side (Villasenor et al. 2010). 
These cells have a ‘constricted apical side of a bottle-shaped body cell’ and 
they appear scarcely in random locations, with a tendency to cluster together 
and form ‘rosettes’. Once together, these rosettes re-localise the expression 
of ZO-1 to the apical side in the centre of a ‘rosette’. As a consequence, the 
rosettes start to open up the microlumens between them. These lumen-
rosettes appear to connect together progressively during development around 
E12.5 (Villasenor et al. 2010). As a consequence of microlumen fusion and 
coalescence, the initial plexus is formed. Hence, the authors of this article 
present the cellular mechanism of microlumen formation within the body cells 
of the pancreas, which leads to the formation of a framework for ductal 
structures. Other than the correlative evidence of lumen formation and the 
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appearance of polarity within the rings of cells, the authors do not provide a 
cellular mechanism of the microlumen formation. For instance, it is not clear 
whether the lumen appear independently of apoptosis.  
The process of lumen formation is believed to be additionally mediated by 
cdc42 (Kesavan et al. 2009). The protein is suggested to play a key role in the 
establishment of the apical-luminal polarity, and it could act either via the 
targeting of vesicles to luminal surface or the targeting of tight junctional 
complexes. However, the upstream molecular regulatory pathways affecting 
the protein expression and/or activation are unknown. 
Overall, the initial central plexus is a convoluted structure with intermingled 
modules and disconnected clusters not joined to one another in a clear 
tubular fashion. How the conversion of this plexus into the mature structures 
of branched ductal epithelium observed by the end of secondary transition 
takes place is not understood and has been a focus of very few studies 
(Bankaitis et al. 2015).  
 
An important molecular mechanism suggested to play a key role in both the 
microlumen formation and plexus remodelling involves EphB2/B3 signalling. 
EphB2/B3 receptors are expressed in the pancreatic epithelium, while the 
ligands are expressed in the mesenchyme around E12 and arteries around 
E11.5 (Villasenor et al. 2010). Mutant mice lacking the expression of EphB2 
and B3 show disrupted microlumen and rosette formation, together with 
delayed plexus remodelling (Villasenor et al. 2010). The mutant pancreata 
produce fewer of the multipotent Ptf1a+ progenitors, which results in a 
reduced total pancreatic mass. Hence, it appears that EphB2/B3 is required 
for normal pancreatic epithelium morphogenesis, including the formation of 
microlumen.  
The mechanism of EphB signalling and its effect on plexus formation and 
remodelling seems to act independently of the cdc42-related lumen formation 
mechanism (Kesavan et al. 2009), as it involves decreased epithelial 
adhesion evident by the decreased expression of β-catenin and E-cadherin. 
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This mechanism may be similar to plexus remodelling during vasculogenesis 
and angiogenesis (Oike et al. 2002). 
Deletion experiments described above (Villasenor et al. 2010; Kesavan et al. 
2009) have proved very useful in gaining certain degree of understanding 
about the key molecular players involved in plexus remodelling. However, a 
cellular mechanism of the process is still missing. Pan and Wright in their 
review propose a model in which the remodelling of the internal plexus 
pushes the outgrowth of the pancreas, consistently with the formation of tip 
protrusions during tip-trunk segregation (Pan & Wright 2011; Schaffer et al. 
2010). Plexus remodelling seems to occur in an outside-in fashion, because 
central immature plexus domains seem to be retained until later in gestation, 
when already side ductal branches have formed (Bankaitis et al. 2015). 
Plexus structures and remodelling may persist even by E15 (Pan & Wright 
2011; Bankaitis et al. 2015). 
It is not understood how plexus remodelling into epithelium of the right size 
and shape takes place, and should be the focus of future studies. The 
possible clues as to the cellular and molecular mechanism might lie in the 
analogy to vascular plexus based on structure similarities, which have been 
suggested (Risau & Flamme 1995). In the case of the latter, the 
hemodynamic flow of blood within the primitive vessels (Jones et al. 2006) 
might play a key role, but it is unresolved whether exocrine secretions would 
be significant enough to drive the remodelling.  
1.5.3 Establishment of tip-trunk polarity 
At around E12.5, the tip and trunk domain arise with distinct potencies of the 
two populations. The origin and mechanism of their appearance, as well as 
the relationship between the specific location within these domains and the 
potency are not fully understood.  
The emergence of tips might be a result of basal constriction of scattered cap-
associated progenitors and integrin-mediated signalling from the surrounding 
ECM (Shih et al. 2016). Tip cells retain multipotency until E13.5, while trunk 
cells are ductal-islet bipotent progenitors (Shih et al. 2013; Pan & Wright 
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2011). Later on, the initially tripotent tip domains become restricted to the 
acinar lineage. However, a significant proportion of cells both within the tip 
and trunk domain retain tripotency until E14.5 (Kopp et al. 2011; Kopinke et 
al. 2011; Solar et al. 2009; Furuyama et al. 2011; Zhou et al. 2007), with some 
lineages retaining tripotency even until birth (Kopp et al. 2011). Hence, it is 
not understood how despite the morphological separation of the two domains, 
tripotency is maintained. The symmetry and sharpness of tip trunk separation, 
and the existence of potential intermediate zones, is therefore not clear.  
The separation of domains has been suggested to be guided by Nkx6-1 and 
Ptf1a cross-repression, which are initially co-expressed in multipotent 
progenitors (Schaffer et al. 2010). However, it is not clear if more factors could 
be involved in the regulation of the tip-trunk polarity generation given the 
intermediate cell states reported. Such a candidate molecule is Prox1. Prox1-
deficient mice lack the second phase of endocrine production and the 
pancreata display enhanced acinar specification (Westmoreland et al. 2012; 
Wang et al. 2005). This could be due to imbalanced tip-trunk separation and 
hence Prox1 could have an impact on the separation of domains and 
determine the sharpness of the two boundaries, perhaps leaving a more 
plastic zone in between.  
Notch signalling is also transiently employed in orchestrating tip versus trunk 
decisions at the beginning of branching morphogenesis. During segregation, 
Notch-responsive cells were shown to contribute to the trunk domain, while 
cells expressing dominant negative mastermind like 1 (MAML1), which 
supresses transcriptional activation downstream of Notch signalling, 
contributed to the tip domain (Horn et al. 2012; Esni et al. 2004). 
Overexpression of Notch intracellular domain (NICD), on the other hand, 
prevents acinar and endocrine differentiation leaving pancreatic cells in a 
progenitor-like state even after birth (Murtaugh et al. 2003; Hald et al. 2003). 
Altogether, this suggests that multiple factors may be involved in the 
generation of tip and trunk domains, which may result in a less symmetrical 
domain separation and existence of intermediate regions of a more 
multipotential character than previously suggested (Shih et al. 2013).  
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Currently, it is not clear whether the tip-trunk polarity is a separate step or 
occurs in parallel with plexus remodelling. Pan and Wright in their review 
propose a model in which the remodelling of the internal plexus pushes the 
outgrowth of the pancreas, consistently with tip trunk segregation (Pan & 
Wright 2011). Furthermore, it is not clear if tip-trunk separation is a single step 
process, which occurs only at the onset of secondary transition or if it is 
conveyed during generation of side branches in the process of mature ductal 
tree formation.  
1.5.4 Branching morphogenesis 
Branching morphogenesis has fascinated biologists and theoreticians, as it is 
a process underlying the basis of organogenesis. Branching morphogenesis 
is the formation of tubular ductal network with associated other tissues. The 
process maximises surface area of an organ and its compartments in a limited 
space within organisms. A remarkable conservation of tools applied during 
branching morphogenesis between different organs has been described 
(Andrew & Ewald 2011; Iber & Menshykau 2013) such as communication 
between tissues and the use of common branch regulating genes and 
pathways. The regularity of the process and the existence of stereotypical 
branching patterns in certain organs such as lung suggest that branching may 
not be random, but controlled by genetic information (opinion from Iber & 
Menshykau 2013).  
How the pancreatic branches achieve their specific branching pattern is not 
clear. Branching morphogenesis of pancreas appears to be partially 
stereotyped with the framework branches being conserved and giving rise to 
conserved tissue pattern such as the formation of heel and ridge (Villasenor et 
al. 2010). However, large variation in the branches within subtrees with 
stochastic variability between individuals has been reported (Dahl-Jensen et 
al. 2016; Villasenor et al. 2010). The highest variation in the protrusion/branch 
number was reported for E12.5-E13.5, however, between E13.5 and E17.5 
the morphology of pancreata converges in appearance (Villasenor et al. 
2010).  
Generation of tip protrusions during the tip-trunk separation mediated by 
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Nkx6.1-Ptf1a cross-repression could be considered the onset of branching 
morphogenesis. The tip domains would undergo a process of extension and 
branching, accompanied by maturation into ductal structures. This has not 
been demonstrated directly in vivo however, as it would require live imaging, 
which is not currently technologically possible in embryos, in utero.  
What controls the process of branching morphogenesis is not clear. 
Mesenchyme and the factors it produces, such as Fgf10 and Bmp4, have 
been reported to induce the first pancreatic protrusions and affect correct 
pancreatic development (Bhushan et al. 2001). 
To start with, Fgf signalling provided by mesenchyme is a key pathway 
thought to play an important role in branching morphogenesis. Ex vivo 
organoids fail to grow without Fgf10 (Bhushan et al. 2001), while sustaining it 
uniformly in the medium maintains the branching (Miralles et al. 1999). 
However, it is plausible that mesenchyme is necessary for pancreatic bud 
growth induction but not branching per se (Dahl-Jensen et al. 2016). Indeed, 
SU5402 inhibition of Fgf signalling prevents organoid formation and 
expansion, but does not affect the expansion in the branching phase (Greggio 
et al. 2013). This is consistent with the fact that FGFR2IIIb inactivation leads 
to hypoplasia at E12.5 and the hypoplasia is maintained but does not worsen 
as development proceeds (Pulkkinen et al. 2003). Therefore, it is not clear if 
inhibition of Fgf signalling could affect the variability of subtree branch size, 
and should be the focus of future studies.  
Additionally, BMP signalling in addition to its role in early pancreatic budding 
(Pan & Wright 2011; Shih et al. 2013), may also play a role in influencing 
pancreatic branching besides its role in early budding. Its inhibition via either 
noggin overexpression or the expression of dominant-negative BMP receptor 
causes pancreatic hypoplasia in mice combined with reduced branching and 
excessive endocrine differentiation (Ahnfelt-Rønne et al. 2010).  
ECM has also been shown to play a significant role in regulating branching 
morphogenesis. In addition to its effect on cell adhesion of cap cells via ECM-
integrin signalling (Shih et al. 2016), which may result in the generation of the 
tip protrusions, the ECM secretes molecules such as laminin-1. Blocking 
Introduction 
 
 
33 
laminin-1 in pancreatic explant cultures, impaired branching and reduced the 
expression of acinar markers (Li et al. 2004). The role of ECM in regulating 
acinar differentiation could work in a concentration-based fashion, whereby 
initially the exposure to ECM is low but with subsequent rounds of branching, 
increased exposure causes more cells to adopt acinar identity. 
Cdc42, in addition to its pivotal role in microlumen formation, also has an 
important function in branching morphogenesis. Firstly, tubulogenesis is 
disrupted in cdc42 deletion mutants, and the maintenance of the tubes fails, 
as the branch structure is impaired when cdc42 is deleted from E12.5 
onwards. This shows that cdc42 not only plays a key role in plexus formation 
and the initial tubule formation which could result from its role is contribution 
to the plexus, but also in the maintenance of branches (Kesavan et al. 2009). 
Similarly to cdc42, EphB3/B2, which plays a role in microlumen formation 
(described in Section 1.5.2), is also very important in branching 
morphogenesis. EphB3-null/EphB2-dominant negative mice develop a 
hypobranched pancreas with fewer and shorter branches, and an overall 
lower exocrine mass (Villasenor et al. 2010).  However, none of the single 
mutants, EphB3-null or EphB2 dominant negative, showed defects in 
pancreatic morphology and branching, suggesting that both receptors are 
required in the coordination of pancreatic branching. Whether the branching is 
disrupted as a consequence of the initial microlumen formation and hence 
plexus generation, or whether EphB3/2 has an effect on branching 
morphogenesis from E12.5 onwards, is not clear. 
The EGFR pathway also seems to be a requirement for normal pancreatic 
development. Branching morphogenesis is impaired in EGFR (-/-) mice 
(Miettinen et al. 2000). Therefore, the search for EphB and EGF inhibitors 
expressed in the epithelium might be an important focus for future studies, as 
it could explain localised inhibition of branching and the resulting stochastic 
variability of subtree branch number within different regions of pancreas 
(Dahl-Jensen et al. 2016) 
Ephrin and EGF could act by affecting the Rho GTPase activity in the 
pancreas as in other organs it has been shown that Rho GTPases are 
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regulated by Ephrin, EGF and ECM integrin signalling (Heasman & Ridley 
2008; Huveneers & Danen 2009; Poliakov et al. 2004). GTPases are believed 
to be important in tubulogenesis (Heasman & Ridley 2008). It has been 
reported that tubulogenesis of pancreas is prematurely arrested in the 
absence of RhoA GTPase inhibitor Stard13 (Petzold et al. 2013) and that it 
acts via the regulation of cytoskeleton organisation and ERK signalling.  
Another signalling molecule, which could control the ductal branch formation 
in the pancreas, is the hepatocyte growth factor (HGF), as it controls 
branching of prostate through the Hedgehog pathway (Lim et al. 2014). Both 
the Hedgehog and HGF are expressed during pancreatic development, 
however, conditional inactivation of HGF receptor has not been associated 
with any defect in pancreas morphogenesis (Sonnenberg et al. 1993; 
Mellado-Gil et al. 2011). On the other hand, HGF mediated migration of 
progenitors has been observed and this process could contribute to correct 
morphogenesis in mouse pancreas, as this has been previously shown in 
zebrafish (Anderson et al. 2013).  
In addition to studying the effect of various pathways on the branching patters, 
the cellular mechanism of pancreas morphogenesis has also been the focus 
of numerous studies. Enhanced proliferation of cells in the tip area at E12.5 
has been observed both in vivo and ex vivo (Zhou et al. 2007; Dahl-Jensen et 
al. 2016; Petzold et al. 2013). However, contradicting evidence has also been 
provided recently (Marty-Santos & Cleaver 2016).  
The proposed primary mechanism of pancreas expansion in vivo involves the 
extension of the proliferative tip domain, followed by lateral appearance of 
side branches (Villasenor et al. 2010). Another study, in ex vivo pancreatic 
explants, has suggested that 76% of bifurcations during ductal branching 
occur via lateral branching, while 13% appear as a result of terminal 
bifurcation (Puri & Hebrok 2007). The relative proportions of branching modes 
might be dependent on time in development and could coexist or be exclusive 
for specific timepoints. Figure 5 presents the two modes of branching. 
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Figure 5. Modes of branching morphogenesis (adapted from Iber & 
Menshykau, 2013). Lateral branching is based on extension of the leading 
branch by proliferation of tip region (in red) and side branches emerging 
subsequently (top panel). Tip bifurcation driven branching is driven by 
proliferation and simultaneous bifurcation of leading branch(es), which 
continues over generations of branches (bottom panel).   
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Despite the increasing understanding of how various signalling pathways 
affect the formation of branches and the cellular mechanism of pancreatic 
branching itself, the field calls for a model of a cellular mechanism guiding the 
process of branching morphogenesis including the coordinated development 
and expansion of all pancreatic compartments, i.e. ductal, acinar and islet. 
Such a model should explain the simultaneous specification of tissue into 
ducts and enzyme secreting cells at the tips of the branches.  
1.5.5 Mechanism of islet formation 
The molecular pathways controlling the differentiation of progenitors into 
endocrine precursors and mature islet cells have been studied intensively, 
due to keen interest in differentiation of hormone expressing and glucose 
responsive islet β-cells in vitro for potential treatment of diabetes (D’Amour et 
al. 2006; Pagliuca & Melton 2013; Pagliuca et al. 2014). However, the cellular 
and mechanical mechanisms controlling islet formation and growth are 
unclear. Islet neogenesis follows a set of steps including transient expression 
of Ngn3, delamination of endocrine precursors from ductal epithelium into 
surrounding stromal tissue, and migration and coalescence into endocrine 
clusters, which later mature into islets (Gouzi et al. 2011). In the following 
sections, I will outline the cellular and mechanical models of these processes 
according to the current literature. 
1.5.6 Islet delamination control 
Islets are formed from cells delaminating from ductal epithelium. It is not clear 
how the tubular network of ducts supports efficient endocrine specification 
and how cells become mature hormone producers. It is likely that the apico-
basal polarity of ducts might play a role in correct delamination of endocrine 
precursors, which is essential for the cells to migrate and receive 
differentiation-stimulating signals (Villasenor et al. 2010). The process of 
delamination itself may be crucial for ensuring efficient islet mass production. 
Cells detaching and migrating away from the ductal epithelium may prevent 
over-crowding within ductal structures and enable the generation of new 
waves of endocrine progenitors from the ductal epithelium (Johansson et al. 
2007). 
Introduction 
 
 
37 
The process of delamination itself, i.e. the mechanism, which enables the 
cells to detach, change their shape into ovoid (Miller et al. 2009) and migrate 
through stroma, is not fully understood. Endocrine precursors are believed to 
be leaving the epithelium via either asymmetric cell division (ACD) or via 
epithelial to mesenchymal transition (EMT). However, it is not understood if 
these processes overlap, coexist independently, are mutually exclusive, or 
occur in sequence. ACD is related to the fact that cell fate determinants are 
distributed unevenly between daughter cells (reviewed in Knoblich 2008) and 
may result in one of the cells taking a “drop-like” phenotype (Miller et al. 
2009). Evidence for components of EMT still need to be provided, however, 
there is an increasing number of studies which suggest this is the process 
taking place extensively during endocrine delamination.  
A factor mediating delamination, migration and the switching on of EMT 
programme is Ngn3, also a master regulator of endocrine differentiation 
(Rukstalis & Habener 2007; Miyatsuka et al. 2011). The function of Ngn3 
seems to be regulated in a dosage-dependent manner. Indeed, sustained 
Ngn3 expression is necessary to induce delamination from the epithelium and 
endocrine differentiation in the chick. On the other hand, transient Ngn3 
overexpression is able to induce differentiation into glucagon expressing 
endocrine cells, however, these cells rarely delaminate from the epithelium. 
This shows that Ngn3 can induce a differentiation program without inducing 
the epithelium delamination program. Indeed, in the chick embryo, Ngn3 
controls delamination and endocrine differentiation independently (Gouzi et al. 
2011), but to the best of my knowledge this has not been shown in the mouse.  
The mechanism via which Ngn3 promotes islet delamination has been 
investigated by studying the expression of markers associated with migration. 
In particular, the research has focused on the analysis of co-expression 
between Ngn3 and markers of EMT, as EMT promotes cell shape changes 
and migration. EMT is commonly associated with increased Snail2 
(associated with increased migration; as in del Barrio & Nieto 2002; 
Belgiovine et al. 2016; Henderson et al. 2015) and decreased E-cadherin 
levels (associated with decreased adhesion to surrounding cells). In mouse 
and chick embryos the cells at the periphery of the ductal epithelium lose 
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apical polarity, strongly decrease E-cadherin, break-down basal lamina and 
cluster into islets of Langerhans (Gouzi et al. 2011). Decrease in the 
expression of E-cadherin is sufficient to promote delamination from the 
epithelium (Gouzi et al. 2011). Indeed ectopic Ngn3 expression triggers E-
cadherin expression decrease and EMT marker expression (Gouzi et al. 
2011), which suggest a role of Ngn3 in driving the EMT-like delamination of 
endocrine precursors in addition to their specification. Furthermore, 80% of 
cells expressing high levels of Ngn3 co-express Snail2 (Rukstalis & Habener 
2007), which suggests that the EMT programme may be switched early on, at 
the beginning of endocrine commitment. Finally, Gouzi et al. show that Ngn3 
directly controls Snail2 protein post-transcriptionally to repress E-cadherin 
(Gouzi et al. 2011). Hence, it appears that Ngn3 is essential for endocrine 
delamination induction.  
Another factor, which may play a key role in regulating this process, is cdc42. 
The role of cdc42 in ensuring correct tubulogenesis by regulating the polarity 
of cells (Kesavan et al. 2009) has been discussed in Section 1.5.2. However 
cdc42 also appears important for correct endocrine lineage differentiation 
(Kesavan et al. 2014). Given the role of cdc42 in tubulogenesis, it is likely that 
by affecting ductal tree formation, the endocrine differentiation from ductal-
delaminating cells is also influenced. Furthermore, cdc42 may play a role in 
regulating the adhesive properties of Ngn3 precursors. Indeed, fewer Ngn3+ 
cells were found in cdc42 knockout mice as compared to wild type, and fewer 
and smaller clusters of insulin and glucagon expressing cells were observed 
at E15.5 (Kesavan et al. 2009).  
At the same time, overexpression of constitutively active Cd42 impaired islet 
delamination and endocrine differentiation (Kesavan et al. 2014). Cdc42 has 
been suggested to work via impairing cell-cell junction disassembly. 
Therefore, while in the initial stages, this junction establishment is important 
for apico-basal polarity and correct duct establishment (tubulogenesis), as a 
consequence resulting in correct islet differentiation, later on it could regulate 
cellular adhesion and hence control islet delamination and specification. 
However, from the study, it is not clear if decreased hormone production is a 
consequence of impaired delamination (Kesavan et al. 2014). Cdc42 
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regulates β-cell differentiation by acting via N-WASP signalling. Constitutively 
active cdc42 mice express higher levels of N-WASP and genetic ablation of 
N-WASP in β-cells expressing constitutively active cdc42 partially restores 
both delamination and B cell differentiation (Kesavan et al. 2014). Overall, it 
appears that cdc42 may influence endocrine cell specification by regulating 
ductal tubulogenesis as well as adhesive properties of delaminating 
precursors. The right dose of cdc42 expression appears therefore essential 
for correct islet development.  
Rac1 is another factor, which may play a role in regulating endocrine 
delamination from the ducts. Blocking Rac1 in β-cells impairs β-cell migration. 
As a consequence the islet clusters remain in much closer contact with the 
ductal epithelium (Greiner et al. 2009), possibly due to blocked Rac1 being 
unable to reduce E-cadherin levels. 
Lastly, EGFR signalling has been shown to play a role in the formation of 
islets. Even though the EGFR-/- mice die within 1 week after birth, the 
pancreas appeared macroscopically normal. The islets, however, displayed 
an abnormal ‘streak-like’ phenotype with association with the ducts unlike the 
normal spherical shape. The proliferation of β-cells was also reduced 
(Miettinen et al. 2000).  
1.5.7 Generation of correct islet mass 
In addition to understanding the process of endocrine precursor delamination 
and migration, it is important to understand how islets acquire their specific 
size, shape and structure. What makes islets adopt an ovoid shape (Miller et 
al. 2009), how many endocrine precursors coalesce together to form an islet, 
how the composition of islets with particular distribution of constituent 
hormone-producing cells is achieved, and how the optimal pancreatic mass is 
achieved? This will be outlined in the current and following sub-sections. 
An important role in the regulation of the total islet mass is played by the Ngn3 
transcription factors, as both deficiency and excess of Ngn3 cause abnormal 
endocrine development. In Ngn3 null mice, the development of endocrine 
cells is impaired (Wang et al. 2007). Only a few glucagon-producing cells 
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persist, but these may arise due to activity of Mist1 (Wang et al. 2008). 
Similarly, the over-expression of Ngn3 results in a decreased endocrine cell 
mass (Apelqvist et al. 1999). Over-expression causes pre-mature 
differentiation of progenitor cells into the endocrine lineage at a cost of the 
pool of progenitor cells, which results in an overall decreased mass of 
endocrine tissue (Apelqvist et al. 1999). 
The cellular mechanism that leads to correct islet mass production is partially 
understood. 80% of islet cell mass at birth is due to endocrine-progenitor 
proliferation and subsequent differentiation, while the remaining 20% arises 
from endocrine cell duplications (Bouwens & Rooman 2005). After birth, new 
endocrine cells stop arising. It might either be due to loss of competency or 
the lack of instructive signals. Indeed, the injury models suggest the latter, as 
in such extreme conditions it might be possible to activate Ngn3 (Kopp et al. 
2011). After birth, self-duplication becomes the predominant mechanism of 
increasing and maintenance of islet cell mass to accommodate for the growth 
of the body and organ itself (Dor et al. 2004; reviewed in Pan & Wright 2011) 
1.5.8 Islet size control 
The regulation of islet size is not well understood. Both in embryos and in 
neonates, the endocrine cells proliferate contiguously, forming branched cord-
like structures (Miller et al. 2009). Aggregation of cell clusters, i.e. fusion, is 
another probably coexistent mechanism of islet formation in the embryonic 
pancreas, considering the polyclonal origin of islets (Deltour et al. 1991; Ma et 
al. 2010). At postnatal day 1, the largest islets are 1000 times larger in terms 
of area than the smallest islets (Jo et al. 2011). Such variability may arise both 
from heterogeneous proliferative potential of islet cells and from islet fusion 
events (Jo et al. 2011). 
In the postnatal stages, islet fission of large interconnected islet-like structures 
is taking place, presumably at the α -cell spanning regions (Miller et al. 2009), 
generating islets of different sizes. It has been suggested that α-cells cause 
constriction of islets resulting in the formation of the core and mantle structure 
(Cabrera et al. 2006; Brissova et al. 2005). However, a more recent study has 
contradicted the hypothesis of mantle formation (Kharouta et al. 2009). The 
Introduction 
 
 
41 
most active phase of islet fission is at 3 weeks after birth (Jo et al. 2011). 
However, it needs to be noted that there is a very large increase in islet 
number between P18 and P21 and fission does not contribute significantly to 
the islet number increase at this period. In small islets, only 30-50% of 
existing small islets are a result of fission, while the remaining ones results 
from normal growth from single β-cells (Miller et al. 2009; Jo et al. 2011). The 
latter might reflect the division of progenitor cells or neogenesis from the 
ducts. Islet cell neogenesis seems an unlikely process, as most lineage 
tracing studies so far have revealed that no de novo islet cell production takes 
place after birth (Solar et al. 2009; Shih et al. 2012; Zhou et al. 2007; 
Furuyama et al. 2011; Kopinke et al. 2011; Kopp et al. 2011) 
Islet fusion is probably insignificant at postnatal stages, because: a) the 
number of islets initially increases and then becomes constant in adult tissue, 
b) islets become more circular with time, c) the number of segments in “mutli-
joined” islets decreases over time (Jo et al. 2011). The abundance of fission 
events and lack of fusions explains the drastic morphological difference 
between the cord-like branching islet structures in embryos and neonates and 
the spherical islets in the adult. 
Overall, postnatal stages are the phase of major islet number and size 
increases. It has been shown that 80% of total β-cell mass in adult mice 
results from postnatal islet formation and growth (Jo et al. 2011). The process 
of islet formation is complete by 4 weeks, with little or no islet formation 
afterwards and a low β-cell proliferation potential in the adult regardless of 
islet size (Jo et al. 2011). 
Interestingly, the size of islets seems to be conserved between species 
including human and mice, while the number of islets generally increases with 
the size of a species. This suggests a certain intrinsically regulated limit to 
islet size. Little is known about the mechanism regulating islet size (Jo et al. 
2011; Jo et al. 2007; Kilimnik et al. 2012; Jo et al. 2012), but it is expected 
that there is an optimal size of an islet as a functional unit (Henderson 1969). 
For example, it has been shown by Jo et al. that coupled β-cells secrete 
insulin more effectively than the single β-cells, and they can generate bursting 
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action potentials, in contrast to single β-cells that produce spiking action 
potentials (Jo et al. 2005). 
Focusing on the variability of islet sizes within an individual organism, there is 
a significant extent of variation following exponential dynamics, with size 
ranging from small clusters of less than 10 cells to large islets containing 
several thousand endocrine cells (Jo et al. 2011; Jo et al. 2012). It has been 
suggested that the variability of islet sizes may arise from stochastic 
proliferation of cells, or that islet fusion and fission may account for this 
variability (Jo et al. 2011; Jo et al. 2012; Jo et al. 2007; Seymour et al. 2004). 
Islets of various sizes are distributed throughout the whole pancreas – 
through head, body and tail (Jo et al. 2011). Furthermore, islet distribution 
does not depend on gender of mice (Jo et al. 2011). 
1.5.9 Islet structure control 
The delaminated Ngn3+ cells are unipotent precursors (Desgraz & Herrera 
2009), but as a population they can differentiate into α, β, δ, PP and ε cells. It 
is not well understood what controls the proportions of different islet cells, but 
it may be partly dependent on timing. Johansson and colleagues induced 
Ngn3 expression at different times (Johansson et al. 2007). They found that 
endocrine progenitors go though phases of different “competence states”, in 
which certain endocrine cell subtypes are more likely to form (Fig. 6). For 
example, activation of Ngn3 during the first 48 hours of pancreatic 
development (E8.5-E10.5) results in exclusive production of glucagon-
secreting α -cells. This is followed by a second competency window, in which 
insulin and pancreatic polypeptide cells arise. Finally, after E14.5, 
somatostatin-producing cells appear and α-cell formation ceases (see Fig. 6). 
These competency windows seem to be due to cell-autonomous rather than 
extrinsic factors from surrounding mesenchyme, because epithelium-
mesenchyme co-culture from different stages of development does not alter 
the outcome of different competency stages (Johansson et al. 2007). Notch 
signalling could be involved in the regulation of endocrine cell proportions in a 
dosage or signal duration fashion (Ninov et al. 2012; Li et al. 2012; Li et al. 
2015). 
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Furthermore, islets are known to be of an ovoid shape (Miller et al. 2009) and 
composed of the so called α-cell ‘core’, and β-cell surrounding peripheral 
‘mantle’ (Cabrera et al. 2006; Brissova et al. 2005). However, a more recent 
study has contradicted the hypothesis of mantle formation in mice (Kharouta 
et al. 2009). 
Interestingly, several factors involved in the possible regulation of islet 
composition have been identified. One of them is HNF6, expressed in islet 
cells until E18.5 in vivo (Gannon et al. 2000). It appears that downregulation 
of HNF6 after E18.5 in developing pancreata is essential for correct structure 
formation (Gannon et al. 2000). Gannon et al. have shown that persistent 
expression of HNF6 in islet cells causes disrupted islet architecture and loss 
of β-cell function. In their experiment, the transgenic mice were diabetic, and 
islets were composed of hyperplastic islets, which remained in contact with 
the ducts. The numbers of α, β, Δ and PP cells was significantly increased, 
and abnormal intermingling of endocrine cells with β-cells was observed. 
Furthermore, β-cells displayed a profound dysfunction, evident by the lack of 
insulin response to elevated glucose levels and severely reduced Glut-2 
(glucose transporter) expression (Gannon et al. 2000).  
CTGF, connective tissue growth factor, is another molecule expressed during 
the pancreatic development – at high levels in the ductal epithelial cells and 
the pancreas-associated vasculature, as well as at low levels in the 
developing insulin+ cells, but it is downregulated in the β-cells after birth 
(Crawford et al. 2009). CTGF is required for the establishment of normal islet 
endocrine cell ratio and architecture, as CTGF null embryos result in a highly 
elevated number of α-cells, paralleled by a significant decrease in the β-cell 
count. The islets also show a dramatic decrease in β-cell proliferation during 
late gestation (Crawford et al. 2009). The molecular mechanism of CTGF 
action is unknown, however, it is believed to be a secreted protein known to 
modulate several growth factor signalling pathways including TGF-β, BMP 
and Wnt (Crawford et al. 2009). 
Finally, Nkx2.2, which is normally required for correct endocrine 
differentiation, has been shown to affect islet structure and composition. 
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Nkx2.2 repression results in an impaired maintenance of β-cell function and 
as a consequence disrupted islet architecture (Doyle & Sussel 2007).  
 
 
 
Figure 6. Ngn3 is expressed in two waves during pancreatic development 
(adapted from Johansson et al. 2007). The first wave starts at E9.5 and lasts 
until the onset of secondary transition at E12.5 and results in the formation of 
early α-cells. The second wave begins soon after secondary transition, during 
which the cells are capable of differentiation into β and PP cells, followed by 
δ-cells.  
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1.5.10 Control of pancreas size 
The understanding of pancreatic size control is limited and it is not clear which 
factors regulate pancreatic size. The formation of branches appears to be an 
important mechanism of controlling the pancreas size, as mice with mutations 
of genes affecting branching morphogenesis resulted in reduced branch-tree 
size and decreased size as a consequence (Bhushan et al. 2001; Kesavan et 
al. 2009; Villasenor et al. 2010; Miettinen et al. 2000, see Section 1.5.2). 
The major contribution to the understanding of this question comes from a 
study by Stanger et al. (Stanger et al. 2007). When early progenitor cells were 
deleted until E12.5, pancreas growth was vastly diminished to 6% of the wild 
type pancreas size. Hence, the initial pool of progenitors determines the final 
pancreas size. This suggests that the initial pool of progenitors might contain 
cells which are already highly committed and which therefore cannot 
compensate ablation by enhanced proliferation, as is the case in the liver 
(Stanger et al. 2007). This is in contrast to previous studies, which suggest 
relatively high extent of multipotency, and by extension stem cell-like 
character, in the pancreas for these stages (Solar et al. 2009; Shih et al. 
2012; Zhou et al. 2007; Furuyama et al. 2011; Kopinke et al. 2011; Kopp et al. 
2011). It is also plausible, however, that the cells perform ‘cell-counting’, 
meaning that they can only carry out a certain number of divisions, as 
observed in other systems (Bernitz et al. 2016). Therefore, the low 
proliferation of cells might not be related to their potency state. Alternatively, 
the effect of ablation of cells at specific developmental stages on pancreas 
growth could be related to morphological processes taking place. It has been 
suggested that plexus formation and remodelling, which takes place between 
E9.5 and E12.5 (Pan & Wright 2011), could be responsible for determining the 
final pancreas size. Ablation of cells during that time would result in an 
incorrect/decreased size of plexus, setting an incorrect framework for 
pancreas formation.  
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1.5.11 Role of blood vessels in pancreas morphogenesis 
Similarly to the mesenchyme, the role of which was outlined in previous 
sections, blood vessels, which associate with the growing pancreatic bud, 
also play a very important function in influencing pancreas morphogenesis.  
At E8.5, the dorsal pre-pancreatic region comes in contact with vascular 
endothelium, which is absolutely necessary for the establishment of the 
pancreatic domain. Aorta-less Xenopus laevis embryos fail to express 
pancreatic genes, while the co-culture of mouse dorsal pre-pancreatic 
endoderm with dorsal aortae induces Pdx1 and insulin expression in cells 
(Lammert et al. 2001). The mechanism of action may be via VEGF, which is 
secreted by vascular endothelium. Mis-expression experiment of VEGF-A 
under Pdx1 promoter causes islet hyperplasia and ectopic number of insulin-
positive cells (Lammert et al. 2001). Knockout VEGFR2 mice fail to activate 
Ptf1a expression in dorsal pancreatic bud (Yoshitomi & Zaret 2004). The 
maintenance of Pdx1 expression requires interaction with aortic endothelium 
even though it is not initially required for the induction of the gene (Yoshitomi 
& Zaret 2004). It has also been suggested that aortic signals may be 
conveyed via promotion of survival of dorsal mesenchyme, which produces 
Fgf10 and maintains Ptf1a expression and progenitor pool expansion 
(Jacquemin et al. 2006), hence not affecting pancreas specification directly. 
The nature of influence of the aorta on pancreas development requires further 
investigation. 
Later on, during branching morphogenesis the endothelial cells become 
localised to the central/trunk regions (Lindsay et al. 2006; Magenheim et al. 
2011; Pierreux et al. 2010), and remain distant from the tip region where the 
acinar cells differentiate. It appears that amongst the factors expressed by 
endothelial cells, non-nutritional signal, VEGF-A is a key player affecting 
pancreas morphogenesis (Magenheim et al. 2011; Pierreux et al. 2010). In 
vivo ablation of VEGF-A results in reduced endothelial differentiation and 
excessive acinar differentiation (Magenheim et al. 2011; Pierreux et al. 2010). 
Forced VEGF-A expression-induced hypervascularisation enhances 
expression of trunk marker Hes1 and loss of tip markers Cpa and amylase 
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(Magenheim et al. 2011; Pierreux et al. 2010). VEGF ablation in explants 
favours acinar formation and causes hyperbranching (Magenheim et al. 2011; 
Pierreux et al. 2010). Lastly, VEGF-A signalling is also required but not 
sufficient for endocrine differentiation (Magenheim et al. 2011). Overall, it 
appears that VEGF-A controls pancreas morphogenesis physically and by 
means of molecular signalling restricting branching and differentiation of 
acinar and endocrine lineages.  
1.5.12 Unanswered questions of pancreas morphogenesis 
Despite an increasing understanding of pancreas morphogenesis and how 
signalling might affect some of the morphogenic processes, certain important 
questions remain unanswered.  
First, it is not understood what roles are played by plexus remodelling and tip 
branching in establishing the mature ductal branch patterns and in 
determining the final pancreas size. Our understanding of the two processes 
is currently limited. How plexus remodelling takes place requires further 
investigation. In the future, research should focus on mapping the plexus 
dynamics, in order to determine whether any conserved patterns of 
remodelling can be identified or whether the process is stochastic. It is also 
not clear how plexus remodelling is linked to tip-trunk domain generation. 
Some reviews suggested that plexus remodelling could exert pressure in the 
core parts of the pancreas hence pushing outwards the protrusions of the 
epithelium (Pan & Wright 2011). However, no evidence for this has been 
provided, and therefore this should be addressed in the future studies. 
Furthermore, it is not clear what the mode of tip branching is, as most studies 
have been carried out on early tip domain (until E14.5), without focusing on 
later stages of branching morphogenesis (Zhou et al. 2007). Others were 
conducted in ex vivo explant systems and therefore require validation in in 
vivo settings (Puri & Hebrok 2007; Villasenor et al. 2010; Dahl-Jensen et al. 
2016; Petzold et al. 2013) 
Secondly, the regulation of ductal branching requires further mechanical 
understanding. Even though the factors regulating proliferation and branching 
have been examined (Bhushan et al. 2001; Kesavan et al. 2009; Villasenor et 
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al. 2010; Miettinen et al. 2000), it is not clear how the structure of individual 
ductal subtrees is regulated and how individual branches are initiated and 
terminated. It should be the focus of future studies to identify the cellular 
mechanism of this process as well as the inhibitory molecules locally affecting 
the branches. The candidate factors could involve inhibitors of pathways 
playing a role in branch structure regulation (Villasenor et al. 2010; Miettinen 
et al. 2000; Petzold et al. 2013). Furthermore, the role of ECM and 
mesenchyme and their secreted molecules should be the focus of future 
investigations, in order to identify the inhibitors (Li et al. 2004; Bhushan et al. 
2001; Ahnfelt-Rønne et al. 2010). 
Thirdly, much focus in the field of pancreatic biology has been devoted 
towards the molecular and spatial characterisation of possible multipotent 
cells (Zhou et al. 2007; Kopp et al. 2011; Solar et al. 2009; Kopinke et al. 
2011; Rovira et al. 2010), due to their potential use in the β-cell differentiation 
for diabetes replacement therapies. A previous study has indicated the tip 
domain as the host of multipotent cells (Zhou et al. 2007), which requires 
further verification using clonal-level lineage tracing . It is not clear what 
molecular or physical cues could have an effect on this restriction, and 
whether the restriction within the niche would be random or related to position 
and hence subject to exposure from different physical and biochemical cues. 
This area requires further investigation. 
Finally, the field is currently lacking a refined theory, which would explain the 
3-dimentional development of all pancreatic lineages. Despite an increasing 
understanding of molecular pathways driving the specification of distinct 
lineages, the coordination of these with morphological changes taking place is 
not clear.  
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1.6 Aims of the Thesis 
In my thesis I aim to study cell specification and morphogenesis of the 
developing pancreas, based on lineage tracing of random populations of 
pancreatic progenitors traced from R26 ubiquitous promoter induced at low, 
statistically-defined frequency, exploiting the R26-CreERT2; R26-Confetti 
system. Previous studies have been based on lineage tracing at non-clonal 
induction levels, with quantification of clones arising from possibly more than 
one labelled progenitors (Kopinke et al., 2011; Kopp et al., 2011; Shih et al., 
2012; Solar et al., 2009; Zhou et al., 2007), hence affecting the readout of 
potency outcomes. The lineages were traced from specific pancreatic 
promoters, hence providing useful information about the potency of small 
pancreatic populations, but failing to provide the information about the general 
potency of the whole tissue. I therefore set out to optimise the R26-CreERT2; 
R26-Confetti system to ensure clonality within statistical confidence, and to 
enable the 3-dimentional clonal data acquisition involving the information 
about the constituent cell types.  
I then sought to understand the potency of cells in primary and secondary 
transition, and whether there was any relationship between clone sizes and 
their potency. Next, I aimed to study the morphological processes, with a 
focus on ductal branching morphogenesis, using the EdU proliferation kinetics 
assay, lineage tracing from the R26, as well as Sox9 promoter. I aimed at 
identifying the mechanism driving pancreatic growth and the coordinated 
development of 3 pancreatic lineages in order to understand how the 
pancreas reaches its final size and composition. I also wanted to examine if 
there was any relationship between morphological and specification events. 
Furthermore, I aimed at optimising the single cell sorting and sequencing 
technique in order to determine cellular heterogeneity and decipher the 
relationship between the main pancreatic lineages, which would serve as a 
molecular mechanism shedding light on the functional lineage tracing 
analysis.  
Lastly, I aimed at studying islet morphogenesis using the R26-CreERT2; R26-
Confetti system in order to gain understanding about how the islet size 
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regulated, what is the mode of islet cell proliferation during islet formation, 
how many endocrine precursors contribute to islet formation, and whether the 
proliferative capacity of individual endocrine precursors regulates islet size. 
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Chapter 2 
Materials and methods 
2.1 Studying pancreatic development in vivo 
2.1.1 Breeding and Tamoxifen treatment of transgenic animals 
For lineage tracing experiments, mice expressing an inducible version of cre 
recombinase ERT2 under a direction of a promoter (Rosa26 or Sox9) were 
crossed with transgenic reporter mice expressing the Confetti ‘Brainbow 2.1” 
cassette (Livet et al. 2007; Ventura et al. 2007). 
Pregnant females at various stages of their pregnancy were injected 
intraperitoneally with 10mg/mL Tamoxifen in corn oil after careful optimisation 
to induce the cells at a clonal frequency. The doses and stages of injection 
are provided in the Table 1. The tissues form the pups were collected at 
E14.5, E18.5, P14 and P28.  
Mouse genotype Stage of injection Dose of 
Tamoxifen 
Rosa26-ERT2; Confetti (Brainbow 2.1) E9.5 0.020 mg/g 
 E12.5 0.025 mg/g 
 E15.5 0.015 mg/g 
 E18.5 0.010 mg/g 
Sox9-ERT2; Confetti (Brainbow 2.1) E12.5 0.020 mg/g 
Table 1. Tamoxifen dose for injection of transgenic mice at different 
developmental stages.  
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2.1.2 EdU (5-ethynyl-2’-deoxyuridine) injection for EdU proliferation 
assay 
To study the proliferation kinetics of developing pancreas, the pregnant 
females were injected with 20ug/g of weight at various stages of pregnancy. 
Pancreata from embryos or pups were collected and fixed in 4% PFA at 4°C 
as described below.  
2.1.3 Tissue fixation 
The dissected tissues were fixed in 4% PFA at 4°C – lengths of fixation were 
dependent on stage of pancreatic tissue, and are provided in the Table 2. 
Tissue developmental stage Fixation length 
Until E16.5 45 minutes 
E16.5-E18.5 4 hours 
P0 and older Overnight 
Table 2. Length of fixation of the pancreas in 4% PFA depending on the 
developmental stage of the tissue. 
Subsequently the tissues underwent three PBS washes – each half an hour 
and 1 hour long for pancreata aged below E16.5 and pancreata above E16.5, 
respectively. 
2.1.4 Tissue preparation and cryostat sectioning 
Pancreata aged E16.5 or younger were placed in a well with 500µl of 20% 
sucrose in PBS for half an hour. Older pancreata were placed in a tube with 
5ml of 30% sucrose in PBS for approximately 2-4 hours until the pancreas 
moved to the bottom of the tube. Tissues from E16.5 embryos or younger 
were washed in PBS 3 times for half an hour. Older tissues were washed 3 
times in PBS for 1 hour. Subsequently the samples were placed in OCT and 
stirred around to remove the excess PBS covering the tissue. Finally, the 
pancreata were placed in OCT in an embedding form, which was then placed 
on dry ice to freeze. The frozen blocks were either sectioned immediately with 
the Leica cryostat or stored at -80°C beforehand. 
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Thin sections were cut at 10µm, while thick sections amounted to 80 or 
100µm. After the thick sections were placed on slides, they were left to dry for 
5-10 minutes. After sectioning the slides were either moved to the freezer or 
immunostained. 
2.1.5 Staining of thin cryostat sections 
This method was used initially in the optimisation of visualisation of 3D clonal 
data together with visualisation of pancreatic compartment markers, in order 
to be used for serial reconstructions of thin sections. If the cryostat sections 
were stored in the freezer previously, then the slides were thawed at room 
temperature for about 5 minutes. The slides were rehydrated 3 times in PBS 
for 5 minutes. The slides were then immersed in 0.01% Triton-100X in PBS 
for 5 minutes. Next, the slides were briefly dried and the tissue sections on the 
slide were then surrounded with a hydrophobic barrier pen and left until the 
barrier dried. The non-specific binding between the primary antibodies and the 
tissue was blocked by incubating in 2% donkey serum, 0.01% Triton-100X in 
PBS for 45 minutes in a humid chamber. Subsequently, the primary 
antibodies diluted in 2% donkey serum, 0.01% Triton-100X in PBS were 
applied overnight at 4°C. The list of primary antibodies used for staining of 
thin sections is presented in Table 3. The slides were then washed in PBS 3 
times for 15 minutes. The sections were next incubated with secondary 
antibody and DAPI diluted in 2% donkey serum, 0.01% Triton-100X in PBS for 
2 hours at room temperature in humid chamber in the dark. The slides were 
washed in 0.01% Triton-100X in PBS once for 5 minutes, and 3 times in PBS 
for 15 minutes. The slides were then dried briefly and mounted with an anti-
fading Calbiochem mounting medium from Sigma-Aldrich. The coverslip was 
placed on the slide covered with mountant avoiding the bubble formation.  
2.1.6 Staining of thick cryostat sections 
This method was used for obtaining 3D clonal data together with visualisation 
of tissue compartments. The slides taken from the freezer were left to thaw for 
5 minutes at room temperature. The slides were washed with PBS two times 
for 5 minutes, and then 3 times for 5 minutes with 0.5% Triton-100X in PBS. 
Next, the slides were briefly dried and a circle around the tissue was drawn 
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with a barrier pen. Permeabilisation buffer composed of 0.5% Triton-100X, 4% 
DMSO, 2% donkey serum in PBS was applied onto tissue encircled by the 
barrier pen and incubated in humid chamber overnight at 4°C. Next the tissue 
sections were incubated in primary antibodies diluted in 2% donkey serum, 
1%DMSO, 0.5% Triton-100X in PBS for 3 days at 4°C. The list of primary 
antibodies used for staining of thick sections is presented in Table 3. The 
samples were subsequently thoroughly washed by rinsing 3 times in 0.2% 
Triton-100X in PBS, washing for 30 minutes in 0.2% Triton-100X in PBS and 
then for 1 hour. The sections were next incubated in secondary antibody 
(1:800) and DAPI in 0.5% Triton X-100, 1% DMSO, 2% DS in PBS for 3 days. 
Next, the samples were washed thoroughly in 0.2% Triton-100X in PBS by 
rinsing three times in 0.2% Triton-100X in PBS, washing for 15 minutes in 
0.2% Triton-100X in PBS, and washing in PBS twice for 2 hours.  
2.1.7 Mounting of immunostained thick sections 
Special method for mounting thick cryostat sections was necessary, due to 
opaque nature of pancreatic tissue. The sections were left to dry briefly. Next, 
a 200µm spacer from SunjiLab was placed on the slide to surround a tissue 
section. Subsequently, RapiClear 1.52 mountant medium from SunjiLab of 
refractive index 1.52 was applied to sections to match the tissue refractive 
index. A coverslip was then placed on the slide covered with mountant and 
spacer. 
2.1.8 Staining of whole-mount pancreata 
Whole-mount immunostaining was used to visualise clones and pancreatic 
compartments, where the tissue clearance methods were sufficient for the 
thickness of the whole organ. All staining steps were performed in wells of a 
4-well plate from NUNC for tissues from animals younger than P7, and 5ml 
tubes for older pancreata, shaking on a shaker. Whole-mount pancreata were 
permeabilised and blocked in 0.5% Triton-100X, 4% DMSO, 2% donkey 
serum in PBS overnight at 4°C. Next, the pancreata were incubated in 
primary antibodies diluted in 2% donkey serum, 1%DMSO, 0.5% Triton-100X 
in PBS for 3 days at 4°C. The list of primary antibodies used for staining of 
whole-mount samples is presented in Table 3. The samples were 
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subsequently thoroughly washed by rinsing 3 times in 0.2% Triton-100X in 
PBS, washing for 30 minutes in 0.2% Triton-100X in PBS and then for 1 hour. 
The sections were then incubated in secondary antibody (1:800) and DAPI in 
0.5% Triton X-100, 1% DMSO, 2% DS in PBS for 3 days. Next, the samples 
were washed thoroughly in 0.2% Triton-100X in PBS by rinsing three times in 
0.2% Triton-100X in PBS, washing for 15 minutes in 0.2% Triton-100X in 
PBS, and washing in PBS twice for 2 hours.  
2.1.9 Mounting of whole-mount pancreata 
Whole-mount pancreata required mounting of tissue with clearance method, 
as this would enable imaging of the sample through the whole thickness 
without significant loss of information. Whole-mount pancreata were placed on 
MatTek plates and dried briefly with Kimwipes tissue from KimTech. The 
pancreas was then incubated in RapiClear 1.52 (amount covering the tissue) 
overnight. The next day fresh RapiClear 1.52 was applied onto tissue, before 
imaging.  
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Antibody Species Company Dilution Use 
Anti-CK19 (Troma 
III) 
Rat Hybridoma 
bank 
1:270 Thick and thin sections, 
Whole-mount 
Anti-
Chromogranin A 
Rabbit 
polyclonal 
Abcam 
(ab15160) 
1:190 Thick and thin sections, 
Whole-mount 
Anti-Amylase Goat 
polyclonal 
Santa Cruz 
Biotechnology 
(sc-12821) 
1:250 Thick and thin sections, 
Whole-mount 
Anti-Nr5a2 Goat 
polyclonal 
Abcam 
(ab18293) 
1:250 Thick and thin sections, 
Whole-mount 
Anti-Sox9 Rabbit 
polyclonal 
Millipore 
(AB5535) 
1:250 Thick and thin sections, 
Whole-mount 
Anti-GFP Rabbit 
polyclonal 
Life 
Technologies 
(A11122) 
1:500 Thick and thin sections 
Anti-Insulin Guinea 
pig 
polyclonal 
Abcam 
(ab7842) 
1:200 Thick and thin sections, 
Whole-mount 
Anti-Glucagon Mouse 
monoclon
al 
Abcam 
(ab10988) 
1:200 Thick and thin sections, 
Whole-mount 
Anti-
Somatostatin 
Rabbit 
polyclonal 
DAKO 
(A0566) 
1:200 Thick and thin sections, 
Whole-mount 
Anti-Polypeptide 
P 
Goat 
polyclonal 
Abcam 
(ab77192) 
1:200 Thick and thin sections, 
Whole-mount 
Table 3. List of antibodies tested for immunostaining of thin and thick cryostat 
sections, and whole-mount samples. 
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2.1.10 EdU ClickiT reaction staining of whole-mount pancreata for EdU 
proliferation assay 
EdU incorporation into S-phase active cells had to be visualised upon 
collection of EdU injected samples. Whole-mount pancreata or thick 
cryosections were incubated in 0.5% Triton-100X, 4% DMSO, 2% donkey 
serum in PBS at 4°C overnight in wells of 4-well plates from NUNC or on 
slides in a humid chamber respectively. The next day the samples were 
incubated in ClickiT reaction cocktail as outlined and in the order of Table 4. 
for 4 hours at room temperature protected from the light.  
Component Preparation Volume per 500µl total 
Click-iT EdU reaction 
buffer (Component D) 
Prepare at 1X by diluting 
in deionised water 
440µl 
CuSO4(Component E) None 10µl 
Alexa Fluor azide 
(Component B) 
None 1.2µl 
Click-iT® EdU buffer 
additive (Component F) 
Prepared at 1X by diluting 
in deionised water 
50µl 
Table 4. EdU ClickiT reaction cocktail components.  
Subsequently the reaction cocktail was removed and samples were washed in 
2% donkey serum in PBS 3 times for 15 minutes and then the thick section or 
whole-mount staining and mounting protocol was followed. 
2.1.11 Imaging with Leica SP5 
Confocal microscopy was used for imaging thin and thick sections or whole-
mount embryonic and neonatal pancreas. The settings for different 
fluorophores imaged are presented in Table 5. 
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Fluorophore Laser Detector Wavelength detection 
range [nm] 
DAPI UV PMT1 430-471 
CFP 458nm hyD2 467-502 
GFP/ 488 Alexa Fluor 476nm hyD2 495-521 
YFP 514nm hyD2 527-559 
RFP/ 555 Alexa Fluor 561nm hyD4 572-614 
647 Alexa Fluor 633nm PMT5 645-711 
Table 5. Multichannel imaging settings on confocal Leica SP5 microscope. 
Z stack imaging and tissue tiling were performed, where necessary, in order 
to visualise whole clones.  
2.1.12 Image analysis with Volocity software 
Volocity software was used to record parameters from imaged tissue sections 
such as volumes of objects, the 3D (x,y,z) coordinates of centres of objects, 
as well as boundary points. By setting intensity thresholds manually for every 
image, to account for the variability of the intensity in clone visualisation and 
marker immunostaining, the differently coloured clusters were identified and 
the required parameters computed by the software. In addition to this, 
information about the cluster constituent cell types was collected by looking at 
co-localisation of clusters with pancreatic markers in the Z-layer mode of 
Volocity. 
2.1.13 Image processing with Imaris 8.1.2 
To obtain 3D images from Z-stacks from an image captured by the Leica SP5 
microscope, Imaris software was used. The software was also used to create 
3D objects, such as ductal reconstructions, by setting intensity threshold and 
smoothness parameters.  
2.1.14 3D reconstruction with Unwarp J in Image J software 
Unwarp J is a plugin developed for Image J that enables 3D reconstruction of 
images by matching them together by unwarping a source image so that it is 
deformed/warped to resemble a target image. The plugin was used with 
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interactive landmarks to provide guidance to the registration procedure. Thick 
section images containing multiple Z-stacks were first 3D projected into a flat 
image and then the matching point pairs were applied at the landmark regions 
of the source and target image (usually boundary of tissue or characteristic 
clones spanning multiple sections). The image warping was then performed 
by the software, using vector-spline regularization term to constrain the 
deformation to be physically realistic. The warping algorithm was saved and 
applied to all Z-stack images of the target image. All the Z-stacks of source 
and target images were subsequently merged together in Image J, and 3D 
reconstruction created in Imaris 8.1.2. 
2.1.15 Preparation of pancreatic buds for FACS sorting for single cell 
RNA-sequencing (scRNA-Seq) analysis 
In order to look at gene expressions of single pancreatic cells, I carried out 
fluorsecence activated cell sorting (FACS) followed by single cell RNA 
sequencing. Pancreatic buds were dissected from embryos at either E13.25 
or E15.25. In addition to the samples for FACS sorting and subsequent single-
cell sequencing, pancreatic buds or stomach tissue for FACS negative 
controls were collected. Single buds and control tissues were dissociated in 
200µl TrypLE-5X from Thermo Fisher Scientific in sterile Eppendorf tubes for 
20 minutes at 37°C in a heat block and re-suspended gently with a pipette 
every 5 minutes. Subsequently the dissociated pancreatic buds in TrypLE-5X 
were quenched in 250µl of 2% FCS in PBS (FACS buffer) and spun for 5 
minutes at 400rcf in a swing bucket centrifuge. The supernatant was then 
removed leaving about 20µl of liquid to avoid the aspiration of cells. Next the 
cells were washed with 250µl of FACS buffer, centrifuged at 400rcf in the 
swing bucket centrifuge and the supernatant aspirated. The samples for 
single cell sequencing, the single stained controls (Tie2-positive or CD45-
positive), the triple/ quadruple-stained controls (Tie2-positive, CD45-positive, 
DAPI positive) were incubated in 1:100 diluted 25µl FcyR (anti-mouse 
CD16/32 clone: 93) from eBioscience in FACS buffer for 10 minutes on ice. In 
the meantime 500µl of FACS buffer was added to DAPI-positive and non-
stained control tubes. Following the incubation in FcyR solution, the cells were 
incubated in single (Tie2 or CD45) or double antibody solutions (Tie2 and 
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CD45) at 1:200 in FACS buffer for 30 minutes on ice. Antibody details are 
outlined in the Table 6. Subsequently the immunostained samples with 500µl 
FACS buffer were washed and spun. Next DAPI solution was placed in tubes 
at 1:5000 dilution, where appropriate. The contents of all Eppendorf tubes 
were moved to labeled polypropylene Falcon FACS tubes and stored on ice.  
Antibody against Fluorophore Manufacturer Concentration 
Tie-2  APC Biolegend 1:200 
CD45  FITZ Biolegend 1:200 
Table 6. Antibodies used for FACS sorting of pancreatic bud cells. 
2.1.16 Single cell lysis for scRNA-Seq 
The scRNA-Seq protocol was adapted from Smartseq2 (Picelli et al. 2014). All 
experiments up to (but excluding) the cDNA amplification step were 
performed under a UV-sterilised hood with laminar flow, with all the surfaces 
free of RNase and DNA. 
Initially 96-well plates for single cell collection and lysis were prepared. One µl 
of RNase inhibitor to 19 µl of 0.2 % (vol/vol) Triton X-100 solution, and 2.3 µl 
of the solution was aliquoted per well. Single cells were then sorted into wells 
of the 96-well plate by FACs. The gates were set to sort for DAPI-, CD31-, 
Tie2- cells of embryonic pancreatic buds. The plates were sealed with an 
adhesive lid and spun down the plate at 700 g for 1 minute. The plates were 
stored at -80°C before the sequencing for up to 6 months.  
2.1.17 Reverse transcription for scRNA-Seq 
The annealing mixture was prepared as in Table 7. and 2µl of annealing mix 
per well used. The 96-well plate was then centrifuged at 700g for 1 minute. 
Subsequently the samples were incubated at 72°C for 3 minutes and 
immediately placed on ice afterwards. The plates were then centrifuged at 
700g for 1 minute.  
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Component Amount  
ERCC 20x 10µl 
Oligo-dT 100µM 10µl 
dNTP 10mM 100µl 
dH20 80µl 
TOTAL 200µl 
Table 7. Annealing mix components.  
The reverse transcription mix was then prepared as in Table 8. and 5.6µl of 
reverse transcription mix added per well. The 96-well plate was then 
centrifuged at 700g for 1 minute.  
Component Volume per well Volume per 96-well plate 
Superscript II RT (200U/ 
µl) 
0.5 µl 50 µl 
RNase inhibitor (20 U/µl) 0.25 µl 25 µl 
5X superscript II first 
strand buffer 
2 µl 200 µl 
100 mM DTT 0.5 µl 50 µl 
5 M Betaine 2 µl 200 µl 
1 M MgCl2 0.06 µl 6 µl 
TSO (100 µM) 0.1 µl 10 µl 
dH2O 0.29 µl 29 µl 
TOTAL 5.7 µl 570 µl 
Table 8. Reverse transcription mix components.  
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The 96-well plates were then placed in the PCR machine and the programme 
as in Table 9. used.  
Cycle Temperature Time Purpose 
1 42 90 min RT and template switching 
10 50 2 min Unfolding of RNA secondary structures 
10 42 2 min Completion/continuation of RT and template 
switching 
1 70 15 min Enzyme inactivation 
- 4 Hold Safe storage 
Table 9. SMART-RT PCR machine programme.  
2.1.18 PCR preamplification for scRNA-Seq 
The PCR mix was prepared as in Table 10. and 15µl added per well of a 96-
well plate. The 96-well plate was then centrifuged at 700g for 1 minute.  
Component Volume per well Volume per 96-well plate 
KAPA HiFi Hotstart 
ReadyMix (2x) 
12.5 µl 1250 µl 
IS PCR primer (10 µM) 0.25 µl 25 µl 
dH2O 2.25 µl 225 µl 
TOTAL 15 µl 1500 µl 
Table 10. PCR mix components for PCR preamplification step.  
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The PCR programme was run for the samples according for the settings 
outlined in Table 11. 
Cycles Temperature (oC) Time Purpose 
1 98 3 min Denature DNA 
21 98 
 
20 sec Denature DNA 
 67 15 sec Anneal DNA 
 72 6 min Extend DNA 
1 72 5 min Extend DNA 
- 4 hold - 
Table 11. SMART-PCR settings. 
2.1.19 PCR purification for scRNA-Seq 
Ampure XP beads were equilibrated to room temperature for 15 minutes, then 
vortexed for several seconds. 25µl of Ampure XP beads were added to each 
sample (1:1 ratio) and mixed by pipetting until the solution appeared 
homogenous. The solutions were transferred to a 96-well plate with a 
compatible magnet stand. The mixture was incubated for 8 minutes at room 
temperature to allow the DNA to bind to the beads. The 96-well plate was 
placed on the magnetic stand for 5 mins or until the solution was clear and the 
beads had been collected at one corner of the well. The liquid was then 
carefully removed without disturbing the beads. The beads were washed with 
200 µl of 80 % ethanol (vol/vol) for 30 seconds, and then the ethanol 
removed. This step was repeated and any trace of ethanol was removed and 
the beads left to dry completely at room temperature for 5 minutes. 
Subsequently, 20µl of EB from Qiagen was added and mixed 10 times to re-
suspend the beads. The plate was first incubated in EB away from the magnet 
for 2 minutes, and then for 2 minutes on the magnet or until the solution 
appeared clear and beads have accumulated in a corner of the well. Finally, 
the supernatant was collected without disturbing the beads and transfer to a 
fresh tube.  
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2.1.20 Library preparation for scRNA-Seq 
Tagmentation, which involves transposon cleaving and tagging of double-
stranded DNA with a universal overhang, was carried out using the Illumina 
Nextera XT DNA sample preparation kit. The protocol was based on the 
Tagmentation protocol from Fluidigm. First, the NT Buffer was brought to 
room temperature, and vortexed if precipitate was visible. The Tagment DNA 
Buffer was warmed to room temperature. The other reagents from the Illumina 
Nextera XT DNA sample preparation kit were thawed and mixed by gently 
inverting the tubes 3–5 times, followed by a brief spin in a microcentrifuge. 
The Pre-mix was created in a 1.5 ml PCR tube, according to the Table 12. 
3.75 µl of the pre-mix was added to each well of a library preparation 96-well 
plate, and 1.25µl of the sample from the sample plate was moved to the 
library preparation plate. The plate was then sealed and centrifuged at 2,000 
rpm for 1 minute to remove bubbles. 
Reagent Volume per 
sample (µl) 
Volume per 96 well plate 
(with 25% overage) 
Tagmentation DNA buffer 2.5 300 
Amplification Tagment Mix 1.25 150 
Sample 1.25  
Total 5.0  
Table 12. Pre-mix for library preparation.  
The library preparation plate was then placed in the thermal cycler according 
to the table 13. 
Temperature (oC) Time 
55 10 minutes 
10 Hold 
Table 13. Thermal cycler protocol.  
Subsequently 1.25µl of NT buffer per sample were placed in each well to 
neutralise the samples. The plate was then sealed and centrifuged at 2000 
rpm for 1 minute. Next, 3.75µl of Nextera PCR Master Mix (NPM) was added 
to each well of the library preparation plate. 1.25µl of Index Primer (1-12) 
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were pipetted to the corresponding well of each row of the library preparation 
plate, as presented in Table 14.  
 N701 N702 N703 N704 N705 N706 N707 N708 N709 N710 N711 N712 
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Table 14. Indexing of single cell RNA-sequencing samples.  
The plate was then sealed with adhesive film and centrifuged at 2,000 rpm for 
1 minute. Next, the plate was placed onto a thermal cycler and PCR 
amplification performed according to protocol in Table 15. 
Temperature (oC) Time Cycles 
72 3 minutes 1 
95 30 seconds 1 
95 10 seconds 12 
55 30 seconds  
72 60 seconds  
72 5 minutes 1 
10 hold - 
Table 15. PCR amplification protocol. 
The amplified products were stored at -20 oC.  
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2.1.21 Library pooling and clean-up for scRNA-Seq 
Agencourt AMPure XP beads were warmed up to room temperature and 
vortexed. Library pool was created by pipetting the appropriate volume from 
each sample and the corresponding AMPure bead volume. For 96 samples, 
1µl volume of each sample was taken to reach 96µl total volume, with 87µl 
AMPupe bead volume (90% of total pool volume). The two were mixed well by 
pipetting up and down 5 times and left to incubate at room temperature for 5 
minutes. The tube was then placed on a magnetic stand for 2 minutes, and 
the supernatant carefully removed without disturbing the beads. Next, 1ml of 
freshly prepared 80% ethanol was added and incubated for 30 seconds on 
the magnetic stand. Then the ethanol was removed. This ethanol wash step 
was repeated, and the beads were allowed to air dry on bench for 10-15 
minutes. For the elution of 96 samples, 50µl of elution buffer were used. The 
tube was then vortexed and incubated for 2 minutes at room temperature. 
Then the tube was placed on a magnetic stand for 2 minutes. The entire 
volume of supernatant was transferred to another PCR tube. Finally, the 
library size distribution was checked on an Agilent high-sensitivity DNA chip. 
The quantification of pooled library was carried out using KAPA library 
quantification kit.   
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2.2 Studying pancreatic development with ex vivo explant system 
2.2.1 Ex vivo explants in collagen culture 
2.2.1.1 Culture 
Ex vivo explant system was optimised in an attempt to use it for live imaging 
and the study of clonal development. Pancreatic buds were dissected at 
E12.5 or E13.5. Plates with fibroblasts in ex vivo culture medium were 
prepared, in order to provide the explant with growth signals, as outlined in 
Table 16. Filter membranes with a drop of collagen in the middle were placed 
floating in the medium. Dorsal pancreatic bud was inserted into the collagen 
and then the whole filter was moved down to stick to the bottom of the plate. 
The explants were left to grow for 2, 4 and 7 days with the medium being 
changed every 2 days. At each end-point the buds were removed gently from 
collagen, fixed for 45 minutes in 4% PFA at 4°C and then washed 3 times in 
PBS for 15 minutes each wash. 
Component Concentration Manufacturer 
GMEM 550 ml Life Technologies 
Penicillin/Streptomycin 100x Life Technologies 
Sodium pyruvate 100x Life Technologies 
Non-essential amino acids 100x Life Technologies 
Glutamine 100x Life Technologies 
Fetal Bovine Serum 100ml Life Technologies 
b-mercaptoethanol 100x Life Technologies 
Table 16. Ex vivo pancreatic bud culture medium. 
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2.2.1.2 Vibratome sectioning 
For visualisation of clones from ex vivo cultured pancreatic buds, thick section 
Vibratome sectioning was used. Following fixation in 4% PFA as described 
above, the tissue was immersed in liquid 3% low melting point agarose (40 ̊C) 
and left to cool down. The solid agarose with pancreatic buds was cut with a 
vibrating microtome (Leica VT100S, velocity: 0.9mm/s, amplitude: 0.65mm) 
into semi-thick sections (150µm). Sections were embedded in Vectashield 
(Vector Laboratories) on microscope slides.  
2.2.1.3 Staining of vibratome sections 
The vibratome sections were permeabilised in 0.5% Triton-100X, 2% donkey 
serum, 4%DMSO in PBS overninght at 4°C in wells of 4-well plates from 
NUNC.  
The primary antibody dilution was made up in 0.5% Triton-100X, 2% donkey 
serum, 1%DMSO in PBS. The incubation in primary antibody solution was 
carried out for 2-3 days at 4 ̊C. The samples were subsequently thoroughly 
washed by rinsing 3 times in 0.2% Triton-100X in PBS, washing for 30 
minutes in 0.2% Triton-100X in PBS and then for 1 hour. The sections were 
then incubated in secondary fluorescently-tagged antibody (1:800; secondary 
antibodies were from Life Technologies) and DAPI in 0.5% Triton-100X, 1% 
DMSO, 2% DS in PBS for 2-3 days. Next, the samples were washed 
thoroughly in 0.2% Triton-100X in PBS by rinsing three times in 0.2% Triton-
100X in PBS, washing for 15 minutes in 0.2% Triton-100X in PBS, and 
washing in PBS twice for 2 hours. The sections were finally mounted on slides 
with mountant from Calbiochem and coverslips. The summary of primary 
antibodies used is presented in the Table 17. 
Antibody against Manufacturer Antibody species Dilution 
Pdx1 Abcam (Ab47267) Rabbit polyclonal 1:200 
Insulin Abcam (ab7842) Guinea pig polyclonal 1:200 
GFP Life technologies; A11122 Rabbit polyclonal 1:500 
Table 17. Primary antibodies – summary of manufacturer and dilution used in 
immunostaining of Vibratome sections of ex vivo explants.  
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2.2.2 Ex vivo culture on fibronectin 
2.2.2.1 Culture 
Another ex vivo system was optimised to improve upon the limitations of the 
previous system. The ex vivo growth on fibronectin system is based on a 
previous publication (Petzold & Spagnoli 2012), and has been shown to be 
effective at achieving branching morphogenesis and is a suitable system for 
live imaging. Amongst the substrates tested, the authors found that fibronectin 
gave best result when it comes to observation of branching morphogenesis. 
35-mm Petri dish with 20-mm diameter glass microwell bottom from MatTek 
Corporation were used – 1 dish per 1 pancreatic explant. One day before the 
dissection and isolation of the pancreatic buds, the bottom of the wells was 
coated with fibronectin (50ug/ml in 1X-PBS) with a minimum volume of 150µl 
and left at 4°C overnight. On the day of dissection, the fibronectin was 
aspirated, the well was rinsed with PBS and 150µm of Ex vivo pancreatic bud 
medium (see Table 16.) added and placed in the incubator at 37°C.  
The dissected pancreatic bud was transferred into MatTek dish with a glass 
Pasteur pipette. To ensure spreading during culture, the mesynchyme 
surrounding the explant was slightly ripped with a fine needle. Then the 
dishes were gently placed in a tissue culture incubator (37°C, 5% CO2) for a 
few hours to enable the attachment of explants to the glass bottom. Once 
attached, the dish was filled with 1.5-2ml of the culture medium, pre-warmed 
at 37°C. The culture medium was changed every 2 days. 
2.2.2.2 Whole-mount immunostaining of pancreatic buds grown ex vivo 
on fibronectin 
Whole-mount immunostaining was carried out on pancreatic explants grown 
on fibronectin in order to preserve the spreading pattern achieved during ex 
vivo culture (see above) and to enable imaging in the MatTek plates. The 
culture medium was aspirated and the explant was washed once with PBS. 
The explants were fixed with 2ml 4% PFA on ice for 20 minutes. The plate 
was gently swirled from time to time. The 4% PFA solution was removed and 
the explant washed 3 times with 2 ml of PBS for 10 min each at room 
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temperature. Then the samples were placed in 2ml of blocking solution of 
0.1% Triton-100X, 3% donkey serum in PBS for 30 min at room temperature. 
The primary antibody was diluted in blocking solution and about 150µl of the 
solution added to the microwell to cover the whole explant, and left overnight 
at 4°C. Information about primary antibodies used is presented in Table 18. In 
order to prevent evaporation, the MatTek plates were placed in a humid 
chamber. The next day the antibody was removed, and the samples washed 
in 1X PBS, 3 times for 30 minutes. The secondary antibody was diluted in 
blocking solution, using Alexa Fluor dye secondary antibodies diluted 1:750. 
DAPI was added to the solution for nuclear staining. About 150µl of the 
dilution was added to microwells and left to incubate at RT for 2 hours in the 
dark, in a humid chamber to avoid evaporation. Finally, the samples were 
washed 3 times with 2ml of 0.1% Tween-20 in PBS for 30 minutes each at 
room temperature and then once in PBS to remove Tween-20. The samples 
were mounted in Calbiochem mountant.  
Antibody against Manufacturer Antibody species Dilution 
Insulin Abcam (ab7842) Guinea pig polyclonal 1:200 
GFP Life technologies (A11122) Rabbit polyclonal 1:500 
CK19 Abcam (ab52625) Rabbit monoclonal 1:200 
Glucagon Abcam (ab10988) Mouse monoclonal 1:200 
Amylase  Santa Cruz Biotechnology 
(sc-12821) 
Goat polyclonal 1:200 
Table 18. Primary antibodies – summary of manufacturer and dilution used in 
immunostaining of pancreatic explants grown according to Petzold & Spagnoli 
2012. 
2.2.3 Tamoxifen treatment ex vivo 
For ex vivo Tamoxifen induction of ex vivo culture system of Rosa26-
CreERT2; Rosa26-Confetti pancreatic buds 10nM OH-Tamoxifen was 
provided in the medium for 18 hours and then replaced with OH-Tamoxifen-
free medium. 
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2.3 Statistical methods 
2.3.1 Statistical analysis of clonality of lineage tracing induction 
The assessment of clonality of induction of R26-CreT2; R26-Confetti system 
was necessary in order to assure the correct assessment of potency of tissue. 
First, spatial x,y and z coordinates of individual clones, as well as their relative 
volume in terms of acinar, ductal and islet compartments (for the E9.5 to P14, 
E12.5 to P14 and E12.5 to P28 tracings) were manually assessed. This 
information was collected for all tracings considered. 
Statistical analysis of clonality of data was performed in collaboration with Dr 
Edouard Hannezo from the University of Cambridge. It involved computing the 
probabilities of distances between clones of the same and different colour and 
comparing their distributions. An assumption was set that all clones were 
independently induced, meaning that the probability of finding clones of the 
same colour should be independent of distance, i.e. P(r) constant, which we 
set as our null-hypothesis.  
Next, a non-parametric bootstrapping method was used to build confidence 
intervals on the prediction from the null hypothesis. We thus calculated for 
each individual pancreas the probability for a clone to have one of the four 
confetti colours, and randomly re-assign colours of clones according to this 
average property. This procedure was performed 1000 times, and calculated 
in each case the rescaled probability P(r). Finally, we calculated a 95% 
confidence interval at each distance r from this resampled probability 
distribution, in order to assess how much experimental deviations of P(r) from 
a constant value can be due to random statistical variations. We plotted in Fig 
16 these confidence intervals for each individual mouse induced at E12.5 and 
traced until P14, together with the experimental measurements of P(r). 
Exponential probabilities, although showing statistical variations, were 
consistently included within the 95% confidence interval from the null-
hypothesis. Where statistically significant excess of clones of the same colour 
at short distances was observed (mouse 1, Fig. 16), this was then corrected 
statistically for this bias by grouping all clones of the same colour within a 
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given radius, in order to return to the probability value expected from clonal 
induction.  
The details of clonality tests and demonstration of potency outcomes are 
presented in Chapter 3.4.3.  
Finally, for the E15.5 to P14 and E18.5 to P14 induction lineage tracings, only 
the potency was assessed, via the same methods as described in Chapter 
3.4.3. In order to ensure clonality, given that the density of labelled clones 
was higher, I only used the rare colours in the quantifications. 
2.3.2 Comparison of distributions 
Cumulative distributions of rescaled clone and ductal subtree sizes were used 
in this thesis to present and compare clonal and ductal subtree size variability. 
Cumulative distribution presents a function of variable X being smaller or 
equal to a certain value. 
Mann-Whitney statistical test was used to assess the match of any two 
distributions. Mann-Whitney test is based on a null hypothesis, which 
assumes that all the observations of both groups are independent of each 
other, or in other words it is equally likely that a randomly selected value from 
one sample will be less than or greater than a randomly selected value from a 
second sample. Two distributions are independent if P<0.05. The comparison 
of clone and subtree size distributions, as well as distributions of potency 
outcome between amylase-control and initial potency experiment resulted in 
P>0.5, indicative of a close match of distributions under study. 
Quantile-quantile plots were also computed to compare the various 
distributions. In order to provide an additional goodness of fit metric, we 
computed the coefficient of determination R2 of the quantile-quantile plots to 
the predicted curves of f(x)=x if the distributions were perfectly identical. We 
found R2=0.87 for the E18 subtree distribution versus the P14 acinar 
distribution, R2=0.83 for the E18 subtree distribution versus the P14 ductal 
distribution and R2=0.99 for the P14 acinar distribution versus the P14 ductal 
distribution. Moreover, we found R2=0.89 (respectively R2=0.93) when 
comparing the P14 acinar (respectively ductal) distribution versus the 
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theoretical subtree size distribution (derived for mammary gland branching 
morphogenesis; Chapters 4.6 and 4.7). These are indicative of close 
correspondence between the shape of these various distributions. 
2.3.3 Model of branching morphogenesis 
Computational modelling was carried out to infer the dynamics of growth of 
pancreatic compartments. The model of stochastic bifurcation and termination 
of ductal branches was developed in collaboration with Dr Edouard Hannezo 
from the University of Cambridge, making use of a model previously shown to 
predict the network heterogeneity of the mouse mammary gland epithelium 
(Scheele et al. 2017). The model is based on a paradigm, whereby equipotent 
“active” terminal end-buds choose stochastically between ductal bifurcation 
and termination (inactivation), where cells irreversibly stop contributing to 
branching morphogenesis. 
In the case of purely ductal end-driven morphogenesis, the history of 
branching decisions can be “read off” from the topology of the ductal tree 
network. By averaging across branches of the same generation, n, defined as 
the number of branch points separating a given branch from the primordial 
central ducts from which branching morphogenesis proceeds, estimates can 
be made of the evolving bifurcation/termination probabilities. The generation 
number can be uniquely defined as both mammary and pancreatic ductal 
trees are simple graphs, i.e. we do not observe any loops or reconnections 
between two independent subtrees starting from the main trunk. 
Moreover, in common with the mammary gland, the reconstruction and 
modelling of pancreatic ductal trees is simplified by the fact that 
morphogenesis proceeds in a largely two-dimensional setting (See Chapter 
4.8), with subtrees not growing below or above one another, and ductal cross-
overs occurring rarely. This offers a simple heuristic explanation for how 
environmental signals can provide a feedback mechanism to arrest ductal 
bifurcation, viz. ductal termination. A generic feature of this type of dynamics 
is that the probabilities of ductal branching versus termination converge 
towards balance (as steric constraints require each branching event to be 
compensated, on average, by a ductal termination event; Scheele et al. 2017)  
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Thus, when averaging ductal branching versus termination decisions at a 
given generation, n, the problem reduces to a Galton-Watson process in a 
spatially varying environment. An active ductal terminus An, at generation n, 
can either divide symmetrically to give rise to two active offspring termini An -> 
2An+1, with probability 1-q(n), or stop contributing to ductal morphogenesis 
(i.e. terminate), An -> ∅, with probability q(n). In the case of mammary gland 
pubertal morphogenesis, the probability q(n) quickly converged, within a few 
generations, towards balance with q(n)=½, indicative of near compensation 
between ductal branching and termination. This results in subtree size 
distributions, expressed in terms of the number of total branches in a given 
subtree, which are characteristically broad with an exponential tail, fitting 
quantitatively with the experimental data. This means that most subtrees 
stochastically stop contributing to branching morphogenesis, while an ever-
diminishing surviving population ends up giving rise to nearly all of the 
peripheral regions. Interestingly, as discussed in the main text, this is very 
much the phenomenology that we see in the branching pattern of whole-
mount pancreas (Fig. 27). Accordingly, we find a broad subtree size 
distribution which matches well with both the distribution of clone sizes (acinar 
and ductal) and its mammary gland counterpart. This argues for a common 
mechanism of branching morphogenesis resulting, at least in part, from ductal 
bifurcation and termination.  
Thus, we made use of the measured branching probabilities q(n) obtained for 
the mouse mammary gland to obtain a prediction of the total subtree size 
(which is defined as ∑n An ) distribution, through a numerical integration of the 
associated Galton-Watson “birth-death” process. We also simulated in Figure 
33 typical outputs of such tree topologies, using the Galton-Watson model 
described above for q=1/2, independent of n. 
Again, as described previously (Scheele et al. 2017), we assume that ducts 
consist of N equipotent multipotent precursors, which are randomly allocated 
to one the two offspring ducts upon bifurcation, such that each new duct 
received N/2 self-renewing precursors. One should note that relaxing this 
equal repartition assumption does not give rise to qualitatively different 
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behaviour to the one we describe here. Each cell then divides to replenish the 
pool, to give rise again to N precursors per tip. Interestingly, even in the 
absence of any active competition between cells, this is expected to drive 
monoclonal conversion of lineage-labelled ducts. This is because, upon 
bifurcation, a clone will be randomly segregated, and thus enriched in one of 
the tips, and depleted in another. In the limit of randomly allocated cells, i.e. 
cell mixing, which is relevant here (as we do not see cohesive streams of 
clones before monoclonal conversion), monoclonal conversion is expected to 
occur slowly, as clone sizes increase linearly with the number of tip 
bifurcations undergone.  
Therefore, for N=30 precursors per tip, one never observes monoclonal 
conversion over the time-scales relevant for pancreatic morphogenesis (Fig. 
33). This is in stark contrast to the experimental data, which is characterized 
by very rapid monoclonal conversion of ducts (Fig. 33), on the scale of just a 
few generations. Therefore, this heavily constrains the number of tip 
precursors that are located in each individual ductal terminus. Simulations of 
as few as N=4 precursors per ductal terminus yield a reasonable speed of 
monoclonal conversion.  
One should note that cell competition during ductal bifurcation would speed 
up the process, but not yield qualitatively different results, as average clones 
sizes would still increase only linearly with generation number. Interestingly, 
such a behaviour of monoclonal conversion of entire ductal subtrees of the 
pancreas, seen both from ductal-containing clones and acinar-containing 
clones validates a posteriori such a ductal end-splitting mechanism of 
morphogenesis.  
2.3.4 Single cell sequencing methods 
Pooled libraries were sequenced using the Illumina HiSeq 4000 system 
(single-end 50 bp reads). Reads were aligned using G-SNAP (Wu & Nacu 
2010) and the mapped reads were assigned to Ensembl genes (release 81) 
(Flicek et al. 2014) by HTSeq (Anders et al. 2015). Raw data has been 
uploaded to National Center for Biotechnology Information GEO (accession 
number GSE89798). 
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The single cell sequencing analysis was carried out in collaboration with Dr 
Steffen Rulands from the University of Cambridge. To identify poor quality 
cells, three metrics were used: (1) the proportion of aligned reads, (2) the 
number of endogenous reads and (3) the number of features with more than 1 
read. We filtered for cells with (1) more than 20% aligned reads, (2) more than 
200,000 endogenous reads and (3) more than 5000 detected features. We 
only considered genes that were detected in at least 2 cells, with a variance 
greater than 0.001. 
Out of the 672 cells that were captured in the experiment, 516 (77%) were 
used for downstream analysis. Reads were normalized using the 
deconvolution method as implemented in the scran package (A & K 2016).  
We then performed dimensionality reduction using PCA, resulting in two 
distinct groups of cells. Using the epithelial marker Epcam we identified one of 
these clusters as pancreatic cells (303 cells). Focusing on the pancreatic cells 
alone, we performed t-SNE (Krijthe 2015) followed by k-means clustering from 
R’s statistics package on the 500 most variable genes and identified the 
cellular identity of cells in the three clusters using known markers for acinar, 
ductal and islet cells. 
To identify co-varying genes, we computed Spearman’s 𝜌 for a list of genes 
which, according to literature, are associated with pancreatic development, 
and used 2− 𝜌 as a dissimilarity index for hierarchical clustering.  
Using the destiny package (Angerer et al. 2016), we employed a diffusion 
map (parameters: sigma=95, k=302) and used the DPT function to arrange 
cells in pseudo time. Three distinct branches were identified and, based on 
the expression of proliferation markers (such as Mki67) and various 
specification and differentiation markers (such as Cpa1 or Neurog3), we 
identified the branch containing sample “SLX-11256.N701_S506” as the one 
“earliest” in its developmental stage and used this cell as a starting point to 
calculate the diffusion pseudo time. 
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2.4 Statistical reporting 
In Fig. 8, representative images were selected based on analysis of n=4 mice 
for each 2, 4 and 7 days of ex vivo culture. In Fig. 9, representative images 
were selected based on analysis of n=4 mice for E13.5 and E14.5 collection 
timepoint.  
In Fig. 10, representative images were selected based on analysis of sections 
from n=4 mice for E18.5 collection timepoint and n=3 mice for the P14 
collection timepoint. In Fig. 11, representative images were selected based on 
analysis of sections from n=3, 3, 2 and 2 mice for E9.5, E12.5, E15.5 and 
E18.5 induction timepoint, respectively. In Fig. 13, representative images 
were selected based on analysis of sections from n=3 mice.  
In Fig. 15, 16, 17, 20, 21, 24, 25, 27, 28, 29 and 30, 254 clones induced at 
E12.5 and traced until P14 were scored from n=3 mice. Error bars represent 
mean and SD or SEM (outlined in Figure legends). In Fig. 16, 18, 20, 22, 32 
representative images were selected based on analysis of 254 clones induced 
at E12.5 and traced until P14 were scored from n=3 mice. 
In Fig. 16, 17, 20, 41, 25, 27, clones induced at E9.5 and traced until P14 
were scored from n=2 mice. 
In Fig. 17, and 25, 84 clones induced at E12.5 and traced until P28 were 
scored from n=2 mice. Error bars represent mean and SD. 
In Fig. 19, EdU+ cells were analysed for n=3 (E13.5) n=2(E15.5) and n=9 
mice (18.5).  
In Fig. 23 and 24, 26 clones induced at E12.5 and traced until P14 were 
scored from n=2 mice for the amylase immunostaining control.  
In Fig. 26, 27, subtree sizes were measured for n=3 mice and n=43 
independent subtrees. Error bars represent mean and SD. 
In Fig. 28, pancreas mass was measured for n=3 mice (E18), n=5 mice (P7), 
n=11 mice (P14) and n=4 mice (P28). Error bars represent mean and SEM. In 
Fig. 28, pancreas length, width and height were measured for n=3 mice 
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(E13.5), n=3 mice (P14) and n=3 mice (P28). Error bars represent mean and 
SEM. In Fig. 28, the percentage of DBA+ cells was calculated from sections 
from n=5 pancreata.  
In Fig. 33, 78 clones induced at E15.5 and traced until P14 were scored from 
n=2 mice. In Fig. 33, 70 clones induced at E18.5 and traced until P14 were 
scored from n=2 mice. 
For Fig. 36, 37, 38, 39, 40, and Table 21 and 22, 516 single cells were 
isolated from n=7 mice for the single-cell RNA sequencing (n=5 for E13.25 
and n=2 for E15.25). 
In Fig. 41-44, 26 islet clones from n=2 mice were quantified for E9.5 induction, 
and 68 islet clones from n=3 mice for E12.5 induction. 
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Chapter 3 
Results: Clonal analysis 
3.1 Introduction 
This chapter is the first of the four Results chapters. In this chapter, I present 
outcomes of the optimisation of lineage tracing to study the development of 
pancreas, together with the assessment of the levels of induction in R26-
CreT2; R26-Confetti mice, and general characterisation of clone types 
observed with lineage tracing of E12.5-induced cells.  
The chapter aims at answering the following research questions: - What is the best system and conditions to study pancreatic 
development with R26-CreT2; R26-Confetti lineage tracing? - How do I ensure that clonal levels of induction are achieved? - What is the potency of pancreas in primary and secondary transitions? - Is there variability between clone sizes and is it related to potency? 
 
The chapter starts by presenting the principles behind confetti lineage tracing, 
and the optimisation of the method. This is followed by an outline of the 
quantification of clone and tissue landmarks, and explanation of the 
conducted clonality assessment, essential for ensuring the accuracy of 
potency analysis. I then discuss the potency of tissue at the onset of primary 
and secondary transition. 
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3.2 Optimisation of the system for studying cell fate decisions in 
development with Confetti reporter system 
3.2.1 Confetti reporter line 
Genetic lineage tracing has been used to study the effects of some genes on 
pancreatic development. These have helped the understanding of lineage 
relationship in the pancreas. However all the studies to date have been 
performed at high density of labelling (Zhou et al. 2007; Solar et al. 2009; 
Kopinke et al. 2011; Schaffer et al. 2010; Kopp et al. 2011; Pan et al. 2013). 
Clonal density of induction, i.e. clones arising from a single cell, are required 
for accurate analysis of lineage potencies.  
In order to achieve statistically defined clonal density level of induction, 
Confetti reporter mice (R-26-Confetti) were used in this thesis. R26-Confetti is 
a multicolour Cre-reporter that was first used for lineage tracing by Snippert et 
al. in their study of intestinal homeostasis (Snippert et al. 2010). They 
integrated the construct consisting of a strong CAGG promoter, a LoxP-
flanked NeoR - which serves as a transcriptional roadblock, and the Brainbow-
2.1 cassette (Livet el al., 2007), into Rosa26 locus. After Cre-recombination 
the roadblock is removed and the Brainbow 2.1 cassette is recombined to 
produce one of the 4 fluorescent proteins in random (see Fig. 7).  
With the aid of multicolour reporter – confetti – driven by a ubiquitous 
promoter R26 (R26-RCreT2; R26-Confetti), random, non-lineage specific cells 
in the pancreas can be labelled at different frequency (in a Tamoxifen 
concentration-dependent manner) and at different developmental stages. The 
labelling of cells in different colours enables the statistical assessment of 
clusters of the same colour as to whether they belong to one or several clones 
(see later), based on the comparison of probabilities of finding clones of the 
same colour versus different colour at a certain distance. Furthermore, the 
use of such a multicolour system enables the discrimination between the 
clonal progeny of neighbouring progenitor cells within the same niche. 
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In this project, I aimed to study the potency of cells in primary and secondary 
transition of pancreatic development and examine the dynamics of pancreatic 
ductal, acinar and islet compartments in the secondary transition.  
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Figure 7. The basis of the stochastic multicolour Cre-Reporter R26-Confetti 
cassette reporter (Livet et al. 2007) and fluorescent protein expression 
(nuclear GFP – nGFP, cytoplasmic YFP – cYFP, cRFP, and membrane CFP 
– mCFP). Brainbow2.1 encoding 4 fluorescent proteins was inserted into 
Rosa26 locus. Upstream of the cassette, a strong CAGG promoter, a loxP 
site, and a neomycin resistance roadblock were placed. Upon Cre-activation, 
the neomycin roadblock is removed while the brainbow2.1 cassette 
recombines stochastically to generate one of the four fluorescent protein 
sequences. GFP is nuclear, CFP is membrane-bound, while the remaining 2 
are cytoplasmic.  
  
Results: Clonal analysis 
 
 
84 
3.2.2 Cre induction ex vivo and in vivo 
I aimed at optimising the protocol for the induction of cells in R26-RCreT2; 
R26-Confetti embryonic pancreas, in order to study the potency of cells and 
morphogenic processes during development. Hence, I prioritised the 
optimisation of ex vivo and in vivo methods described below, in order to obtain 
clonal levels of R26-Confetti-reporter induction, as well as to achieve systems 
recapitulating normal development and tissue morphogenesis. 
Ex vivo  
Initially, I aimed at using an ex vivo pancreatic development system to induce 
and live-trace the induced cells, in order to take record of cell proliferation and 
migration in real time. Furthermore, this method would enable the avoidance 
of complications related to in vivo injection of pregnant females. Specifically, 
embryo abortion and inability to reach full term of pregnant females have been 
reported, as Tamoxifen interacts with oestrogen receptor (Grese et al. 1997). 
Therefore, I set out to test the range of concentrations of OH-Tamoxifen to 
achieve clonal level of induction. 
R26-Confetti mice were mated with R26-CreERT2 mice. Pancreatic buds 
were dissected from embryos at E13.5, as I planned to exploit this system to 
look at the events of secondary transition. In the first ex vivo protocol tested, 
the explants were embedded in a drop of collagen that was placed on a filter 
membrane. The membrane, in turn, was floating in a medium for ex vivo 
culture (see methods) similar to the liquid-air phase method previously 
described (Duville et al. 2007). Collagen was used to replicate the stimuli that 
the buds may receive from ECM during development in vivo. 
Different concentrations of OH-Tamoxifen were tested and the 10nM OH-
Tamoxifen was eventually applied for 18 hours as an optimal concentration for 
the induction of cells. The explants were maintained in the medium for 2, 4, 
and 7 days, subsequently fixed and sectioned with Vibratome and co-stained 
against insulin. The result of Tamoxifen induction and co-staining against the 
endocrine marker is presented in Figure 8. 
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Figure 8. Confetti pancreatic bud growth ex vivo in collagen, on filter 
membranes, in pancreatic bud medium. Recombination was induced with 
10nM OH-Tamoxifen for 18 hours and the buds were fixed after 2, 4 and 7 
days of ex vivo growth. Cyan, green, yellow, and red are confetti colours. 
Insulin is grey. Periphery of the tissue is marked with navy blue dashed line 
based on tissue autofluorescence visualised in Imaris software. 
Representative images were selected based on analysis of n=4 embryos from 
3 litters for each 2,4, and 7 days of ex vivo culture.   
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Figure 8 reveals that at subsequent ex vivo chase timepoints, the number of 
confetti+ cells decreases, suggesting that the cells are dying in this ex vivo 
growth system. Furthermore, the cells seem to be induced preferentially at the 
periphery of the bud, which suggests that Tamoxifen in unable to penetrate 
into deeper layers of the tissue due to collagen encapsulating the pancreatic 
bud. Finally, the ex vivo grown pancreatic bud displays a round, restricted 
shape as compared to that of the in vivo developing pancreata, which could 
be due to collagen limiting the growth of the bud by exerting pressure. 
Altogether, it appears that the ex vivo growth of pancreatic buds in collagen 
has significant disadvantages, such as an impaired growth and survival of 
cells. I therefore decided to undertake an alternative protocol for the culture of 
embryonic pancreatic explants. The new method involves growing the buds 
on laminin-coated MatTek plates in a pancreatic growth medium according to 
a protocol developed previously (Petzold and Spagnoli 2012). This system 
has been suggested to reliably recapitulate the branching morphogenesis 
process with the evidence for development of the major pancreatic lineages 
(Petzold and Spagnoli 2012). This system is also optimal for live imaging, as 
MatTek plates contain imaging coverslip at the bottom of the dish. 
I therefore first aimed to characterise the development and growth of 
pancreatic buds using this system. Pancreatic buds were dissected at E13.5 
(for studying secondary transition phase of pancreatic development), and the 
same concentration (10nM) and duration of OH-Tamoxifen treatment (18 
hours) as in the previous method was applied. I found that, in contrast to the 
collagen embedding method, the development of pancreatic explant was not 
space-constrained. 
However, I encountered an antibody immunostaining problem when staining 
the explants against various pancreatic compartments (data not shown). 
Finding optimal conditions for immunostaining, which would enable long 
enough exposure to antibodies for good penetration without detaching the 
explants from the surface of the culture MatTek plate turned out to be 
unfeasible. In the future, the optimisation of staining and clearance protocols 
should resolve this problem.  
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In vivo 
The two ex vivo protocols were optimised and tested in order to potentially 
apply them for live imaging analysis. Ex vivo OH-Tamoxifen system has the 
advantage of avoiding the adverse effects of Tamoxifen injection into 
pregnant females. However, ex vivo pancreatic development did not 
recapitulate the in vivo development to a satisfying degree. I therefore turned 
to in vivo system optimisation. I sought to determine if feasible concentrations 
of Tamoxifen could be used for injection of pregnant females without adverse 
effects related to pregnancy. I also aimed at using the samples obtained from 
in vivo tracing for assessment of the two ex vivo methods described above, as 
they would serve as a reference point. Furthermore, were this experimental 
set-up successful, then I would be able to look at the potency of cells and 
morphogenic events of primary transition in addition to secondary transition 
events. Studying the primary transition phase would be impossible with an ex 
vivo approach, as technically, I would be unable to dissect pancreata at 
embryonic stages below E12.0 due to its small size. 
I first optimised the dose for Tamoxifen injection of pregnant females at E12.5, 
as studying the cell fate and morphogenesis of secondary transition was our 
primary focus. Additionally, studying the structure and clonal morphology of in 
vivo obtained pancreata would enable the comparison with and validation of 
the two ex vivo systems outlined above. 
The optimised dose of Tamoxifen for injection at E12.5, which provided clonal 
density labelling in embryonic pancreas, amounted to 0.025ug/g weight of 
pregnant mouse. Embryos were collected at different developmental stages – 
E13.5, E14.5 to assess whether suitable induction frequencies were obtained; 
and E18.5, P14, P28 to obtain information about the morphological changes 
within the tissue and clonal structure. The samples were then fixed in 4% PFA 
and imaged whole-mount (E13.5, E14.5 and E18.5) or in thick sections (P14) 
with confocal Leica SP5 microscope (representative images shown in Fig. 9, 
10). Optimisation of sectioning and immunostaining methods is outlined in the  
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next section. None of the embryos were aborted, and the pancreata were of 
normal size and macroscopic phenotype. 
The observation of clones traced between E12.5-E13.5 and E12.5-E14.5 
revealed that the clonal levels of induction were achieved, as sparse clones 
consisting mainly of single cells were detected (Fig. 9). The fluorescent 
proteins were induced evenly throughout the pancreatic bud, showing an 
advantage over the ex vivo in collagen protocol, whereby labelled cells were 
located at the peripheral parts of the pancreas. Furthermore, the construct 
was non-leaky, i.e. no confetti fluorescent proteins were detected in the 
negative control samples without Tamoxifen injection (Fig. 9). Lastly, there 
was an increase in the number of fluorescent proteins between E13.5 and 
E14.5, suggesting that recombination is not complete by E13.5, consistent 
with a previous report suggesting that Cre recombination can take between 12 
and 36 hours (Danielian et al. 1998). 
The clones collected at the end of secondary transition, at E18.5, and at P14, 
show cohesive morphological structures spanning over 100 µm or more (Fig. 
10). The structure of clones is more complex as compared to the clones 
obtained with ex vivo system (Fig. 8, 10). This suggests that the ex vivo 
system might not recapitulate pancreatic development in vivo. The apparent 
significant advantage of the in vivo method is that all divisions, migration 
events and other processes occur in embryos in utero and therefore cannot 
be a consequence of artificial conditions.  
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Figure 9. Confetti pancreatic bud induction with 0.025ug/g mouse Tamoxifen 
injection in R26-CreT2; R26-Confetti mice. The injection was performed on 
E12.5 and the samples were collected at (a, a’) E13.5 and (b, b’) E14.5 to 
verify that the clonal levels of induction were achieved. For each timepoint 2 
independent pancreata are presented (c) Non-injected samples showed no 
confetti-colours, revealing that the construct is non-leaky. Confetti colours are 
cyan, green, yellow, and red. Boundaries of tissue based on autofluorescence 
are in blue. Representative images were selected based on analysis of n=4 
embryos from 2 litters for E13.5 and E14.5 collection timepoint.  
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Finally, given the successful experiment of E12.5 induction of pancreata in 
utero, I decided to optimise the injection protocol for the lineage tracing of 
cells at other developmental timepoints. I was interested in E9.5 induction to 
study the events and potency of cells in primary transition phase. Additionally, 
I looked at E15.5 and E18.5 timepoints of induction in order to study 
branching morphogenesis and potency of cells at later stages of the 
secondary transition. The optimised doses for all Tamoxifen injection 
timepoints, together with representative images of samples induced at those 
timepoints and collected at P14 are presented in Figure 11.  
From the representative images of samples induced at different 
developmental timepoints and collected at P14, it is clear that clonal levels of 
induction were obtained with E9.5 and E12.5 Tamoxifen injections. For E15.5 
and E18.5, the induction levels were higher than for the other timepoints, 
despite testing a series of lowering doses aimed at achieving the clonal levels 
of induction. However, I have observed that not all confetti fluorescent 
proteins are expressed to an equal extent (see Section 3.3.3 for more details), 
with some of the labels, such as green and cyan being almost five times less 
abundant than the common red and yellow labels (see Section 3.3.3). I 
therefore decided to focus on the green and cyan clones when further 
analysing the E15.5 and E18.5 induction timepoints.  
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Figure 10. Clones from E12.5 induction lineage tracing with collection 
timepoints at (a-c) E18.5 and (d-f) P14. The clones were very cohesive, with a 
significant amount of variation between clone sizes, ranging from just a few 
cells as the RFP clone in (d) to large clones (a-f). DBA marks ducts in white 
for (a-f). Chromogranin A marks ducts in white for (d-f). Nuclei are stained 
with DAPI in blue (d-f). Representative images were selected based on 
analysis of sections from n=4 mice from 3 litters for E18.5 and n=3 mice from 
3 litters for the P14 collection timepoint.  
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Figure 11. P14 samples induced at various timepoints. Dosage of Tamoxifen 
injection written in the top left corner for (a) E9.5, (b) 12.5, (c) E15.5, and (d) 
E18.5. Induction was clonal for (a) E9.5 and (b) E12.5 timepoints of injection.  
Higher levels of induction were obtained for E15.5 and E18.5 injection 
timepoints, and therefore only rare confetti colours – green and cyan – were 
used for the analysis of clones. Representative images were obtained based 
on analysis of sections from n=3, 3, 2 and 2 mice (3, 3, 2 and 2 litters) for 
E9.5, E12.5, E15.5 and E18.5 induction timepoint, respectively.   
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3.2.3 Summary of ex vivo and in vivo optimisation 
In summary, the three methods described above reveal distinct advantages 
and disadvantages, and can therefore be used for distinct purposes. The 
advantage of the two ex vivo approaches is that cellular dynamics can be 
traced in real time. The first ex vivo in collagen growth system, however, turns 
out unsuitable, because the OH-Tamoxifen is able to induce the cells only at 
the periphery and the cells start to die after four days of culture. The second 
ex vivo method of culturing cells on MatTek plates adapted from Petzold and 
Spagnoli, 2012 appears more feasible in terms of the morphology of the 
explants. Differentiation into all three major pancreatic lineages has been 
reported previously (Petzold and Spagnoli, 2012). This method would require 
further verification of how well the pancreatic development is recapitulated in 
this system. Furthermore, this method would require immunostaining 
optimisation in order to achieve sufficient penetration of the antibody without 
detachment of the explants.  
Hence, in summary, the ex vivo explant system on MatTek plates (Petzold 
and Spagnoli, 2012) would enable the study of secondary transition events 
and potency upon further confirmation of the model. However, the system 
would not be applicable for use of studying the primary transition processes, 
due to my inability to dissect embryos earlier than E12.0. 
Finally, the in vivo induction by Tamoxifen injection of pregnant females is 
ideal for pulse and chase experiments, but live lineage tracing is not possible 
in embryos. However, this method provides information about cellular events 
in normal physiological development. From the initial snapshot of samples 
traced from E12.5 to P14 and E9.5 to P14, it is clear that clones were 
cohesive and their evolution could be easily inferred, based on relatively 
limited migration of cells and small distances between individual clusters (see 
schematic in Fig. 12). Therefore, despite the infeasibility of live lineage tracing 
in vivo, this system appears to be an optimal choice for the study of 
pancreatic development at various developmental stages.  
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Figure 12. Evolution of clones during development. The clones were 
cohesive, with distances between fragments being usually smaller than 30µm, 
occasionally reaching 50µm. This enables the study of the evolution of clones 
over time, i.e. their migration and proliferation of constituent cells. mCFP label 
in the schematic depicts a clone, which has migrated over distance in the 
direction of tissue growth, leaving the trace of smaller clusters behind, and 
larger clusters at the leading edge due to more time for proliferation.  
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3.2.4 Optimisation of 3D clonal data acquisition 
In this study, I aimed to look at dynamics of different pancreatic compartments 
during secondary transition and maturation, as well as the potency of cells 
both in the primary and secondary transition. For that purpose, acquiring 3-
dimensional (3D) clonal information was necessary, as migration of cells in 
development is significant. Hence, a protocol of sectioning and 
immunostaining required optimisation (see Methods).  
Previous studies of development and potency of pancreas have involved the 
analysis of serial thin sections (Zhou et al. 2007; Solar et al. 2009; Kopp et al. 
2011; Kopinke et al. 2011; Pan et al. 2013). I therefore attempted to use this 
method to analyse our samples. However, even though the potency of 
confetti+ clusters could be easily determined, the assignment of clusters into 
clones turned out to be problematic, as typically clones spanned multiple 
sections. Furthermore, with the use of thin sections it would be nearly 
impossible to infer the 3D shape and morphology of clones. Hence, I 
attempted to carry out 3D reconstruction of serial sections. Multiple softwares 
were tried, and eventually Image J with a plugin, UnwarpJ, was used (see 
Methods, Section 2.1.14). However, the process of reconstruction from 
multiple 7µm sections was very time consuming. Therefore, I attempted to 
optimise other sectioning methods, which were not previously commonly used 
in the lineage tracing studies of pancreatic development. 
Consequently, I next attempted to obtain thick vibratome sections, 200-300µm 
(as in Fig. 8, see methods). This method proved very useful for small 
pancreatic buds and collagen ex vivo explants. However, for neonatal and 
adult tissue this method turned out to be unfeasible, as the sections tended to 
separate into smaller parts due to lobular structure of pancreas at these 
stages. This would prevent the accurate acquisition of whole 3D clonal 
structures. Similarly, I tested the tissue chopper from Leica, and a similar 
issue of section disintegration was encountered. 
I then tested the use of whole-mount tissue for immunostaining (see 
Methods). This method was very useful for embryonic pancreas as it could 
depict whole clones and their position with respect to the tissue outline. 
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However, the method proved to be unsuccessful for immunostaining of whole-
mount neonatal pancreas, as the antibody penetrance was problematic.   
Therefore, the methods tested, such as vibratome sections and whole-mount 
used for immunostaining, turned out to be very suitable for the analysis of 
embryonic tissue, but were inadequate for neonatal pancreas. Hence, as a 
solution for obtaining 3D clonal reconstructions in neonatal samples, I set out 
to test thick cryostat sectioning of 100µm, followed by subsequent 
immunostaining. This method proved to be effective, as the thick sections 
adhered well to slides maintaining the lobular structure of pancreas in the 
correct arrangement. Immunostaining optimisation was successful.  
Altogether, all the methods were very useful and can be applied to serve 
different purposes (See Table 19). For my project, I decided to use whole-
mount immunostaining for the analysis of embryonic pancreata, and thick 
cryosection immunostaining for neonatal tissue analysis. 
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Sectioning method Advantages Disadvantages 
Thin frozen sections Good antibody 
penetrance, used in 
previous studies (Zhou et 
al. 2007; Solar et al. 2009; 
Kopp et al. 2011; Kopinke 
et al. 2011; Pan et al. 
2013) 
Difficult to infer constituent 
cell types in the whole 
clone and to infer 
morphological features 
Vibratome sections (200-
300µm) 
Good for embryonic 
pancreata 
Structure not preserved in 
neonatal and adult 
pancreata, as lobules 
disintegrate 
Tissue chopper from 
Leica 
Good for embryonic 
pancreata 
Structure not preserved in 
neonatal and adult 
pancreata, as lobules 
disintegrate 
Whole-mount Good for embryonic 
pancreata, as whole 
clones and their position 
with respect to tissue 
outline preserved 
Not suitable for neonatal 
and adult pancreas due to 
antibody penetrance and 
imaging issues 
Thick cryostat sections 
(up to 100µm) 
Good for both embryonic, 
neonatal and adult 
pancreata. Enables the 
preservation of lobular 
structure of neonatal and 
adult tissue. 
Whole embryo clonal data 
cannot be obtained 
directly 
Table 19. Advantages and disadvantages of the tested sectioning methods. 
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3.2.5 Optimisation of immunostaining 
Since I was interested in studying the potency of clones and their contribution 
to the dynamics of different pancreatic compartments, a set of markers 
needed to be used simultaneously, such as the islet marker (anti-
Chromogranin A antibody), ductal marker (dolichos biflorus agglutinin, DBA), 
and acinar marker (anti-amylase antibody). However, I was limited by the 
number fluorophores that could be used without bleedthrough between the 
imaging channels with the use of Leica SP5 confocal microscope. Five 
imaging channels on the confocal microscope were already used by imaging 
of the confetti cassette and nuclear stain DAPI, so only one channel for 
staining of the tissue for pancreatic compartments was left. It is important to 
emphasise the importance of the use of a multicolour confetti reporter for 
verifying the clonality of induction, i.e. verifying with statistical confidence that 
an assigned clone is not a merge of multiple clones. This is not possible with 
single colour reporter mice, unless extremely low induction levels paralleled 
by an unfeasible number of embryos are used.  
Therefore, I looked for markers which could be assigned to the one remaining 
imaging channel. Fortunately, since the islets and ducts displayed distinct 
morphologies (see Figure 13), so I was able to stain ducts and islets in one 
channel after careful optimisation of the Chromogranin A antibody and DBA 
concentrations, which would enable simultaneous detection of their intensities 
of staining for the two compartments.  
The amylase antibody could not be used in parallel, as then nearly the whole 
volume of pancreas would be stained in one channel and the distinct 
compartments could not be identified. However, in a set of control stainings, I 
verified that nearly all non-ductal and non-islet parts of the dissected 
pancreata were acinar (see Figure 13), and I decided to use this as an 
approximation of cell type, given the large number of clones I was planning to 
quantify (over 200 clones, see Section 3.3.2). 
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Figure 13. Verification of staining markers. (a) Combination of two markers 
for islet Chromogranin A (green) and ductal DBA (white) shows that the two 
compartments display clear morphological differences and therefore can be 
stained in one channel for potency analysis of confetti+ cells. Since hallmark 
morphological differences distinguish ductal and islet compartments, in the 
clonal lineage study, these features can be imaged using the same channel. 
This allows us to reserve other channels for DAPI staining and to discriminate 
all of the fluorescent reporters used in the confetti tracing. (b) Combination of 
all three markers with islet Chromogranin A (green), ductal DBA (white) and 
acinar amylase (pink) shows that all the markers are exclusive and the 
majority of DBA- Chromogranin A- tissue is amylase+. (c) Combination of two 
markers for islet Chromogranin A (white) and acinar amylase (green) shows 
complete exclusion of two markers. Representative images were selected 
based on analysis of sections from n=3 mice.  
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3.3 Clonal analysis: E9.5 and E12.5 induction 
3.3.1 Collection timepoints 
In the first part of the analysis, I wanted to focus on samples induced at the 
onset of primary and secondary transition, i.e. E9.5 and E12.5 respectively. 
This would enable the comparison of potencies and morphological behaviours 
between the two phases. Therefore, the experimental protocol involved an 
intraperitoneal injection of pregnant females at E9.5 or E12.5 of their 
pregnancy. The samples were collected at E18.5 (before birth), P14 and P28 
(Fig. 14). This would allow enough time for the structure of clones to develop, 
in order for us to be able to conclude morphological patterns in the developing 
tissue, as well as acquire an accurate estimate of potency of clones, as the 
mature markers of pancreas development would be expressed by these 
stages.  
 
 
Figure 14. Outline of experiment for R26-RCreT2; R26-Confetti lineage 
tracing. Injections were carried out at either E9.5 or E12.5 and collection 
timepoints were at E18.5 embryos and P14 and P28 neonates. 
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3.3.2 Quantification of clonal data 
In order to gain a better understanding of clone size distributions, the position 
of clones with respect to tissue landmarks, as well as their potency, I aimed at 
assessing clonal features by quantifying a comprehensive set of parameters. 
These are outlined in the Table 20, and include clone volume, coordinates of 
the centre of clusters within clones, constituent cell types, and others. The 
potencies of clones were subsequently inferred – tripotent clones contained 
all three major cell lineages (acinar, ductal, and islet), bipotent clones 
contained any two of the three lineages, while unipotent clones contained only 
one lineage. These were quantified for 244 clones from 3 mice for E12.5 to 
P14 tracing, 50 clones from 2 mice for E9.5 to P14 tracing, and 84 clones 
from 2 mice for E12.5 to P28 tracing. These were later used for the 
downstream quantitative analysis.  
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Parameter Explanation 
Clone ID Each clone is given a unique number to group all clusters 
belonging to one clone together. 
Clone volume Clone volume is used as a measure of clone size, as it is 
proportional to cell number. 
Clone surface area Clone surface area together with clone volume provides a 
measure of clone complexity. 
Centroid X, Y, Z Coordinates of the centre of a confetti cluster. Helps 
determine whether multiple confetti clusters arise from one or 
several clones. 
Bounds X, Y, Z The dimensions of a smallest possible cuboid to include a 
given cluster, provides an indication of the complexity of clone 
structure. 
Shape Factor Between 0 and 1. The greater the value, the more round the 
cluster is.  
Longest Axis Gives information about the extent of migration of a given 
clone/cluster. 
Cluster shape 
comments 
Descriptive category, used to provide any additional 
information. 
Cell composition Used broadly to describe the constituent cell types and hence 
infer the potency of clones. These include acinar only, acinar 
majority, ductal only, ductal majority, islet only, islet majority, 
tripotent clones, mixed (with equal contribution of 2 
compartments). 
Total number of 
islets 
Total number of islets in a given section studied. 
Number of 
confetti-labelled 
islets 
Number of islets containing a confetti+ cell(s) in a given 
section. 
Labelled islet ID All labelled islets are assigned a unique number so that the 
appearance of several confetti colours (indicative of 
polyclonality) can be reported.  
Labelled islet 
volume 
This enables the assessment of islet clone size in proportion 
to the size of islet compartment it occupies. As a 
consequence, the relative contribution of a given clone to islet 
growth can be assessed.   
Islet Centroid X,Y, 
Z 
Helps determine the processes of possible islet fission, where 
multiple islets are labelled in the same colour.  
Surface Area Together with the volume, provides a measure of shape of the 
islet. 
Any other 
comments about 
the clone 
behaviour 
Provides any other information about clonal morphology and 
composition, which may be important for analysis.  
Table 20. Parameters quantified in the analysis of lineage tracing data with 
E9.5 and E12.5 induction.  
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3.3.3 Analysis of clonality of data 
I aimed to study the potency of cells during pancreas development, and 
therefore I set out to analyse individual clones, ensuring all clones were 
derived from single cells rather than the merging of multiple cells. In 
developmental contexts, where proliferation and migration are vast, it is 
particularly important to ensure that the induction levels of reporter construct 
are clonal, i.e. all clones derive from a single cell. 
There has been a large number of lineage tracing studies performed in the 
past, suggesting abundant tripotency until E14.5 or later. In particular, lineage 
tracing studies based on Cpa1 expression in tip cells and Hnf1β expression in 
trunk cells suggest that both domains retain tripotent precursors until at least 
E13.5 (Solar et al. 2009; Zhou et al. 2007). Indeed, tracing studies of Sox9 
expressing cells suggest that tripotent cells may persist even after birth (Kopp 
et al. 2011; Furuyama et al. 2011). However, these studies were based on 
non-clonal induction levels, meaning that the apparent tripotency could result 
from the merging of several populations of lineage-restricted cells. Hence, I 
sought to readdress the question of potency with the methodological 
advancement of using clonal-level lineage tracing, and therefore I prioritised 
ensuring the clonality of our lineage-traced samples. 
Initially, the clusters of labelled cells and their progeny were identified as 
belonging to one clone based on threshold distances separating the clusters. 
Two clusters would be categorised as a single clone unless the distance 
between them was exceeding the threshold (Fig. 15a). 
I then wanted to verify this heuristic clonal assignation to confirm that the 
clonal grouping was correct. In order to assess this, I turned to statistical 
analysis. This was carried out in collaboration with Dr Edouard Hannezo from 
the University of Cambridge. We challenged the clonality of our manual 
reconstructions in several ways.  
We first took advantage of the fact that we label cells in four different colours 
(CFP, RFP, GFP and YFP) and computed the probability of finding two clones 
of the same colour at a certain distance for all clonal pairs in a given pancreas 
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analysed given the distribution of distances between clones of different 
colours. We reasoned that, if we had under-estimated clonal fragmentation in 
our heuristic reconstructions, i.e. clusters coming from separate clones were 
grouped as one clone, then there should be an excess of clones of the same 
colour at small distances in heuristic grouping as compared to the calculated 
probability. In the converse case, there should be an insufficiency of clones of 
the same colour at small distances. In an ideal clonal assay, all clones should 
have been independently induced, so that the probability of finding clones of 
the same colour should be independent of distance, i.e. P(r) constant.  
In order to statistically assess such clonality, we needed to statistically 
determine what the null-hypothesis would give, i.e. “our assay is clonal”. In 
order to rescale the probability of finding two clones of the same colour at a 
given distance, and in order not to be influenced by the complex shape and 
convolution of the pancreas, we computed the probability of finding two clones 
of any colour at a given distance and used this to rescale the probability of 
finding two clones of the same colour. In the clonality hypothesis, clones are 
independent, so the resulting rescaled probability should be independent of 
distance. Next, we used a non-parametric bootstrapping method to build 
confidence intervals on the prediction from the null-hypothesis. We thus 
calculated for each individual pancreas the probability for a clone to have one 
of the four confetti colours, and randomly re-assigned colours of clones 
according to this average property. We performed this procedure 1000 times, 
and calculated in each case the rescaled probability P(r). Finally, we 
calculated a 95% confidence interval at each distance r from this resampled 
probability distribution, in order to assess how much experimental deviations 
of P(r) from a constant value can be due to random statistical variations. We 
plotted these confidence intervals for each individual mouse induced at E12.5 
and traced until P14 in Figure 15b, together with the experimental 
measurements of P(r). Interestingly, we found that the experimental 
probabilities, although showing statistical variations, were consistently 
included within the 95% confidence interval from the null-hypothesis. 
However, in some mice (such as mouse 1) we observed a statistically 
significant excess of clones of the same colour at short distances. We thus 
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corrected statistically for this bias by grouping all clones of the same colour 
within a given radius, in order to obtain the probability value expected from 
clonal induction (values shown by black dashed lines in Figure 15b).  
To further test the clonality of the data, we performed two independent 
controls. First, we noticed that one of the mice was stochastically induced at a 
dose twice as low as its two other counterparts (Fig. 15c). We therefore 
segregated the potency data (see Section 3.4 for details) for each individual 
mouse in order to check whether the labelling dose influenced our results. For 
instance, one could have assumed that tripotency observed in the data 
resulted from unwanted merger of independent clones. However, 
interestingly, we found that the potency outcome was faithfully reproduced for 
each individual mouse (Fig 15d), lending additional credence to our results.  
Second, we also noticed that the four confetti colours were represented in 
very different proportions (Fig. 15e), we grouped all three mice for this 
statistical assay). In particular, there were more than 5 times as many RFP 
clones than CFP clones, with GFP and YFP clones sitting at an intermediate 
probability. We therefore segregated the potency data for each individual 
colour, and found both that the degree of unipotency was independent of the 
colour examined (Fig. 15f), and that in general, the ratio of unipotency, 
bipotency and tripotency were consistent in all colours examined (Fig. 15f). 
This again strongly argues in favour of the clonality of the data, given that 
CFP cells consisted of less than 0.3% of all pancreatic cells, making the 
merger events very unlikely.  
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Figure 15. Clonality assessment. (a) Schematic indicating methods of clonal 
assignment based on cohesiveness and distances between constituent 
labelled cell clusters (see Section 3.4.3, Statistical Methods in Section 2.3). 
(b) Rescaled probability (purple thick line) of finding another clone of the same 
colour as a function of rescaled distance from a given clone, for all three R26-
Confetti mice induced at E12.5 and traced until P14 (left, centre and right 
panels). For each mouse, the clone-clone distance was rescaled by the 
average distance in three-dimensions between two clones randomly chosen 
across sections of a given pancreas. The probability of finding a clone of the 
same colour at a given distance was rescaled by the probability of finding two 
clones of any colour at the same distance. The shaded lines represent the 
95% confidence interval of rescaled probability under the assumption that the 
data was clonal. The dashed black line shows the distance used for fragment 
grouping to define a clone. (c) Fraction of fluorescently labelled cells at E12.5 
in the P14 pancreas of different mice. (d) Global potency of P14 clones 
induced at E12.5, segregated for each individual mouse, showing that the 
potency of each is consistent with the ensemble average (see Fig. 17a), and 
independent of the frequency of induction shown in (c). (e) Colour balance of 
confetti clones induced at E12.5 and traced until P14, grouping all three 
pancreases. Cyan is the least represented colour while Red is the most 
represented. (f) Global potency of P14 clones induced at E12.5, segregated 
for each individual confetti colour. 254 clones from 3 mice from 3 litters were 
scored. Figure generated in collaboration with Dr. Edouard Hannezo, using 
data that I collected. 
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3.4 Clonal lineage tracing with E9.5 and E12.5 induction provides 
evidence for early and progressive lineage restriction 
Pancreatic samples were thick cryostat sectioned and immunostained for the 
compartment markers such as ductal DBA and islet Chromogranin A. The 
clones, which were at the intersection of several thick sections were then 
serially reconstructed, in order to obtain correct clonal parameters, such as 
clone volume, cellular composition and location with respect to tissue 
landmarks (see Section 3.3.2).  
The analysis of E9.5 and E12.5 lineage traced samples revealed that clones 
remained remarkably cohesive in both ductal and acinar compartments. This 
was revealed in the E18, P14 and P28 collected timepoints, as individual 
clusters belonging to a clone were not separated by large distances (usually 
less than 200 µm)  (Fig. 16 a-h). However, the E9.5-traced clones were 
slightly more spread out than the E12.5-traced clones. This indicates that, 
despite large-scale cell rearrangements, the dispersion of proximate cells 
during the development, particularly during secondary transition, is limited.  
Clones were observed over a wide range of sizes, with some containing 
thousands of cells spanning large areas of tissue, while others contained only 
a few cells (Fig. 16 d,e). I therefore quantified the size of all clones and could 
see that the distribution was indeed very broad (Fig. 16i). This raises the 
question of what is the underlying tissue growth principle, giving rise to such a 
wide variation in proliferation capacity of cells. I hypothesised that the large 
variability in clone sizes could result from the variable potency of clones. 
I therefore turned to the analysis of potency. In order to assess this, I 
quantified 248 clones from 3 mice for E12.5 to P14 tracing, and 50 clones 
from 2 mice for E9 to P14 tracing. Each clone was labelled specifically with 
respect to its potency (as well as the other parameters, as in Chapter 3.3.2) 
based on the mature pancreas markers expressed. Hence, based on cell 
composition, I identified uni-, bi- and tripotent clones with only one, two or 
three acinar compartments present within a clone respectively. Amongst the 
Results: Clonal analysis 
 
 
112 
clones, I identified different permutations across all three lineages (Fig. 17a-
d).  
Strikingly, examining the composition of clones traced from E12.5 to P14 and 
P28, I found that the majority were unipotent (Fig. 17a,c-d). This implies that 
the lineage potential of most precursors has already become restricted by 
E12.5, contrasting with previous findings (Zhou et al. 2007; Solar et al. 2009; 
Kopp et al. 2011; Furuyama et al. 2011). Indeed, these results suggest that 
reports of extensive tripotency as late as E12.5-E14.5 may be an artefact of 
high density labelling, tracing the evolution of lineages instead of individual 
cells.  
I was then interested in comparing these results with the potency of cells at 
the beginning of primary transition, E9.5, as according to literature the 
precursors at this stage should be entirely tripotent (Shih et al. 2013). 
Examination of the clonal composition from E9.5 to P14 tracing (Fig. 17a,b) 
performed under the same conditions revealed that the majority of clones 
remain bi- or tripotent (64%), as expected from the lack of tip-trunk 
segregation at this early stage (Pan and Wright 2011). Yet, even at this 
timepoint, around 25% of induced cells generated unipotent clones, indicating 
that lineage restriction begins unexpectedly early in development.  
Hence, altogether the potency outcome was very surprising and revealed that 
very early and rapid lineage restriction is taking place during pancreas 
development, with most of cell specification being complete by the end of 
primary transition. From secondary transition onwards only rare tripotent 
progenitors are present in the tissue. 
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Figure 16. Quantitative lineage tracing reveals evidence of early lineage 
commitment of heterogeneous pancreatic precursors. (a) Thick 100µm 
section of P14 pancreas induced at E9.5. (b) Zoom on tripotent clone from (a) 
containing islet, acinar and ductal components (indicated by arrowhead, 
asterisk and arrow, respectively) with zoom on single Z-sections 
demonstrating the contribution of clones to different pancreatic compartments. 
(c) Thick 100µm section of P14 pancreas induced at E12.5 reveals 
heterogeneous clonal outcomes of various potencies. (d) Acinar majority 
clone from (c) (acinar compartment indicated with asterisk) surrounding a 
network of ducts with rare labelled ductal cells (indicated by arrow) and shown 
in zoom on single Z-section. (e) Small clone from (c) containing a few cells (f). 
Representative unipotent acinar-only clone from (c) surrounding unlabelled 
ducts (indicated by arrow). The lack of overlap between clone and ducts is 
indicated in single Z-section images on the right (g) Ductal-only clone from (c), 
containing monoclonal ducts (indicated by arrow) and ductal overlap show on 
single Z-sections on the right. (h) bipotent clone from (c) in red (cRFP) (islet 
and ductal compartments indicated by arrowhead and arrow, respectively) (i) 
Complete size distribution for all clones induced from E12.5 to P14.Bars 
indicate mean and S.D. Nuclei are stained with DAPI (blue), islets 
immunostained using Chromogranin A antibody (white) and ducts stained with 
DBA (white). I counted 41 clones from n=2 mice (2 litters) for the E9.5 to P14 
tracing, 254 clones from n=3 mice (3 litters) for the E12.5 to P14 tracing.   
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Observing such wide distribution of clone sizes and all potencies of clones 
(uni-, bi-, and tripotent) with both induction timepoints, I wondered whether 
heterogeneity of progenitor potency could explain the wide variability of clone 
sizes, with multipotent progenitors giving rise to large clones and unipotent 
progenitors generating small clones. As outlined in the previous section 3.3.2, 
both potency and clone sizes were recorded simultaneously; hence the 
correlation between the two parameters could be examined. Although 
multipotent clones were, on average, slightly larger than unipotent clones, 
each category still contained clones spanning three orders of magnitude in 
size (Fig. 17e) suggesting that the observed heterogeneity does not derive 
from the labelling of progenitors with different specification potentials. 
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Figure 17. Rapid cell fate restriction in the developing pancreas. (a) Global 
potency of clones induced at E9.5 and E12.5, indicating a shift towards 
unipotency. (b-d) Table of all clone types traced from (b) E9.5 to P14, (c) 
E12.5 to P14, and (d) E12.5 to P28. (e) Complete size distribution for all 
clones induced from E12.5 to P14 segregating unipotent and multipotent 
clones. Mean and SD presented. I counted 41 clones from n=2 mice (2 litters) 
for the E9.5 to P14 tracing, 254 clones from n=3 mice (3 litters) for the E12.5 
to P14 tracing, 84 clones from n=2 mice (2 litters) for the E12 to P28 tracing.  
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3.5 Discussion 
In this chapter, I applied the technique of multicolour-reporter lineage tracing 
from a ubiquitous R26 promoter, in order to study the potency of pancreatic 
cells in primary and secondary transition, ensuring clonal density of induction. 
This was a novel approach in studying pancreas development, as previous 
studies have mainly focused on tracing of specific lineages of cells, and were 
based on non-clonal induction levels (Zhou et al. 2007; Solar et al. 2009; 
Kopp et al. 2011; Kopinke et al. 2011; Pan et al. 2013). 
In this chapter, I first aimed to optimise conditions for studying pancreas 
development, to ensure that lineage tracing data recapitulate physiological 
development.  
Next, I aimed to optimise the methods for obtaining 3D clonal data arising 
during pancreatic development. This is a major advancement compared to 
previous studies whereby thin sections were analysed (Zhou et al. 2007; Solar 
et al. 2009; Kopp et al. 2011; Kopinke et al. 2011; Pan et al. 2013). In 
developmental contexts, the migration of cells may be vast and therefore 
correct assignment of clones is essential for the potency outcome. 
Furthermore, I also optimised the dose of Tamoxifen for in vivo injections to 
ensure clonal levels of induction of the confetti construct, followed by 
statistical analysis to carefully assess the clonality. My R26-CreT2; R26-
Confetti lineage tracing enabled us to discover early and rapid lineage 
restriction, taking place already in the primary transition. This is in contrast to 
previous literature (Kopp et al. 2011; Furuyama et al. 2011, Zhou et al. 2007, 
Solar et al. 2009). The difference may be due to the fact that in the previous 
studies the apparent tripotency could arise from the merging of independent 
lineage restricted precursors. Furthermore, the mentioned studies did not 
attempt to look at individual clones, but rather quantified the total percentage 
of islet, ductal and acinar lineage labelling within thin sections, which were not 
serially re-constructed.  
In comparison, I observed that at E9.5 the tissue showed much higher extent 
of tripotency. However, already at this early stage, a quarter of cells were 
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unipotent. This further emphasises that lineage restriction may be taking place 
much earlier than previously reported, when cells are thought to be 
morphologically and functionally identical (reviewed in Benitez et al. 2012; 
Shih et al. 2013; Pan & Wright 2011). One previous study confirms my finding, 
whereby the expression of genes associated with specific lineage maturation 
were shown to be upregulated in certain cells already at this stage (Chiang 
and Melton 2003).  
Altogether, the results summarised above have answered the questions and 
aims set out at the beginning of the chapter regarding the optimisation of 
conditions for the study of pancreatic development with R26-CreT2; R26-
Confetti lineage tracing, ensuring the clonal levels of induction of the tracing 
data, gaining the understanding of the variability of clone sizes and its nature, 
as well as assessing the potency of pancreas in primary and secondary 
transition. In summary, this chapter reveals a rapid lineage restriction taking 
place already in primary transition of pancreatic development.  
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Chapter 4 
Results: Branching morphogenesis 
4.1 Introduction 
This chapter follows after the first chapter of findings based on the genetic 
lineage tracing with R26-CreT2; R26-Confetti combined with statistical 
analysis, showing early lineage restriction starting already in primary transition 
of development.  
In this chapter I present analysis of morphology and other clonal parameters 
from R26-CreT2; R26-Confetti lineage tracing, combined with the analysis of 
tissue macroscopic parameters and tissue kinetics. This is all combined with 
computational modelling of the quantified data, undertaken in collaboration 
with Dr Edouard Hannezo and Prof. Benjamin Simons.  
This chapter aims at answering our main research questions: - How is pancreas morphogenesis coordinated with lineage 
specification? - What drives the growth of the pancreatic tissue? - How does the pancreas reach its final structure and internal 
composition? 
 
The chapter starts by studying the morphology of clones and focusing on their 
dynamics to infer developmental patterns. I then propose ductal branching 
morphogenesis as a process responsible for the coordinated growth of the 
mentioned lineages. Next, I present a set of controls showing the validity of 
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the potency and morphological findings, including an additional lineage tracing 
study from the Sox9 promoter and an immunostaining experiment. Next, I 
present the macroscopic parameters of developing pancreas to infer 
dynamics of pancreatic growth. Finally, I focus on determining the underlying 
mechanism driving the process of branching morphogenesis, identified as the 
process driving parallel development of all pancreatic lineages. 
Altogether, the findings of this chapter enable us to present a model 
explaining the morphogenesis of pancreas with a novel explanation of the 
coordination of organ growth with the simultaneous development of acinar, 
ductal and islet lineages.   
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4.2 Pancreas growth is tip driven based on E12.5 induction lineage 
tracing and EdU proliferation assay 
The findings of the previous chapter showed rapid cell fate restriction within 
developing pancreas, combined with a very wide proliferative heterogeneity, 
evident from the clone size distribution, and independent of the potency of 
individual clones. Therefore, to understand the source of clone size 
heterogeneity and to gain an insight into dynamics and large-scale patterning 
of tissue during the secondary transition, I decided to examine the location 
and spatial organization of clones. 
Pancreas morphogenesis has been a subject of several studies (Zhou et al. 
2007; Pan et al. 2013; Bankaitis et al. 2015; Shih et al. 2016), however the 3D 
cellular mechanism coordinating pancreas growth and simultaneous 
development of acinar, ductal and islet lineages are not well understood. 
As outlined in the introduction, the role of central plexus in driving the 
pancreas growth is not clear, and has been a subject of discussion (Bankaitis 
et al. 2015; Pan and Wright 2011). I therefore first considered whether the 
specification of pancreas relies on an early phase of expansion that precedes 
plexus remodelling, or whether the bulk of expansion takes place through a 
later phase of ductal branching, once the plexus is formed. I reasoned that if 
clonal expansion occurs mainly before plexus remodelling, clones would 
become fragmented and dispersed across adjacent ductal subtrees. However, 
if, on the other hand, ductal expansion is derived from the activity of 
precursors localized to side-branches of the plexus, clones induced at E12.5 
would track segments of individual ductal subtrees (see Fig. 18a for 
schematic).  
Notably, I found that the vast majority of ducts that contained labelled cells 
(ca. 80%) were characterized by a high degree of monoclonality (Fig. 18b), 
meaning that stretches of ducts over subsequent branching (bifurcation) 
points were uniformly labelled with confetti+ cells.  Furthermore, these clonally 
labelled ducts were restricted to the same subtree, generally extending to the 
periphery of the ductal network (Fig. 18b). This suggests that the growth of 
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ductal lineage could be tip-driven, and occurring after ductal plexus has been 
formed. 
Remarkably, I also found that the majority (ca. 90%) of acinar cell-containing 
clones, including unipotent (acinar-only) clones, were closely associated with 
single ductal subtrees across multiple generations of consecutive branching 
events (Fig. 18c), indicating a tight correlation between branching 
morphogenesis and the expansion of the acinar compartment, as well as a 
similar mechanism guiding the development and expansion of the two 
lineages. I was determined to find the mechanism, which guides the parallel 
dynamics of the two lineages. 
Altogether, the fact that the two types of clones follow the ductal branches 
over multiple generations suggests that, during the secondary transition, 
pancreas development follows a coordinated process of ductal-end driven 
branching morphogenesis rather than plexus remodelling, guided by 
precursors at the termini of ducts that self-renew through serial rounds of 
branching and give rise to cells that form the trailing ducts and the acinar cells 
that associate with the ends of terminated ducts.  
Furthermore, from rare and stochastic local high-level induction sections, I 
could occasionally observe ductal branching (Fig. 18b) and branch-associated 
acinar clones (Fig. 18c) occurring within one subtreee (Fig. 18d), lending 
further support to this hypothesis. This is however a qualitative observation, 
and it needs to be shown in a quantitative manner whether real correlation 
between the dynamics of ductal and acinar compartment exists (see Section 
4.6).   
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Figure 18. Morphology and potency of clones reveal evidence for ductal end-
driven branching morphogenesis. (a) Schematic depicting the different types 
of clones that would be expected to arise as a result of pancreatic growth 
being driven either by plexus remodelling or ductal end-driven 
morphogenesis. (b) Ductal branching clone monoclonally labelling the distal 
parts of ducts (arrow) with zoomed in single Z section on the right showing the 
overlap of DBA with cYFP. (c) Ductal terminus-associated acinar clone with 
acinar cells (asterisk) closely surrounding ducts stained with DBA (white), with 
zoomed in single Z section on the right showing very small overlap of DBA 
with cYFP (arrow). (d) Rare local high induction levels that were recorded 
occasionally show ductal branching clone as in (b), and ductal terminus-
associated acinar clone as in (c) occupying the same branch, suggesting a 
common mechanism driving the morphogenesis of the two lineages. 
Representative clones based on analysis of 254 clones from n-3 mice (3 
litters) are shown.   
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Since both the ductal branching clones and ductal terminus-associated acinar 
clones were nearly monoclonally labelling the ductal and acinar compartment 
respectively at the peripheral region of pancreas, I hypothesised that the 
growth of the organ could be tip-driven, i.e. the acinar and ductal cells at the 
periphery proliferate and push the outwards expansion of the growing 
pancreatic bud. In order to verify the hypothesis I turned to EdU proliferation 
assay, which labels cells with an active S phase of the cell cycle. I 
hypothesised that if the mode of pancreas growth is tip driven, then I should 
detect enrichment of EdU+ cells in the peripheral regions of the pancreas. 
Hence, with the short-term EdU incorporation (2h chase) experiment and 
whole-mount imaging at E13.5, E15.5 and E18.5, I studied the kinetics of 
growth in development of pancreas (Fig. 19a). 
I first looked at the general proliferation within whole pancreatic buds. The 
EdU+ cells were distributed densely around the entire pancreatic volume by 
bulk observation. This could suggest that the cells were proliferating evenly 
throughout the pancreas, without any enhancement of proliferation at the 
peripheral/tip regions (Fig. 19b-f), contradicting the tip-driven growth 
hypothesis, suggested in Fig. 18. 
However, since I observed ductal branching clones and branch-associated 
acinar clones located at peripheral tissue areas (Fig. 18), I hypothesised that 
pancreatic growth could be ductal-end driven. I therefore sought to look at the 
proliferation of ducts specifically, expecting higher extent of proliferative 
heterogeneity, with Edu+ cells being enriched at the ductal-ends. 
Furthermore, given the fact that the acinar compartment takes up about 90% 
of the adult mouse pancreas (Benitez et al. 2012), it is not surprising that the 
acinar cells show a generally high proliferation without a clear heterogeneity.  
Results: Branching morphogenesis 
 
 
126 
  
Results: Branching morphogenesis 
 
 
127 
 
Results: Branching morphogenesis 
 
 
128 
Figure 19. Examining proliferative heterogeneity in the developing pancreas. 
(a) Schedule of EdU incorporation experiments. (b-g) Short term (2h) EdU-
incorporation shows proliferative activity of ductal and acinar cells. Top 
panels: whole-mount pancreatic ducts (stained for DBA, white) and EdU 
(green); bottom panels: ductal surface reconstruction (blue) with ductal EdU+ 
cells marked in red. At E13.5 (b,c), proliferation is evenly distributed 
throughout the ducts (n=3 mice, 3 litters) whereas, at E15.5 (d,e), proliferation 
occurs predominantly at the periphery of the pancreas in the tip regions of 
ducts (n=2 mice, 2 litters). At E18.5 (f,g), proliferation patterns become 
heterogeneous with some regions displaying ductal end-enrichment (n=4 
mice, 3 litters, arrowheads, left), while others proliferate more homogeneously 
(n=5 mice, arrows, right). 
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Therefore, I decided to focus on the proliferation in the ducts, and perform a 
threshold based 3D outline of ductal structures using Imaris software and the 
visualisation protocol of all EdU+ cells within the ducts converted into regular 
spheres for data presentation purposes (Fig. 19c,e,g, see Methods Chapter 
2.1.13), in order to analyse ductal and Edu+ colocalisation. Consequently, 
focusing on the proliferation within the ducts, I found a uniform pattern of 
proliferation at E13.5 (Fig. 19b,c). It is likely that by this stage the tissue is still 
morphologically and proliferatively homogenous, as the separation of tip-trunk 
domains has just started to take place. However, at E15.5, ductal proliferation 
(and, to a lesser degree, acinar proliferation) was greater in peripheral regions 
of ductal subtrees, with a particular enrichment of activity at the ends of ducts 
(Fig. 19d,e, arrowheads), consistent with ductal-end driven growth. Short-term 
EdU incorporation at E18.5 showed a more heterogeneous pattern, with some 
parts of the pancreas characterized by enhanced proliferation at ductal termini 
(Fig. 19f,g, arrowheads), while other regions displayed more uniform 
proliferation throughout the ductal network (Fig. 19f,g, arrows). Together, 
these results are consistent with the early stages of branching morphogenesis 
being fuelled by self-renewing precursors positioned at ductal termini, while, 
at later stages, growth is dominated by local expansion of ducts, as well as 
acini and islets.  
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4.3 Precursors at ductal-ends are a mixture of committed and 
multipotent precursors based on E12.5 induction lineage tracing 
Given the hypothesis of ductal-end driven growth, I was interested in finding 
out the cellular composition of the proliferative ductal-ends. I therefore 
considered several alternative possibilities of clone types arising as a 
consequence of different progenitor cell types at ductal ends. Hence, 
concentrating on the E12.5 induction, I reasoned that if branching 
morphogenesis is driven by multipotent progenitors, clones tracking whole 
subtrees should contain a mixture of acinar, ductal, as well as islet cells (Fig. 
20a). If, on the other hand, branching morphogenesis is driven by fate-
restricted progenitors, clones tracking whole subtrees should be of either 
purely acinar or ductal type (Fig. 20b,c). I therefore wanted to verify these 
three options with the clonal data.  
I looked at the potency and morphology of clones induced at E12.5. First, I 
carried out analysis of the potency of clones grouped with respect to 
pancreatic compartment contained within a clone, i.e. the distribution of 
potencies of acinar, ductal and islet compartment containing clones. I found 
that some 70% of acinar-containing clones induced at E12.5 were unipotent 
(representative clone in Fig. 20d), lending support to the second hypothesis of 
fate-restricted progenitors driving branching morphogenesis. For comparison, 
at E9.5, when the pancreatic anlage emerges, the percentage of unipotency 
was much lower and amounted to ~60% (Fig. 20d). The fact that these 
unipotent acinar clones induced at E12.5 often spanned multiple rounds of 
consecutive branching of the same ductal subtree suggests that acinar cells 
arise from acinar-committed precursors that localize at the terminus of 
growing ducts and undergo renewal during ductal bifurcation (Fig. 18c, 16d).  
By contrast, the vast majority of ductal cell-containing clones traced from 
E12.5 were found to be multipotent (Fig. 20e). These included tripotent clones 
(Fig. 20f), bipotent ductal-acinar clones with typically sparsely labelled ductal 
cells (representative image in Fig. 18c), as well as bipotent ductal-islet clones 
(representative image in Fig 20g). The tripotent and ductal-islet bipotent 
clones commonly contained islet precursors delaminating from the trailing 
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ducts left behind the proliferative ductal-ends. The multipotency extent within 
the ductal compartment was even higher for E9.5 induction (Fig. 20e).  
Altogether these findings suggest that growing ductal termini carry both rare 
multipotent progenitors and fate-restricted acinar and ductal progenitors, 
which act cooperatively to drive pancreatic growth. This is in contrast to the 
previous literature suggesting multipotent tip domain driving pancreas 
morphogenesis (Zhou et al. 2007) 
  
Results: Branching morphogenesis 
 
 
132 
 
Figure 20. Ductal ends are composed of a mixture of rare tripotent and 
commited acinar and ductal precursors. (a-c) Schematics demonstrating the 
distinct clone morphologies arising from the labeling of differents type of 
ductal-end precursors with (a) depicting a tripotent clone, (b) a unipotent 
ductal clone, and (c) a unipotent acinar clone. Potency of (d) acinar cell- and 
(e) ductal cell-containing clones induced at E9.5 and E12.5. I counted 41 
clones from n=2 mice (2 litters) for the E9.5 to P14 tracing, 254 clones from 
n=3 mice (3 litters) for the E12.5 to P14 tracing. Ductal cells remain bi- and 
tripotent, whereas acinar precursor clones become increasingly lineage-
committed. Ductal-terminus associated tripotent (f) and bipotent (g) clone. 
Islet, ductal and acinar compartments indicated by arrowhead, arrow and 
asterisk, respectively.  
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I previously found no relationship between the potency of clones and the 
clone size when analysing all clones (see Section 3.4, Fig.17e). However, I 
was interested if there was any relationship between the potency and clone 
size within the individual compartments, and whether fate-restriction of 
pancreatic precursors was accompanied by a decreased propensity to 
undergo self-renewal. Strikingly, I found that the difference between the 
average size of unipotent acinar clones and that of bi-/tripotent clones 
containing acinar cells was not statistically significant (Fig. 21a). The same 
feature was observed for clones containing ductal cells (Fig. 21b), showing 
that ductal and acinar unipotent precursors retained full growth potential even 
after fate-restriction has taken place. These results indicate that the majority 
of self-renewing acinar-committed precursors are specified early in 
development (during the tip-trunk segregation) and are replenished by the 
multipotent ductal precursors only rarely during the later stages of 
development.  
In summary, the potency and spatial localisation of clones shown in this 
section are suggestive of a cellular hierarchy in which, during the secondary 
transition, minority populations of multipotent and fate-restricted self-renewing 
precursors, localized at the growing ductal termini, coordinate the process of 
branching morphogenesis, giving rise to ductal progenitors that expand the 
maturing ducts, acini that arise at the ductal ends, as well as delaminating 
islet precursors (Fig. 21c). 
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Figure 21. Inferring hierarchy of progenitors in the pancreas. Comparison of 
subclone sizes in the (a) acinar and (b) ductal compartment for unipotent vs. 
bi-/tripotent clones, showing no statistically significant differences. Bars 
indicate mean and S.D. I counted 254 clones from n=3 mice (3 litters). (c) 
Hierarchy of multipotent precursors and their lineage-restricted progeny 
inferred from the lineage tracing data.  
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4.4 Sox9-CreERT lineage tracing confirms previous findings of 
ductal-end driven pancreas morphogenesis 
To consolidate the findings from Section 4.2 and 4.3, I turned to a targeted 
lineage tracing strategy using a Sox9-CreERT2 mouse model (Kopp et al. 
2011), to exclude the possibility of the results reported in the previous 
sections arising from some artefacts related to the R26 promoter tracing and 
to exclude the possibility of tracing of non-pancreatic lineage cells such as 
stroma or mesenchyme.  
Examination of clones induced at E12.5 revealed a morphology and potency 
similar to that found using the ROSA26 model (Fig. 22a,b). I observed both 
the monoclonally-labelling ductal clones spanning ducts over multiple ductal 
branchings, as well as the branch-associated unipotent or acinar majority 
clones. These are indicative of the ductal-end driven morphogenesis 
described in the sections before (Section 4.2, 4.3). Although Sox9 expression 
has been associated with tripotency (Kopp et al. 2011; Furuyama et al. 2011), 
my findings suggest that, by E12.5, the majority of individual Sox9+ cells are 
already fate-restricted to either the acinar or the ductal/islet lineage. This 
discrepancy may arise from the non-clonal levels of induction in the previous 
studies (Kopp et al. 2011; Furuyama et al. 2011), with apparent tripotent 
clones arising from a possible merging of lineage-committed cells. 
In summary, Sox9-CreT2 lineage tracing at E12.5 confirms the previous 
findings of extensive tissue fate restriction by the end of primary transition and 
supports the model of ductal-end driven growth and the coordinated formation 
of the three main pancreatic lineages. 
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Figure 22. Sox9 lineage tracing control. (a-b) Sox9-CreERT2; R26-Confetti 
lineage tracing recapitulates the basic morphology and cell type composition 
of clones in Fig. 18b,c with both (a) branched ductal clones and (b) acinar 
subtree-associated clones present in abundance, supporting the hypothesis 
that self-renewing ductal and acinar precursors at ductal termini drive 
pancreatic growth. Ductal and acinar compartments indicated by arrow and 
asterisk, respectively. Representative images from analysis of 50 clones from 
n=3 mice are shown.  
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4.5 Early lineage restriction and potency distribution is confirmed 
by amylase co-immunostaining 
As outlined before, the use of the multicolour reporter system was essential 
for obtaining clonal levels of induction with a use of a feasible number of 
embryos in order to provide an accurate assessment of clonal potency. 
However, with the use of multicolour confetti cassette, I was left with only one 
channel for imaging, when visualising the samples, which was used for the 
simultaneous islet and ductal staining. As a consequence, I was not able to 
stain for the acinar marker in the lineage traced samples. However, I carried 
out an immunostaining control, which revealed that the vast majority of 
dissected pancreatic sections that were not DBA+ Chromogranin A+ were 
amylase+ (see Section 3.2.5 and Fig. 13). I therefore used an assumption that 
all non-Chromogranin A+ non-DBA+ cells were acinar, given the control 
immunostaining and the large number of quantified clones (244 for E12.5 to 
P14 lineage tracing, 50 for E9.5 to P14 tracing). Nevertheless, as the correct 
cell fate assignation was very critical for this study, I decided to re-stain the 
samples with amylase in another channel, controlling for the undesirable 
bleed-through effect.  
As before, I could observe that the vast majority of the tissue, which was not 
ductal and non-islet was acinar (Fig. 23), and the major clone types based on 
potency and morphology as in Figure 18 and Figure 16d-h with only DBA and 
Chromogranin A immunostaining, were confirmed (Fig. 23). I therefore sought 
to quantify the clones obtained with the amylase co-immunostaining control in 
order to compare the distributions of potencies with that of DBA and 
Chromogranin A immunostaining quantification.  
I quantified the potency of 26 clones from 2 mice from the amylase co-
immunostaining control samples, and compared the result with the distribution 
of clone potency in the initial DBA, Chromogranin A-immunostaining 
quantification. Crucially, I found that the potency distribution of the 
requantified clones was very similar to the ones I had reported before in 
Chapter 3.4 (no statistically significant difference, Fig. 24).  
Results: Branching morphogenesis 
 
 
138 
 
Results: Branching morphogenesis 
 
 
139 
 
Results: Branching morphogenesis 
 
 
140 
Figure 23. Comparison of potency outcome between original DBA and 
Chromogranin A immunostaining clonal analysis and amylase co-
immunostaining control. Frequency of different clone types by cell 
composition for (a) E12.5 induction with 26 clones (n= 2mice, 2 litters) 
requantified with additional amylase co-immunostaining in additional to DBA 
and Chromogranin A, and (b) E12.5 induction with 254 clones quantified (n= 3 
mice, 3 litters, same dataset as Fig. 17). (c) Comparison of global potency 
between both quantification methods showed no statistically significant 
difference.  
Figure 24. Additional verification of clone types with amylase immunostaining. 
Branch-associated (a) mCFP and (b) cRFP clone, and (c) branching ductal 
clone co-stained with amylase (pink), islet and duct (white) shown as 3D 
projection and (a’, a’’, b’,c’, c’’) as individual z-sections. The vast majority of 
tissue that was non-ductal and non-islet was acinar. mCFP and cRFP in a and 
b colocalised with amylase+ cells.  mCFP in c colocalised with DBA. 
Representative images from the analysis of 26 clones from n= 2mice (2 litters) 
are presented   
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4.6 Establishing the link between acinar and ductal dynamics 
based on clonal quantification 
As outlined before, qualitatively I observed collaborative behaviour between 
the ductal and acinar compartment. I identified two conserved groups of 
clones by morphology and cell composition: the acinar clones tracking ducts 
over generations of branches, and nearly monoclonally labelled ducts over 
multiple bifurcations (see Fig. 18b-d, 22a-b). However, I wanted to test and 
confirm the hypothesis of this collaborative behaviour by performing statistical 
analysis. 
In order to verify this, I looked at clone size distributions. Clone sizes were 
quantified (see Section 3.3.2). The variability of clone sizes within the ductal 
and acinar lineage was very broad for both compartments, although the acinar 
clones were on average significantly larger (Fig. 21a-b). This is consistent 
with the literature, whereby acinar cells make up 90% of the mature organ 
(Benitez et al. 2012), as this would imply that the acinar precursors need to 
proliferate more during development. As explained above, there was no 
correlation between clone size and potency size for all clones grouped 
together (Fig. 16i).  
I therefore aimed to determine the mechanism responsible for generating 
such broad clonal size distributions, and to compare the structure of acinar 
and ductal clonal distributions. This analysis was carried out in collaboration 
with Dr Edouard Hannezo and Prof. Benjamin Simons. In order to compare 
the two clone size distributions, we rescaled the clone sizes within each 
lineage, by dividing all clones sizes by the average clone size within each 
compartment. This enables the comparison of variability between 
compartments. We then plotted these rescaled clone sizes on a cumulative 
distribution curve, which is a probability function of a variable X (rescaled 
clone size) being of a given value or smaller (multiple of average size and 
smaller). This enables the comparison of the structure of heterogeneity of 
clone sizes, and hence the proliferation of cells, between distributions of 
different ranges of sizes.  
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Comparison of ductal and acinar cell-containing clones showed that the size 
distributions of the respective clone compartments, rescaled by the average 
size, was strikingly similar both between lineages at P14 (Fig. 25a-b, P=0.68, 
Mann-Whitney test). That is, while their average sizes differ by more than an 
order of magnitude (E12.5 to P14 tracing), the chance of finding a clone larger 
than some multiple of average remains the same for both the acinar and 
ductal lineage, revealing similar dynamics of the two compartments. 
Observing the matching pattern of clonal behaviour I wanted to find out 
whether the dynamics of proliferation were consistent for the clones traced 
between E12.5 and P14 and the clones traced between E12.5 and P28. 
Indeed the cumulative distributions of the two were highly matched. (Fig. 25c, 
P=0.63 for acinar lineage and P=0.95 for ductal lineage, Mann-Whitney tests; 
Statistical Methods in Chapter 2.3).  
Furthermore, I wanted to find out if the dynamics of the proliferation within the 
lineages was the same in primary and secondary transition. Indeed, I could 
see that the cumulative distributions of acinar and ductal lineage were 
matching for E9.5 traced clones (E9.5 to P14) (Fig. 25d-e), showing that the 
growth of two compartments is also coordinated in primary transition. 
Additionally, analysing the distributions for the same lineages (acinar or 
ductal) between the two induction timepoints (E9.5 and E12.5), a match could 
be observed, suggesting that the same mechanism is driving morphogenesis 
in primary and secondary transition (Fig. 25f-g).  
Altogether, this suggests that the gross heterogeneity in clone sizes may 
share a common origin in the collective fate decisions of self-renewing 
progenitors during branching morphogenesis.   
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Figure 25. Comparison of distributions of clone sizes from E9.5 and E12.5 
induction timepoints. Sizes in each distribution (x-axis) were rescaled by their 
respective ensemble averages. (a-b) Cumulative size distribution of ductal 
and acinar compartments in clones induced at E12.5 plotted on (a) logarithmic 
and (b) linear y axis. (c) Cumulative size distribution (plotted on logarithmic y 
axis of rescaled P14 and P28 collected acinar clone sizes induced both at 
E12.5. (d-e) Cumulative size distribution of ductal and acinar clones induced 
at E9.5 plotted on (d) log and (e) linear y axis. (f-g) Cumulative size 
distribution of acinar clones induced at E9.5 and E12.5 plotted on (f) log and 
(g) linear y axis. I counted 41 clones from n=2 mice (2 litters) for the E9.5 to 
P14 tracing, 254 clones from n=3 mice (3 litters) for the E12.5 to P14 tracing, 
84 clones from n=2 mice (2 litters) for the E12 to P28 tracing.   
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4.7 Ductal branching morphogenesis provides a common 
mechanism for development of acinar and ductal lineages 
I was interested in identifying the origin of the consistent progenitor 
heterogeneity in the acinar and ductal compartment. As there was no 
correlation between the potency and clone size, I wondered whether the 
broad and heterogeneous distribution of clone sizes could arise from the 
stochastic decision of progenitor proliferation versus proliferation termination. 
Such behaviour of clones has been described previously (Klein and Simons 
2011), and is associated with exponential curve for cumulative distribution, as 
in the birth-death events. However, the cumulative distributions observed for 
ductal and acinar lineages contained larger tails of the distribution, 
inconsistent with this hypothesis.  
Since I observed a matching clonal behaviour and morphology of acinar and 
ductal clones being associated with the ductal network, I hypothesised that 
the progenitors within the ducts could give rise to the specific clone size 
distributions. This would provide a mechanism of coordinated tissue growth in 
development. To challenge this hypothesis, I assessed the emergence and 
degree of gross heterogeneity of the growing ductal network itself by carrying 
out ductal whole-mount immunostaining of pancreata at different stages of 
development. In line with previous reports (Puri and Hebrok 2007; Kesavan et 
al. 2009; Villasenor et al. 2010; Bankaitis et al. 2015; Shih et al. 2016), the 
analysis of whole-mount tissue at E13.5 and E15.5 revealed a transition from 
a plexus structure to central primordial ducts from which multiple smaller 
ducts start to branch (Fig. 26a,b). By E18.5, whole-pancreas ductal 
reconstructions revealed a strikingly complex and intricate ductal network, 
reflecting multiple (>10) rounds of serial branching events tracking back to the 
primordial duct (Fig. 26c,d), consistent with a phase of branching 
morphogenesis. Notably, focusing on measurements made from whole-
mounts at E18.5, I found that some ductal subtrees remain small, localized to 
the centre of the pancreas, and comprise only a limited number of branch 
segments (Fig. 26d). By contrast, other subtrees expanded radially, reaching 
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out to the periphery of the organ and colonizing a large volume of tissue (Fig. 
26d).  
To find out the extent of ductal subtree heterogeneity, I quantified the raw 
distribution of subtree sizes (Fig. 26e,f), defined as the total number of 
branches (i.e. segments between two bifurcation points) within each subtree 
emanating from the primordial ducts (indicated with dashed line in Fig. 26a-c). 
How the ductal network was individually reconstructed for each subtree and 
how subtreees were distinguished is presented in schematic in Figure 26e. 
Strikingly, when compared to the clonal data, I found that the rescaled 
cumulative subtree size distribution (as described in Section 4.6) matched 
closely with that of the rescaled clone size distributions of both the ductal and 
acinar compartments (Fig. 27a-c), suggesting that clone size heterogeneity 
might indeed derive from the heterogeneity of the branching process. I verified 
this finding further by plotting the ductal subtree distributions with clone 
distributions from different lineages and induction timepoints revealing 
consistently matching dynamics (Fig. 27d-e). 
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Figure 26. Ductal network development in vivo. (a-c) Evolution of pancreatic 
ductal network stained in whole-mount with Dolichos biflorus agglutinin (DBA) 
at (a) E13.5, (b) E15.5 and (c) E18.5. Central plexus indicated in outline by 
dashed blue lines. (d) Branching structure of an E18.5 pancreas (ducts 
stained by DBA, white), with insets i-iv highlighting the heterogeneity of 
branch and subtree sizes. (e) Zoomed-in image of two pancreatic subtrees of 
E18.5 pancreas (left) and sketch of the two branches used in subtree size 
quantification (right), demonstrating the heterogeneity of branching 
morphogenesis. (f) Subtree sizes (scored by number of branches arising from 
a large central duct) determined from E18.5 pancreas. Subtree sizes were 
measured for n=3 mice and n=43 independent subtrees. Bars indicate mean 
and S.D.   
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Figure 27. Comparison of subtree size and clone size distributions at E9.5 
and E12.5. Sizes in each distribution (x-axis) were rescaled by their 
respective ensemble averages. (a-b) Cumulative size distribution of ductal 
and acinar compartments in clones induced at E12.5 together with subtree 
size distribution (number of branches) determined from E18.5 pancreas 
plotted on logarithmic (a) and linear (b) y axis. (c) Quintile-quintile plot 
comparing cumulative size distribution of P14 ductal compartment clones 
(induced at E12.5) versus P14 acinar compartment clones (induced at E12.5) 
in cyan; P14 ductal compartment clones (induced at E12.5) versus pancreas 
subtree size (at E18.5) in pink; P14 acinar compartment clones (induced at 
E12.5) versus pancreas subtree size (at E18.5) in dark blue. (d,e) Cumulative 
size distribution of ductal and acinar compartments in clones induced at E9.5 
overlaid with the cumulative subtree size distribution (number of branches) 
determined from E18.5 pancreas plotted on linear (d) and log (e) y axis. I 
counted 41 clones from n=2 mice (2 litters) for the E9.5 to P14 tracing, 254 
clones from n=3 mice (3 litters) for the E12.5 to P14 tracing. . Subtree sizes 
were measured for n=3 mice and n=43 independent subtrees. Bars indicate 
mean and S.D.  
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4.8 Macroscopic quantification of pancreatic growth 
Based on the clonal data, I inferred that pancreas growth was driven by 
branching morphogenesis of ductal-ends. I was therefore interested in how 
the process of tissue morphogenesis related to macroscopic changes in 
pancreas structure, such as mass, dimensions and relative tissue 
composition. 
I therefore first measured the mass of the pancreas for different stages 
including E18.5, P7, P14 and P28, for N= 3, 5, 11, and 4 mice respectively. 
Similarly to previous reports, the curve of growth displayed an exponential 
curve (Stanger et al. 2007) consistent with even proliferation of cells 
throughout development and maturation phase (Fig. 28a). 
Furthermore, from whole-mount dissected pancreata I observed that the 
organ appeared to expand more in the width and primarily length, but 
significantly less in the height dimension (Fig. 28b). Therefore, I attempted to 
quantify these parameters. Indeed between E13.5 and P14 the pancreas 
grew ~6 times in width, ~10 in length and only ~3 in height. For the growth 
between E13.5 and P28, these ratios amounted to ~11, ~10, ~5, respectively. 
Therefore the growth of pancreas appears to take place primarily in 2D.  
Furthermore, since I analysed distributions of ductal and acinar clone sizes, 
as described in the previous sections (Sections 4.6, 4.7), I was therefore 
interested in what was the composition of the tissue with respect to these 
compartments. This would reveal whether the proliferation of cells within the 
clones from the given compartments is proportional to the kinetics of the total 
compartment expansion. 
I first looked at the ductal compartment, as I was able to reliably quantify the 
percentage of ductal area out of total pancreatic area (N= 3 mice). Ducts 
constituted 10% of the whole pancreas, as analysed from multiple thick 
sections taken from different levels of pancreas (Fig. 28c). This value is 
consistent with previous literature (Benitez et al. 2012).  
The second major clone type was acinar. Quantification of the fraction of 
acinar cells in the whole pancreas was impossible due to variable penetration 
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of the amylase antibody through the thickness of sections under study. I 
therefore decided to compare the increase in acinar average clone size 
between E12.5 and P14, as well as between E12.5 and P28, with the 
increase in total pancreas volume (roughly calculated from the measurement 
of parameters in Fig. 28b). Assuming that the acinar compartment amounts to 
as much as 90% of the pancreatic tissue as previously reported (Benitez et al. 
2012), I reasoned that the increase in acinar clone volume should be 
comparable to the increase in pancreas volume. Indeed, this turned out to be 
the case, hence verifying the representativeness of the confetti labelling (Fig. 
28d). 
Altogether, these results indicate that globally pancreatic growth happens by 
even proliferation of cells, which contributes primarily to the increase of 
pancreas in width and length. Therefore, it could be assumed that pancreatic 
development is happening primarily in 2D.  
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Figure 28. Growth characteristics of the murine pancreas including (a) 
changes in pancreatic mass between E18.5 and P28; (b) fold-change in 
pancreas width, length and height from E13.5 to P14 and P28, as defined in 
the schematic inset. Bars indicate mean and S.E.M. (c) Percentage of 
pancreas that belongs to the ductal compartment at P14. (d) Fold increase in 
the size of the pancreas as a whole and in the acinar compartment-containing 
of clones between E13.5 and P14, and E13.5 and P28 indicating that clones 
are representative of the tissue. Bars indicate mean and S.E.M. Pancreas 
mass was measured for n=3 mice (E18), n=5 mice (P7), n=11 mice (P14) and 
n=4 mice (P28). Pancreas length, width and height were measured for n=3 
mice (E13.5), n=3 mice (P14) and n=3 mice (P28). The percentage of DBA+ 
cells was calculated from sections from n=5 pancreata.  
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4.9 Mechanism underlying branching morphogenesis based on a 
modelling scheme 
Based on the previous findings of ductal branching morphogenesis driving the 
coordinated development of pancreatic lineages, we then sought to develop a 
minimal modelling scheme in collaboration with Dr Edouard Hanezzo and 
Prof. Benjamin Simons. We aimed to capture the dynamics of the ductal 
branching process and thereby challenge quantitatively the interpretation of 
the clonal data. To construct the model, we first noted that heterogeneity in 
clone sizes did not correlate with the potency of individual progenitors (see 
Section 3.4). However, we also noted that pancreas development is largely 
two-dimensional (Fig. 28b in Section 4.8). Furthermore, we noted that ductal 
branches show few intersections (see Section 4.7, Fig. 26a-d). We therefore 
questioned whether heterogeneity in clone/subtree size could arise from 
external influences on the collective dynamics of equipotent branching ductal 
termini. In particular, noting that small subtrees were often terminated while 
“shadowed” by surrounding larger expanded subtrees (Fig. 26d), we 
considered whether competition of equipotent ductal termini for space could 
recapitulate such growth heterogeneity.  
We thus proposed a model of branching morphogenesis in which “active” 
ductal termini at the growing pancreas periphery would be free to branch and 
elongate, while branching of termini “imprisoned” by neighbouring ducts in 
more central regions would become arrested (Dahl-Jensen et al. 2016). In this 
model, ductal termini “choose” between branching into two active ductal 
termini, thus expanding clone size, or differentiation arresting further ductal 
growth. Such dynamics gives rise intrinsically to “branched” clones, which are 
heterogeneous in size, with an ever-diminishing minority of ductal termini 
remaining active.  
The model’s predicted subtree size distribution was compared to the 
experimental distribution of acinar and ductal clone sizes. The results showed 
excellent agreement (Fig. 29a, see Statictical Methods in Chapter 2.3 for 
details of the model). This shows that the heterogeneity of pancreas subtree 
(as well as clone) sizes can be explained quantitatively by a simple paradigm 
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in which all ductal termini have a priori the same growth potential, but their 
activity is checked by growth-arresting extrinsic signals (Fig. 29a,b), which 
could arise from neighbouring ducts. Within each ductal terminus, pools of 
self-renewing ductal precursors fuel ductal elongation and bifurcation, while 
differentiated acinar cells arise at the ends of terminated ducts.  
Interestingly, the theory distribution presented in Figure 29 is based on 
theoretical concepts developed previously in the mammary gland epithelium 
and kidney (Scheele et al. 2017). However given its close match with the 
pancreas compartment dynamics, this is a very likely mechanism of 
pancreatic tissue growth. Furthermore, this points to a conserved mechanism 
of branching morphogenesis within different organs.  
I therefore plotted the mammary gland rescaled clone size distribution against 
different combinations of acinar and ductal compartment clones induced at 
different timepoints and subtree sizes at E18.5, to verify if indeed the two 
organs follow the same pattern of proliferation dynamics (Fig. 30). Again, 
there was a striking match in the structure of these distributions, suggesting 
that indeed a process of stochastic bifurcation and branch termination may be 
driving pancreas morphogenesis. 
I therefore decided to look at the network, which would develop in the 
pancreas based on the assumptions of the stochastic bifurcation and 
termination model. The simulation was run by Dr Edouard Hannezo and 
resulted in the ductal network presented in Fig. 31, which resembles the 
pancreas ductal network at E18.5 (see Fig. 26).  
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Figure 29. Acinar and ductal distribution overlaid with the theory plot 
distribution show a good match. Theoretical subtree size distribution (a) based 
on a model of equipotent ductal termini, sketched in (b), choosing with near-
balanced probabilities between symmetric branching into two ductal termini, 
or ductal termination, where branching becomes arrested and cells 
differentiate. (For details of the model, see Statistical Methods in Chapter 2.3). 
Acinar and ductal distribution are obtained from the quantification of 254 
clones from n=3 mice (3 litters) for the E12.5 to P14 tracing. 
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Figure 30. Comparison of subtree size distribution, clone size distribution and 
mammary gland subtree distribution. Sizes in each distribution (x-axis) were 
rescaled by their respective ensemble averages. (a) Cumulative size 
distribution (plotted on logarithmic y axis) of acinar compartments in clones 
induced at E12.5, pancreatic subtree size and mammary gland epithelium 
subtree size (Scheele et al. 2017), showing similar growth dynamics between 
developing pancreas and mammary gland. (b) Quintile-quintile plot comparing 
the cumulative size distribution of P14 acinar compartment clones (induced at 
E12.5) versus mammary subtree size (Scheele et al. 2017). Acinar clone 
distribution was obtained from the analysis of 254 clones from 3 mice for the 
E12.5 to P14 lineage tracing. Subtree sizes were measured for n=3 mice and 
n=43 independent subtrees.   
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Figure 31. Ductal network generated from simulations of stochastic 
proliferation and termination of ductal ends. The model assumes 2D network 
development and termination of branching upon encounter with another 
branch. (a) Main duct with arising side branches are presented for the initial 
stages of pancreatic development (b) ductal network on one side of the main 
duct after a few generations of branching (c) network developed after multiple 
generations of branching.   
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In summary, it appears that pancreas morphogenesis is driven by proliferative 
ductal ends carrying fate restricted and multipotent progenitors, which 
stochastically decide to bifurcate or terminate a branch, as the clonal size 
distributions match the model theory distribution. The encounter of another 
ductal-end may induce signals causing the local termination of a branch. 
However, the question of what may be the source of signals affecting the local 
termination of branches is still outstanding. These could arise from 
mesenchyme and stroma, or from the signalling molecules released by the 
neighbouring termini. This should be the subject of future studies.  
4.10 Multiplicity of ductal-end niche progenitors 
Based on the insights presented in the previous section (Section 4.9), which 
suggest that pancreas morphogenesis is driven by proliferative ductal-ends 
which stochastically decide to bifurcate or terminate, in collaboration with Dr 
Edouard Hannezo and Prof. Benjamin Simons, we turned to consider the 
number of self-renewing precursors within a given ductal terminus, which 
would be responsible for driving the branching morphogenesis. Since the 
ends of ducts appear roughly constant in size throughout development, and 
are frequently cleft-shaped (Bankaitis et al. 2015), we proposed that ductal 
bifurcation segregates precursors approximately equally, after which they 
undergo a round of symmetric duplication to recover their original density.  
Using the inferred branching principles, we then simulated clonal dynamics 
based on random segregation of labelled cells based on a previously 
developed model (Scheele et al. 2017). Chance segregation and expansion of 
clonally-labelled precursors during ductal bifurcation allows the fraction of 
lineage-labelled cells in newly formed ducts to “drift” in size, leading to a 
gradual process of “monoclonal conversion” in which, with increasing branch 
generation along the network, ducts eventually become either fully labelled in 
a single confetti colour or completely unlabelled (Fig. 32a). Importantly, the 
rate of monoclonal conversion scales in inverse proportion to the number of 
self-renewing ductal precursors contained in each terminus, because of the 
relative proportion of a labelled cell out of all ductal-end progenitors (Fig. 32b-
d). 
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Inspection of the experimental data showed that labelled subtrees are initially 
mosaic (both in the acinar and ductal compartment), but undergo rapid 
monoclonal conversion along the ductal network so that, in many cases, more 
distal ends become entirely comprised of confetti+ cells characterized by a 
single colour (Fig. 32e). Importantly, comparing the rate of monoclonal 
conversion in representative ductal-containing clones (Fig. 32e) with the rates 
from theoretical trees generated for different number of precursors (Fig. 32b-
d), it appears that only as a few as 4-6 self-renewing precursors are located at 
the ductal-ends (Fig. 32b-e and Statistical Methods in Chapter 2.3). This is in 
contrast to the mammary gland epithelium, whereby there is a large number 
of “stem cells” hosted in each tip (Scheele et al. 2017). 
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Figure 32. Branching morphogenesis in the ductal termini is driven by a small 
number of self-renewing progenitors. (a) Schematic depicting the process of 
monoclonal conversion. (b-d) Simulation of a theoretical subtree containing 
(b) 4, (c) 30, (d) 10 self-renewing ductal precursors per ductal terminus with 
one initially-labelled precursor cell (for details, see Methods Theory). (e) 
Representative ductal clone showing monoclonal conversion; the direction of 
ductal growth is indicated with an arrow. Comparison with simulations (b-d) 
suggests that growing ductal termini are composed of as few as 4 self-
renewing ductal precursors. Representative image in (e) was obtained from 
the analysis of 254 clones from 3 mice for the E12.5 to P14 lineage tracing.   
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4.11 Branching morphogenesis is very rapid in pancreas 
development inferred from E15.5 and E18.5 induction lineage 
tracing 
Since I could observe dynamic branching morphogenesis based on the 
morphology of clones induced with E12.5 lineage tracing, I was interested in 
finding out until which stages of development the morphogenesis persists. I 
therefore carried out an additional experiment, whereby mice were injected 
with Tamoxifen at E15.5 and E18.5 (Fig. 33a). The dose was optimised, and 
amounted to 0.015 and 0.010 mg of Tamoxifen per g of pregnant female at 
E15.5 and E18.5 respectively. The induction levels were higher than for the 
E9.5 and E12.5 induction experiments. Hence, in order to assure clonality, as 
in the previous experiments, I decided to focus the analysis on the rare cyan+ 
and green+ clones (Fig. 33b,c, see Section 3.3.3).  
At E15.5, I observed smaller clones that still tracked subtrees over several 
rounds of branching. These clones were either unipotent ductal (Fig. 33d,e), 
acinar (Fig. 33d,f), or rarely bipotent ductal-acinar or islet-ductal (Fig. 
33d,g,h). At E18.5, all clones were compact (Fig. 33i,j), with minimal, but non-
zero (ductal-acinar) bipotency (Fig 33d,k), and no longer spanned multiple 
branches, consistent with branching morphogenesis being replaced by a 
process of growth via local dilation of an existing tree structure. Altogether, 
these results reveal that branching morphogenesis is far less active at later 
stages of development, meaning that most rapid branching morphogenesis is 
presumably taking place over the few days between E12.5 and E15.5.  
Furthermore, the quantification of potency reveals that the tissue is vastly 
restricted at these stages. Analysis of 78 clones from 2 mice for E15.5 and 61 
clones from 2 mice for E18.5 showed extensive unipotency, with no tripotent 
clones detected beyond E15.5 (presented in Fig 33b-k). 
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Figure 33. Branching morphogenesis and lineage restriction is very rapid 
during development. (a) Outline of experiment with induction at E15.5 and 
E18.5. Section of (b) E15.5 and (c) E18.5 samples showing the induction 
levels of rare colour, (a) green and (b) cyan. Clones are indicated with arrows. 
(d) Clones induced at E15.5 and E18.5 were mainly unipotent. (e-g) P14 
pancreas induced at E15.5 showing only a few rounds of branching events in 
(e) ductal and (f) acinar compartment. In addition to unipotent clones as in (e) 
and (f), bipotent ductal-acinar clones were also observed (g). (h) Permutations 
of all clone types and their relative frequency for E15.5 induction. (i-j) P14 
pancreas induced at E18.5 revealing only a single bifurcation event within 
traced clones and unipotency in (i) ductal and (j) acinar compartment. (k) 
Permutations of all clone types and relative frequency for E18.5 induction 
timepoint. Ductal and acinar compartments indicated by arrow and asterisk, 
respectively. I counted 78 clones from n=2 mice for E15.5 to P14 tracing, and 
61 clones for n=2 mice for E18.5 to P14 tracing.   
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4.12 Discussion 
In this chapter, I presented the results of the analysis of clone morphology, 
potency and dynamics based on lineage tracing with R26-CreT2; R26-
Confetti, Sox9-CreT2; R26-Confetti at various developmental timepoints. This 
was combined with computational modelling of clonal data. Altogether, this led 
us to a model of branching morphogenesis, explaining the coordinated growth 
of the entire organ. 
The first part of this chapter was concerned with studying the morphology of 
clones, which led to the hypothesis of ductal-end driven pancreatic growth. 
This was further confirmed by EdU proliferation assay, which showed 
enrichment of EdU+ cells at ductal ends as compared to the core parts of 
ducts at 15.5. Previous studies have suggested that proliferation at tips 
around E12.5 may be taking place (Zhou et al. 2007). Additionally, 
proliferative cells were shown to be enriched at ductal-ends of branches in an 
ex vivo system (Puri and Hebrok 2007; Dahl-Jensen et al. 2016), with a recent 
study contradicting these findings (Marty-Santos and Cleaver 2016). 
Altogether, it appears that the mode of pancreatic growth and branching 
morphogenesis of the ducts is not understood. Our study confirms the 
previous findings of enhanced proliferation of cells at peripheral regions of the 
pancreas. While the previous in vivo study (Zhou et al. 2007; Petzold and 
Spagnoli 2013) suggested proliferation in the tip domain of the early bud, I 
show that this peripheral proliferation is maintained at later stages at ductal 
ends of subsequent branches. 
Next, I aimed to decipher the cellular composition of ductal-ends, based on 
the analysis of clones associated with pancreatic ductal subtrees. This led to 
the hypothesis that the proliferative ductal-ends contain both rare multipotent 
precursors and a majority of ductal and acinar-committed precursors. This 
finding provides a cellular mechanism of how morphogenesis of the three core 
pancreatic compartments is coordinated. However, our findings are in contrast 
to a previous study, claiming that pancreas morphogenesis is driven by a 
multipotent domain (Zhou et al. 2007). The discrepancy between our findings 
and the previously published study (Zhou et al. 2007) may arise from the 
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clonal versus non-clonal levels of induction, as well as the fact that the 
previous study looked at the Cpa1+ lineage rather than at random cells from 
the ductal-end/tip domain. 
Subsequently, I presented results of control experiments involving Sox9-
CreERT lineage tracing and amylase co-immunostaining, which demonstrated 
the validity of the clonal potency and morphology outcomes based on R26-
CreERT2 tracing, thereby excluding the possibility of non-pancreatic 
contribution to clone interpretation. Interestingly, the outcome of Sox9-
CreERT2 lineage tracing revealed a significant level of lineage restriction in 
contrast to previous studies suggesting the Sox9+ domain as the site of 
multipotent progenitors (Furuyama et al. 2011; Solar et al. 2009). This 
discrepancy between the results of this thesis and the published studies may 
also arise from the use of non-clonal levels of induction previously, which may 
alter the accuracy of potency assessment.  
The next parts of this chapter were aimed at deciphering the mechanism 
involved in the coordinated ductal and acinar dynamics. I first looked at the 
development of the ductal network, observing extensive heterogeneity, which 
was then quantified. The rescaled subtree size, and the acinar and ductal 
clone size distributions revealed a high correlation, indicating that pancreas 
growth may indeed be driven by the ductal branching morphogenesis. 
Furthermore, the analysis of the distributions of the same lineages (acinar or 
ductal) between the two induction timepoints analysed (E9.5 and E12.5) 
showed that they follow the same dynamics, suggesting that the same 
mechanism is driving morphogenesis in the primary and secondary transition. 
This is a surprising finding, given the literature stressing the importance of 
plexus remodelling at the initial stages of pancreatic growth (Bankaitis et al. 
2015; Pan and Wright 2011). Nevertheless, it is possible that, while plexus 
formation and remodelling are still active, already the first ductal ends/tips 
appear early on and are guiding the pancreatic expansion. 
Furthermore, I aimed at providing a model explaining the coordination of 
acinar and ductal lineages resulting in the particular distributions of clone 
sizes, and hence accounting for the dynamics of the pancreas growth. The 
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assumptions and constraints for the model were set up based on previous 
clonal and ductal network observations described above, as well as the 
quantification of macroscopic tissue parameters. Therefore, in collaboration 
with Dr Edouard Hannezo and Prof. Bejamin Simons, we proposed a model of 
stochastic bifurcation and termination of ductal-ends containing proliferative 
cells at ductal-ends. We found that on average 4 ductal-end precursors at 
each ductal end drive the branching morphogenesis. To the best of my 
knowledge, this is the first model up to date, presenting a cellular mechanism 
for coordination of the morphogenesis of all three pancreatic lineages (Iber 
and Menshykau 2013).  
Finally, from this study it appears that the process of branching 
morphogenesis is very rapid and seems to be most active between E12.5 and 
E15.5 and decreasing in intensity afterwards, with a maximum of two 
branching/bifurcations at E18.5 observed from lineage tracing data.  
The results summarised above have therefore answered the questions set out 
at the beginning of the Chapter regarding the coordination of morphogenesis 
to drive simultaneous specification of the three pancreatic lineages, and the 
way in which pancreas size and composition are regulated. 
In summary, this chapter proposes a mechanism of tissue growth, whereby in 
a largely committed tissue, a minority population of acinar-committed, ductal-
committed, and rare multipotent progenitors at proliferative ductal-ends drive 
the coordinated morphogenesis of the tissue, as presented in the schematic in 
Figure 34. 
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Figure 34. Summary schematic depicting morphogenic events during the 
second phase of pancreatic development. Pancreas morphogenesis follows 
from a process of stochastic ductal bifurcation and termination driven by self-
renewing fate-restricted ductal and acinar precursors, as well as rarer tripotent 
precursors, which become depleted after E15.5. The figure presents the 
potential evolution of a single labelled mCFP+ ductal precursor, cYFP+ acinar 
precursor and cRFP tripotent precursor. 
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Chapter 5 
Results: Single cell RNA 
sequencing analysis 
 
5.1 Introduction 
This chapter follows after the second chapter of findings, which showed early 
lineage restriction and ductal-end stochastic bifurcation and termination 
driving the coordinated morphogenesis of acinar, ductal and islet lineage in 
the pancreas. 
This chapter aims at answering the following research questions, related to 
the functional lineage tracing-based findings of the previous chapter, with the 
use of single cell sequencing method: - Is there molecular evidence of early tissue heterogeneity? - Do single cell RNA sequencing results provide support for the findings 
of proliferative ductal-ends and more quiescent core parts of ducts? - Is there a lineage hierarchy in developing pancreas, which would 
account for the observed localisation of tripotent progenitors together 
with acinar and ductal-committed precursors within the ductal-ends? - What are the potential markers associated with the tripotent 
progenitors at ductal-ends? - What are the potential markers associated with progressive 
differentiation of multipotent precursors? 
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In this chapter, I present the results of single-cell RNA sequencing with the 
follow up analysis, which includes principal component analysis (PCA) 
separation of pancreatic cells for downstream analysis in chapter 5.3, t-
distributed stochastic neighbour embedding (t-SNE (Krijthe 2015)) clustering 
of cells with similar gene expression profiles and the study of the cluster gene 
heterogeneity, the analysis of gene heterogeneity between cells with heatmap 
plots in chapter 5.4, as well as diffusion pseudotime analysis of lineage 
relationship in chapters 5.5 and 5.6. 
The chapter starts by an outline of the optimisation of the method for obtaining 
single cell RNA sequencing data. Next, I describe quality control and 
identification of pancreatic cells, which is followed by the downstream 
analysis. This includes the study of heterogeneity within the tissue based on 
the tSNE plot and heatmap analysis. Subsequently, I demonstrate the lineage 
relationship between acinar, ductal and islet cells using diffusion pseudotime. 
This analysis enabled me to identify genes, which may be expressed in the 
multipotent ductal-end niche cells.  
Altogether, my findings support and share further insight into the findings of 
the functional lineage tracing analysis presented in the previous chapter. 
5.2 Method optimisation for sorting of single cells 
The results of the previous chapters revealed a mechanism of pancreatic 
development, whereby in a vastly cell-fate restricted tissue, proliferative 
ductal-end multipotent and fate-restricted progenitors guide the growth of the 
organ. I therefore looked for molecular justification for the observations and 
results of the functional lineage tracing analysis, i.e. whether I could confirm 
the early lineage commitment and ductal-end driven tissue growth with 
localised niche precursors. I turned to the single cell sequencing analysis to 
investigate the molecular basis of the observed functional heterogeneity of 
pancreatic precursors. I focused on E13.25 as a matching point for the 
lineage tracing analysis, due to Cre recombination taking between 12 and 36 
hours post Tamoxifen administration (Danielian et al. 1998), as well as E15.25 
to investigate whether and how the molecular signature of progenitors evolves 
during development. 
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First, the protocol for obtaining single cells for sequencing had to be optimised 
in order to ensure non-biased FACS sorting of single cells. I decided to avoid 
the immunostaining and sorting for the epithelial marker Epcam, commonly 
used to label cells of the early pancreatic bud (Trzpis et al. 2007), as there is 
evidence that it may be enriched in ductal and islet committed cells during the 
later stages of development (Schnell et al. 2013). Instead, I negatively sorted 
against endothelial CDC45 and blood Tie2 markers, to prevent contamination 
of these non-pancreatic lineages. After optimisation of the single cell isolation, 
I generated single cell sequencing libraries using the previously developed 
protocol (Picelli et al. 2014) in collaboration with the group of Prof. Berthold 
Gottgens from the University of Cambridge (Fig. 36).  
 
 
 
 
Figure 35. Schematic of single cell sequencing experiment. Pancreata were 
dissected at either E13.25 or E15.25 and negatively sorted against CDC45 
and Tie2 endothelial and blood markers, respectively. Subsequently the 
Nextera cDNA library preparation was performed according to Picelli et al. 
2014 protocol.  
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5.3 Quality analysis and identification of pancreatic cells 
In collaboration with Dr Steffen Rulands from the University of Cambridge we 
performed the downstream bioinformatics analysis of sequence reads from 
the two experiment timepoints. To identify poor quality cells, three metrics 
were used: (1) the proportion of aligned reads, (2) the number of endogenous 
reads and (3) the number of features with more than 1 read. We filtered for 
cells with (1) more than 20% aligned reads, (2) more than 200,000 
endogenous reads and (3) more than 5000 detected features. We only 
considered genes that were detected in at least 2 cells, with a variance 
greater than 0.001. Out of the 672 cells that underwent single cell RNA 
sequencing, 516 (77%) passed quality control measured and were used for 
downstream analysis. Reads were normalized using the deconvolution 
method as implemented in the scran package in R software (A and K 2016). 
Combining data from E13.25 and E15.25 single cell sorted pancreata, we first 
performed dimensionality reduction by principal component analysis (PCA). 
This identified two distinct clusters of cells. Based on the complementary 
expression of Epcam and Vimentin, one of these clusters was identified as 
mesenchyme (Epcam- Vimentin+), while the remaining cluster was pancreatic 
(303 cells; Epcam+ Vimentin-). Figure 36 presents t-distributed stochastic 
neighbour embedding (tSNE) clustering of all cells, which groups cells of 
similar gene expression patterns together (Krijthe 2015, Van Der Maaten et al. 
2008), highlighted for Epcam gene expression. Two subsets of Epcam+ and 
Epcam- cells can be distinguished in the tSNE plot, corresponding to 
pancreatic epithelial and non-epithelial lineages (Fig. 36). 
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Figure 36. tSNE plot highlighting Epcam expression with the Epcam+ cells 
(green), which were used for downstream analysis of pancreatic cells. Log10 
normalised expression scale was applied. Single cells were isolated from n=7 
embryos from 7 litters (n=5 embryos for E13.25 and n=2 embryos for E15.25). 
 
 
5.4 Gene expression heterogeneity analysis 
Focusing on the pancreatic cells alone, we performed dimensionality 
reduction by t-SNE (Krijthe 2015) for E13.25 and E15.25 cells, followed by k-
means clustering of 303 cells from R’s statistics package on the 500 most 
variable genes and identified the cellular identity of cells in the three clusters 
using known markers for acinar, ductal and islet cells. This identified 4 distinct 
clusters of cells (Fig. 37a) corresponding to an early endocrine-committed 
cluster (based on Neurog3 expression; Shih et al. 2013, Pan and Wright 
2011) (Fig. 37b), an early (E13.25) and a late (E15.25) acinar cluster (Ptf1a, 
Cpa1, Myc; Shih et al. 2013, Pan and Wright 2011) (Fig. 37c-e), and a cluster 
expressing elevated trunk/ductal markers (Sox9, Hes1, Nkx6-1; Shih et al. 
2013, Pan and Wright 2011) (Fig. 37f-h). The late acinar cluster contained the 
E15.25 cell gene reads, and showed enhanced levels of Ptf1a, Cpa1 and Myc 
as compared to the early E13.25 cluster. This pattern of expression was 
consistent with the early lineage-commitment of pancreatic cells, as observed 
from the lineage tracing data.  
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Figure 37. Single-cell RNA sequencing analysis suggests early fate restriction 
(a) t-SNE plot obtained from combining cells from pancreas obtained from 
n=5 embryos at E13.25 and n=2 embryos at E15.25 showing islet, early 
(E13.25) and late (E15.25) acinar and ductal clusters, as identified by the 
expression of marker genes in respectively (b) Neurog3; (c-e) Ptf1a, Cpa1 
and Myc and (f-h) Sox9, Hes1 and Nkx6-1. Log10 normalised expression 
scale was applied. Single cells were isolated from n=7 embryos from 7 litters 
(n=5 embryos for E13.25 and n=2 embryos for E15.25).  
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Notably, within each of the four clusters, pancreatic genes revealed a 
surprising degree of homogeneity, even between the two timepoints – E13.25 
and E15.25 (Fig. 37). This homogeneity is further evident in a heat plot (Fig. 
38), which presents all individual cells and the expression of genes I selected 
as important for pancreatic development. The uniformity of gene expression 
pattern between E13.25 and E15.25 is surprising, as the E13.25 timepoint 
corresponds to the beginning of secondary transition while E15.25 stage of 
development is characterised by more intense lineage maturation. The major 
difference between the two timepoints was evident in the two separate 
clusters of early and late acinar cells, whereby the E13.25 and E15.25 cells 
were clustered separately (Fig. 37). 
However, the homogeneity of expression within clusters and its conservation 
across timepoints (Fig. 37-38) could suggest that the early tip-trunk polarity 
established at the beginning of secondary transition is conveyed in the 
branching morphogenesis. The exact cellular and molecular mechanism 
controlling this would call for future investigation. However, it is likely that the 
emerging tip regions at E12.5/E13.5 become the first branches. During 
branching morphogenesis, the ductal ends of these branches carry the tip-like 
cells, which are conveyed to future branching generations via rounds of 
bifurcation. The leading edge ductal-ends could therefore carry the ‘tip-like’ 
cells, while the trailing ducts would become more ‘trunk-like’ in character.  
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Figure 38. Heatmap plot showing expression levels of pancreatic genes for 
individual cells reveal a high degree of uniformity within clusters and across 
timepoints, E13.25 and E15.25. Genes are grouped into clusters based on 
their presumed role in development. Log10 normalised expression scale was 
applied. Single cells were isolated from n=7 embryos from 7 litters (n=5 
embryos for E13.25 and n=2 embryos for E15.25). 
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The major variability was between the acinar clusters at E13.25 and E15.25, 
as the E15.25 cells expressed increased levels of Ptf1a, as well Aldh1 and 
Hes1 (Fig. 38). Ptf1a is a known acinar-associated marker (Pan and Wright 
2011; Shih et al. 2013), hence its enhanced expression may be necessary for 
the maturation of acini at later stages. Hes1 is both an early progenitor marker 
and a trunk marker at later stages of development (Pan and Wright 2011; 
Shih et al. 2013). Aldh1 is a presumptive centroacinar marker (Rovira et al. 
2010). The role of Hes1 and Aldh1 in the maturation of acinar lineage requires 
future investigation. Combining the finding of distinct molecular signatures of 
acinar clusters at E13.25 and E15.25 with the model of branching 
morphogenesis based on the lineage tracing study presented in chapter 4, it 
is possible that the later timepoint acinar gene expression corresponds to 
mature acinar cells at ductal-ends, which arise upon termination of a branch. 
Islet precursors were distinguished based on the Neurog3 expression (Fig. 
37b). Within the clusters, I could observe some level of heterogeneity of islet 
maturation-related gene expression. Based on the heatmap plot, 2 and 4 out 
of 303 cells expressed Ins1 and Ins2 respectively, 3 out of 303 cells 
expressed Gcg, 1 out of 303 expressed Sst, and a general pattern of Cdh2 
downregulation was observed, consistently with the associated delaminating 
phenotype of islet precursors (Fig. 38). This early expression of islet 
maturation markers further emphasises the extent of specification within the 
tissue at these early stages, supporting the hypothesis of early lineage 
restriction. 
The most significant variation in the gene expression was observed with pan-
proliferation Mki67 marker, as illustrated in the heatmap plot (Fig. 38) and 
tSNE plot highlighting Mki67 gene expression (Fig. 39). Indeed, the tSNE 
ductal cluster (see Fig. 37a) is divided structurally (by its shape) into two sub-
clusters. Importantly, these sub-clusters are characterised by segregated 
levels of Mki67, with low and high expression in the left and right sub-cluster 
respectively (Fig. 39). Importantly, this separation is not based on 
developmental age. This may be indicative of a separation between 
proliferatively-active ductal termini and less active trailing ducts as presented 
in the previous chapter 4.     
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Figure 39. tSNE plot showing bipolar expression of pan-proliferative marker 
Mki67 in the ductal cluster (top-centre). The left sub-cluster and right sub-
cluster show high and low levels of Mki67 expression respectively, resembling 
the defined functional proliferative boundaries between ductal-ends and core 
ductal parts, as shown with in vivo lineage tracing (Chapter 4). Single cells 
were isolated from n=7 embryos from 7 litters (n=5 embryos for E13.25 and 
n=2 embryos for E15.25). 
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Furthermore, additional Mki67 expression variability could be observed in the 
acinar clusters at E13.25 and E15.25 (bottom right, middle right of Fig. 39). 
This is consistent with the model of branching morphogenesis driven by 
proliferative ductal-ends, proposed in the previous chapter (Chapter 4). The 
growing ductal ends would carry acinar and ductal proliferative progenitors, 
while the terminating ends would contain both acinar and ductal progenitors 
showing low proliferative capacity.  
Interestingly, the other proliferation markers, such as Ccna2, Pcna, Ccnd2 
and Ccnd1 (data not shown), did not show a similar bipolar heterogeneity 
within the ductal and acinar clusters and appeared to be more randomly 
heterogeneous. This discrepancy between Mki67 and the other factors, may 
arise from the fact that Mki67 is a pan-proliferation marker, while the others 
are cell-cycle stage dependent and therefore show much variation. 
Observing such clear Mki67 segregation into two ductal tSNE subclusters of 
high and low expression, indicative of a possible ductal-end and core ductal 
domains, I was interested in finding correlations between Mki67 and other 
gene markers. Such correlated factors would qualify as potential markers for 
the future lineage tracing analysis. This would enable the characterisation of 
the presumptive proliferative ductal-end niche carrying the progenitors driving 
pancreatic expansion. However, the analysis of correlations did not reveal any 
meaningful candidate genes. This may be a result of insufficient number of 
cells analysed in the experiment. 
In summary, the analysis of tSNE plots supports the findings of lineage tracing 
analysis, whereby early lineage commitment was observed. At E13.25 and 
E15.25, I already identify clusters expressing markers of the mature 
pancreatic lineages. The observed uniformity of gene expression within 
clusters and timepoints might be associated with conserved set of rules 
guiding branching morphogenesis (see Chapter 4). The sequencing analysis 
gives further insight into the proliferative heterogeneity, lending support to the 
existence of highly proliferative ductal-end domain and the more quiescent 
core part of ducts.  
Results: Single cell RNA sequencing analysis 
 
 
184 
5.5 Diffusion pseudotime analysis 
To further dissect the lineage relationship between the acinar, ductal and islet 
cells at both E13.25 and E15.25, we employed diffusion pseudo-time (DPT) 
ordering of the single-cell RNA-seq data (Haghverdi et al. 2016). In 
collaboration with Dr. Steffen Rulands we used destiny package (Angerer et 
al. 2016), employed a diffusion map (parameters: sigma=95, k=302) and used 
the DPT function to arrange cells in pseudo time.  
We found ductal cells standing at the apex of the lineage hierarchy (Fig. 40a), 
and diverging into acinar and islet sub-branch. This ordering of clusters was 
further confirmed by the appearance of cells in a timepoint-wise fashion, with 
ductal E13.25 cells followed by ductal E15.25 cells, followed by E13.25 acinar 
evolving into E15.25 acinar cells on one side branch, and islet E13.25 
evolving into islet E15.25 cells in another branch. This supports the validity of 
the arrangement of the clusters, with the ductal cluster at the apex. This 
finding is consistent with the functional lineage tracing findings, whereby 
tripotent precursors can be found within the termini of growing ducts, 
indicating their ductal origin.  
Consistent with the tracing data, we found Sox9 expression present in both 
the ductal and acinar cluster, becoming progressively down-regulated in 
opposition to the up-regulation of the tip maker Cpa1 (P< 5.5 10-12 for both, 
Fig. 40b,c). Cpa1 has been reported to mark the multipotent domain in 
development (Zhou et al. 2007) and hence its up-regulation along the axis of 
the DPT plot is surprising. However, it is possible that in the previous study 
the apparent tripotency results from the non-clonal levels of induction and 
merging of independent lineage-restricted cells (Zhou et al. 2007). 
The other marker, which was correlated with the direction of the diffusion 
pseudotime is Aldh1 (Fig. 40d). Again, this is a surprising finding, as Aldh1 
has been considered to be a marker of multipotent centroacinar cells (Rovira 
et al. 2010), rather than being associated with differentiation. However, the 
mentioned study involved sorting of Aldh1+ cells and growing them as ex vivo 
explants followed by the study of pancreatic lineage specification. Therefore 
Aldh1+ cells may actually not be multipotent in vivo. 
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Finally, we were also interested in looking at Mki67 gene, as it showed an 
interesting bipolar heterogeneity within the ductal tSNE cluster (Fig. 39). 
Interestingly, Mki67-high cells in the ductal cluster plotted on DPT segregate 
toward the acinar branch side, while the Mki67-low cells segregate towards 
the islet branch of the graph (Fig. 40e), consistent with ductal- and acinar-
committed progenitors residing in the proliferative ductal terminus, while islet 
cells derive from less proliferative trailing ducts, left behind the growing ductal-
ends. 
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Figure 40. Diffusion pseudotime reveals lineage hierarchy. (a) Diffusion 
pseudotime plot reveals evidence of lineage segregation with ductal cells at 
the apex of a hierarchy that branches separately into acinar and islet lineages. 
Diffusion pseudotime plots with both E13.25 (circles) and E15.25 (crosses) 
cells indicating that (b) Sox9 is anti-correlated (P< 5.5 10-12) with DPT 
direction, i.e. expression is upregulated at the apex, while (c-d) Cpa1 and 
Aldh1 are correlated (P< 5.5 10-12) with DPT direction, i.e. expression is 
upregulated in differentiating cells. (e) DPT plot for Mki67 showing Mki67 high 
cells segregating towards acinar branch and Mki67 low cells segregating 
towards islet branch, consistent with the lineage tracing data, which indicate 
that acinar and ductal cells retain full proliferative potential. Single cells were 
isolated from n=7 embryos from 7 litters (n=5 embryos for E13.25 and n=2 
embryos for E15.25). 
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In summary, the analysis of the diffusion pseudotime plots indicates a lineage 
hierarchy with ductal cells at the apex of the lineage hierarchy, consistently 
with the observation of ductal associated tripotent clones in lineage tracing 
analysis. I identified genes, which may be up-regulated in ductal-end 
associated progenitors among the known pancreas development associated 
genes. Among them, Sox9 is up-regulated in the multipotent precursors, while 
Cpa1 is up-regulated with the direction of lineage differentiation, inconsistently 
with previous literature (Zhou et al. 2007). 
5.6 DPT Correlated genes 
In the section above, I showed how the expression of three genes associated 
with pancreas development, namely Sox9, Cpa1 and Aldh1, is related to the 
direction of the diffusion pseudotime. This improves the understanding of the 
genes, which may be expressed by multipotent progenitors at ductal-ends. 
Prompted by this initial analysis, I was interested in identifying novel genes, 
which could be associated with precursor multipotency. The analysis provided 
me with an extensive list of genes correlated and anti-correlated with the 
direction of the diffusion plot, i.e. genes associated with differentiation into 
lineages and multipotency, respectively (See Table 21 and 22).  
Among the genes presented in Table 21 and 22, some were general 
regulatory and maintenance genes with an unknown role in the differentiation 
or maintenance of multipotency, such as Map1b coding for microtubule 
associated protein 1b, Ubb coding for ubiquitin B, Rbfox responsible for 
alternative splicing of pre-mRNA, Mcm2 and 6 coding for minichromosome 
maintenance complexes essential for eukaryotic genome replication, Acaa2 
coding for acetyl CoA Acetyltransferase 2 and others. Other genes were 
identified previously as being expressed in pancreatic multipotent precursors 
such as Onecut1 and Sox9 (Shih et al. 2013), or as being associated with 
lineage commitment such as Amy2a1,2,3,4,5, Pax6 and Maf6 (Shih et al. 
2013). There was also a significant group of genes of unknown function.  
In order to narrow down the list of potential genes which could play a role in 
multipotency and lineage specification, I decided to take advantage of a 
recently published list of genes with conserved expression between pancreata 
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from different species (Tarifeño-Saldivia et al. 2017). I reasoned that these 
genes could play a key role in pancreatic development and function. I 
therefore decided to compare the list of genes correlated and anti-correlated 
with direction of diffusion plot with the list of genes from the mentioned study. 
Those genes are presented in the Table 21 and 22 as highlights. It turned out 
that the vast majority of the genes highlighted by the DPT plot analysis have 
shown conserved expression in pancreata from different species.  
I decided to focus on the genes anti-correlated with the direction of DPT in 
order to better characterise the potential multipotent niche. Among the 
highlighted genes there were the known players in pancreatic development, 
such as Sox9 and Onecut 1. Onecut 1 is expressed in the multipotent 
precursor cells of the early pancreatic bud (Shih et al. 2013), and Sox9 has 
been previously associated with tripotency at later developmental stages 
(Solar et al. 2009; Kopp et al. 2011). Therefore it can be speculated that both 
could be the potential markers of the multipotent niche.  
Other interesting candidates were not previously extensively covered in the 
literature of pancreatic development, however their role in other contexts 
indicated a possible function in the establishment or maintenance of 
multipotency. For instance Lgr4, a gene coming from the same family and 
possibly redundant to Lgr5 (Tsai et al. 2016) was identified in the search. The 
association of Lgr5 with the multipotency in the intestinal tissue (Sato et al. 
2011) draws attention to the potential role of Lrg5 in the regulation of 
multipotency during pancreatic development. This speculation could be 
studied in the future. 
Another candidate gene included Fgfr2. The Fgf receptor is commonly 
expressed by cells in response to Fgf signalling. This would imply the 
proximity of the potential multipotent cells to a source of Fgf signalling, such 
as the mesenchyme surrounding the pancreas. (Bhushan et al. 2001). This is 
consistent with the possible location of the stem cell niche at ductal-ends 
(Chapter 4), which are typically located at peripheral parts of the tissue. 
Therefore the expression of Fgfr2 at ductal-ends should be investigated.  
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Furthermore, PTN is another interesting factor, as it has been shown to delay 
the maturation of the mammary gland (Rosenfield et al. 2012). Its role in 
pancreas development could thus also be studied. 
Several other genes have been previously described to be implicated in the 
pancreatic tumorigenesis, such as Ajuba, Lamc2 and Yap1 (Gruber et al. 
2016; Morvaridi et al. 2015; Kosanam et al. 2013; Chen et al. 2016). Cancer is 
commonly associated with abnormal proliferation of cells and stem cells are 
believed to be the cells of origin of multiple tumours (reviewed in Beck & 
Blanpain 2013). Therefore, there is a possibility that these genes could be 
involved in regulating the multipotency and proliferative capacity of cells.  
A surprising candidate gene identified in the list of DPT anti-correlated genes 
was Notch2 and 3. Notch signalling seems to inhibit the differentiation of early 
pancreatic progenitor cells, while at later stages it drives their specification 
into ductal lineage (Kopinke et al. 2011). Hence its role in pancreas 
development seems ambiguous and context dependent, possibly relying on 
the dosage of the expression levels (Kopinke et al. 2011), as well as the 
spatiotemporal dynamics. Its role in the maintenance of multipotency at later 
stages of pancreatic development should be investigated. 
Rbms3 is another interesting candidate as it binds to the 3’UTR of Ptf1a 
mRNA enhancing its expression (Lu et al. 2012). Ptf1a has been shown to 
drive acinar specification, however it is also expressed in early pancreatic bud 
progenitors (Shih et al. 2013). Similarly to Notch, it’s role may be context 
dependent and its possible role in regulating multipotency during later 
pancreatic development could be studied in the future. The expression pattern 
of both Rbms3 and Notch 2 and 3 could be investigated in order to find out 
whether there is any preferential localisation of these factors at ductal-ends. 
In summary, I have speculated a list of factors, which may be up-regulated in 
ductal-end associated precursor cells. It should be the focus of future studies 
to select some of these markers based on literature search and carry out 
immunostaining of E12.5-induced lineage-traced samples. This would enable 
the investigation of the potential co-expression of these factors with the 
tripotent clones and the potential ductal-end proliferative niche, observed with 
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the lineage tracing analysis (Chapter 4). This would help to characterise the 
niche environment driving pancreatic expansion during development.   
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Gja1 Nme4 Peg12 Lamc2 
Wnt7b Greb1 Zfp36l1 Lgr4 
Gm16551 Pxdn Mex3a Hunk 
Habp2 Schip1 Hadh Gm2693 
Dusp9 Fam234b Fmo2 Mir99ahg 
Nrep Acot1 Prdx6 Car14 
Igfbp4 Apoc1 Gm7665 Ezr 
Adamts1 Mcm6 Fjx1 Yap1 
Rbp1 Wfdc15b Ephb4 Bcap29 
Mxra7 Tinagl1 2610035D17Rik Gm6419 
Ccnd1 Hyal2 Jag1 Col27a1 
Gsta3 Hmga2 Tmem55a Parp1 
Cdh3 Cdc42ep1 Frem2 Ptgfrn 
Rest Efna4 Myl12b Dbi 
Serpinf1 Gm11223 Arl4c Gm28710 
Igfbp5 Hmgb3 Epb41l1 Mdfi 
Onecut1 Prss23 P4ha3 Pltp 
Sept9 Bmp7 Svbp Bzw2 
Mgst1 Capg Serpina1b Tmem171 
Ptn Igf2 Arhgef19 Tkt 
Vill Bicc1 Hhex Acaa2 
Smtnl2 Ddah1 Col18a1 Slc39a10 
S100a16 Slc2a2 Msl3 Gm38078 
Capn6 Pde5a Tubb5 Rfc2 
Notch3 Trip10 Rbms3 Eno1 
Fgfr2 Tmem29 Ajuba Itgb5 
2500004C02Rik Adgrg6 Stmn1 Pik3ap1 
Rgma Fras1 Smoc1 Gm5514 
5730416F02Rik Rara Cmtm8 Cyp39a1 
Fzd2 Sdc4 
  Table 21. All genes correlated (P< 5.5 10-12) with the direction of the diffusion 
plot. These indicate genes associated with differentiation into pancreatic 
lineages, including potential novel candidates. Genes of conserved 
expression in pancreata of different species are highlighted in red.  
Table 22. All genes anti-correlated (P< 5.5 10-12) with the direction of the 
diffusion plot. These present potential novel candidates for the multipotent 
domain in developing pancreas. Genes of conserved expression in pancreata 
of different species are highlighted in blue.  
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5.7 Discussion 
Single-cell RNA sequencing has proved essential in providing molecular 
confirmation of the functional lineage tracing study results presented in 
chapters 3 and 4. Firstly, I confirmed the findings of the early lineage 
commitment due to cluster analysis with tSNE plots. This finding is generally 
contradictory to the previous pancreatic literature (Kopp et al. 2011; Kopinke 
et al. 2011; Solar et al. 2009; Furuyama et al. 2011; Zhou et al. 2007), 
whereby the extent of multipotency should be vast, especially at early stages 
such as E13.25. However, one previous study, based on microarray gene 
expression analysis suggested early commitment of cells, with evidence of 
endocrine gene expression already at E9.5 (Chiang and Melton 2003). 
Next, I established lineage hierarchy, based on diffusion pseudotime – a 
method used to decipher branches in lineage relationships (Haghverdi et al. 
2016). This revealed the ductal lineage cells at the apex of the hierarchy, 
giving rise to acinar and islet lineages. This is again consistent with the 
lineage tracing data presented in the previous chapter, whereby tripotent 
clones are associated with ductal-ends. 
Furthermore, the study of genes correlated and anti-correlated with the 
direction of the diffusion pseudotime has revealed a list of genes, which may 
be expressed in the multipotent precursor cells. These factors could be the 
focus of future studies related to characterisation of ductal-end niche and the 
associated tripotent clones.  
Lastly, the gene expression pattern revealed by the t-SNE and heatmap 
analysis show great uniformity of gene expression within clusters and 
between the timepoints studied. This conservation of gene expression 
patterns suggests that, in contrast to previous studies placing emphasis on 
temporal progression of tip-trunk segregation into ductal morphogenesis (Shih 
et al. 2013), branching dynamics may be obeying a simple and conserved set 
of rules throughout the secondary phase of development. This could mean 
that the tip-trunk fate polarity established early on is conveyed via distal 
ductal-ends during consecutive branching processes. 
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In summary, the single cell RNA sequencing study presented in this chapter 
has shed light on the underlying molecular programmes that orchestrate 
pancreatic development. The results generate novel insights into the 
understanding of pancreatic cellular heterogeneity and lineage relationship. 
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Chapter 6 
Results: Islet morphogenesis 
6.1 Introduction 
This chapter is the last of the four Results series. Here, I present the 
outcomes of the ubiquitous R26-CreERT2 lineage tracing and quantification 
(See Chapter 3), with the focus on islet dynamics. The analysis is combined 
with computational modelling. This enables the study of the cellular 
mechanism of islet formation. 
Islets of Langerhans are essential for correct blood glucose level regulation, 
and their abnormal development leads to diabetes mellitus (Edlund et al. 
2001). While previous studies have mainly focused on specification pathways 
leading to β-cell differentiation (D’Amour et al. 2006; Pagliuca & Melton 2013; 
Pagliuca et al. 2014), the understanding of islet morphogenesis is limited. 
Previous research has shown that islets are polyclonal in origin (Deltour et al. 
1991), and originate from the delamination of endocrine precursors from 
maturing ducts (Solar et al. 2009). Based on lineage tracing studies using a 
constitutive promoter, these lineage-restricted unipotent precursors were 
thought to undergo very few rounds of division after populating an islet 
(Desgraz and Herrera 2009). Moreover, it has been noted the islet size is 
highly variable in mouse as well as in human (Jo et al. 2012; Kilimnik et al. 
2012). However, the origin of islet size heterogeneity, as well as the kinetics 
and number of islet precursors, are still largely unresolved. In this study, for 
the first time, I have carried out lineage tracing from the ubiquitous R26 
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promoter to focus on the dynamic contribution of cells - their proliferation and 
migration - to islet development. 
In particular, this chapter aims at answering the following research questions 
regarding the cellular mechanism and dynamics of islet formation: - How is islet size regulated? - How many precursors contribute to islet formation? - Is proliferative capacity of individual endocrine precursors regulating 
islet size? - What is the mode of islet cell proliferation during islet formation? 
The chapter starts with a description of islet compartment-containing clones – 
their potency and morphology. Next, I discuss the polyclonality of islets – a 
previously reported finding (Deltour et al. 1991). I then study the cellular 
mechanism of endocrine precursor delamination. Subsequently, I decipher the 
number of endocrine precursors, which merge together to form a functional 
islet. Lastly, I investigate the proliferative dynamics of precursor cells within 
islets after the early endocrine aggregates have been formed.   
Altogether, this chapter reveals cellular mechanisms of different steps of islet 
formation, which have not been previously studied extensively, from early 
endocrine progenitor delamination, through coalesce of endocrine precursors, 
to local islet cell proliferation. The understanding of islet morphogenesis is 
essential, especially in the fast developing era of tissue engineering and 
regenerative medicine.  
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6.2 Islet clones – potency and morphology 
The aim of this section was to characterise the potency and morphology of 
islet clones. Therefore, I was first interested in characterising the relationship 
between islet cells and other lineages. I wanted to find out whether there is 
any hierarchy between the pancreatic lineages (ductal, acinar and islet) and 
whether any common ancestors between the islet and other cell types can be 
identified. Furthermore, I sought to understand whether islets arise mainly 
from multipotent or committed precursors. I therefore first carried out the 
analysis of the E12.5 to P14 tracing study (see Chapter 3 – 4) and examined 
clones containing an islet component (as assessed by Chromogranin A 
staining), which consist of around one fifth of the total clone fraction (Fig. 17, 
Section 3.5). Parameters analysed included islet clone size, potency of islet-
containing clone, islet size, centre coordinates of an islet, total number of 
islets in a given section, and the fraction of confetti+ labelled islets out of all 
islets in a given section (see Section 3.4.2 for quantification details).  
Interestingly, the inspection of fixed samples at P14 collection timepoint 
(induced at E12.5) showed that the vast majority of islets contained no 
confetti+ cells. Amongst those islets that contained the confetti+ cells, the 
majority (>70%) only showed one confetti colour. This observation confirms 
the clonality of the assay (Fig. 41a). Of those clones that contained lineage 
labelled islet cells, the majority were found to be tripotent at both E9.5 (85%) 
and E12 (60%), although at E12.5 I could find small numbers of bipotent 
(21%) and unipotent (19%) islet-containing clones (Fig. 41b-e). The majority 
of the bipotent clones contained the ductal compartment (Fig. 41c,d). This 
observation is consistent with previous reports indicating that islet cells derive 
from progenitors delaminating from the ducts (Solar et al. 2009).  
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Figure 41. Potency of islet containing clones. (a) Fraction of islets with a 
given number of confetti colour labelling. Most islets contain only a single 
label, confirming the clonality of the lineage tracing data. (b) Potency of islet 
cell-containing clones induced at E12.5 and E9.5 (c) Tripotent clone (d) 
Bipotent islet clone. (e) Unipotent islet clone. Islet, ductal and acinar 
compartment indicated with arrowhead, arrow and asterisk, respectively. 26 
islet clones from n=2 mice (2 litters) were quantified for E9.5 induction, and 68 
islet clones from n=3 mice (3 litters) for E12.5 induction.   
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6.3 Polyclonality of islets 
I aimed to study the clonality of islets, in order to determine whether islets 
arise from the merging of multiple endocrine precursors, or whether single 
endocrine cells contribute to islet formation. Therefore, I analysed the labelling 
of islets with confetti clones. Occasionally, I observed more than one confetti 
colour localised within an islet, suggesting polyclonal origin of islets. 
Furthermore, islet-containing clones occupied only 3.7% of the total islet 
volume on average, further supporting the finding of polyclonality (Fig. 41c-e). 
This result supports the previous reports (Deltour et al. 1991).  
6.4 Initiation of islet formation 
The next aim was to understand how the process of islet formation is initiated. 
The observed polyclonality of individual islets suggests that they must emerge 
from the coalescence of multiple precursors (Fig. 41c-e), (Deltour et al. 1991; 
Jo et al. 2012).  
Since islets arise from delamination of Ngn3+ cells from the ducts, I wanted to 
determine the extent to which the delamination events affect islet size. 
Therefore I investigated whether the size of the endocrine component of islet-
containing bipotent and tripotent clones correlated with the size of the ductal 
counterpart. I reasoned that if an islet results from the collective delamination 
of many ductal precursors with limited proliferation, then size of islet and 
ductal component of a clone ought to be correlated. Alternatively, if the islet 
compartment of a clone originates from the rare delamination of a ductal 
precursor, followed by subsequent proliferation, then islet and ductal clone 
size should be uncorrelated. From the data, I found only a weak correlation 
(R2=0.012), supporting the latter hypothesis of islets arising from rare 
delamination of cells from the ducts (Fig. 42).  
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Figure 42. Relationship between the size of ductal part and islet part of an 
islet clone. No correlation was seen between the two compartments. This 
supports hypothesis of rare delamination of endocrine precursors, followed by 
subsequent proliferation. 26 islet clones from n=2 mice (2 litters) were 
quantified for E9.5 induction, and 68 islet clones from n=3 mice (3 litters) for 
E12.5 induction. 
 
 
6.5 Multiplicity of endocrine progenitors 
As mentioned before, I found that islets were never monoclonal in my 
analysis. Instead, islet-containing clones occupied just 3.7% of the total islet 
volume on average, with substantial variations across islets (Fig 41c-e, 43a). 
Figure 43a shows an example of such clone variability, revealing a smaller 
cRFP and a large cYFP clone. Thus, I wanted to find out if there was any 
relationship between the size of clones and the respective islets, in order to 
determine if islet size was regulated by the proliferative capacity of the 
constituent endocrine progenitors. I also aimed to infer the average number of 
precursors that would contribute to islet formation. 
Since the tracing data were clonal, this enabled me to estimate the average 
number of independent precursors required to build an islet, which is obtained 
simply as the inverse of 3.7% (the average fraction of clone in an islet), i.e. I 
estimated that islets are founded by some N=27 +- 6 independent precursors. 
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This is consistent with the observed high degree of islet polyclonality. 
Importantly, although there were very large variations (>30 fold) in islet 
volume, I could not find any statistically significant correlation between the 
volume of an islet and the size of the clone it contained (R2=0.001 for E12.5 
induction, R2=0.074 for E9.5 induction, Figure 43b,c). This shows that 
variability in islet volume is not caused by local variations in the proliferative 
capacity of constituent cells, but must therefore originate from variations in the 
number of progenitors coalescing to form it.  
This could either be due to local chemotactic cues acting on individual islet 
precursors, or to the subsequent merger/fragmentation of islets. The effect of 
fission and fusion events on the regulation of islet sizes is not understood, and 
it is possible that they are of different significance at different phases of islet 
formation (Jo et al. 2011). Of note, I observed that a small fraction of clones 
spanned multiple islets (8/55 for E12.5 to P14 traced samples), and these 
displayed a characteristic “dumbbell” shape described previously (Seymour et 
al. 2007). This indicates that fusion or fission could play a role at these stages 
of development. The relative significance of the two processes in the period 
between E12.5 and P14 should be investigated in the future.  
To further strengthen my conclusions about the number of precursors 
contributing to islet development, I performed a parallel analysis based on the 
E9.5 tracing. Indeed, as islet formation occurs well after E12.5, I do not expect 
the results above to be different from that obtained with the E9.5 induction 
data. Interestingly, I found a very similar degree of islet polyclonality, with a 
clonal fraction consistent with some N=25 +- 8 independent precursors 
creating an islet. This result confirms the robustness of the analysis and the 
R26-Cre; R26-Confetti system for studying islet morphogenesis. 
In summary, lineage tracing from the ubiquitous R26 promoter shows that islet 
size is not determined by the proliferative capacity of individual endocrine 
precursors, but by the merging of multipotent precursors. I find that on 
average around 26 precursors contribute to islet growth. 
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Figure 43. Islet size is not determined by the proliferative capacity of 
endocrine progenitors. (a) Islet clones occupy different fractions of islet 
volume – red (cRFP) clone occupies a small fraction (arrow), while the yellow 
(cYFP) clone occupies most of the islet (arrowhead). (b-c) Islet clone size 
versus corresponding islet size in which a given clone is localised (volumes in 
µm3). For E9.5 and E12.5 induction, the data show no correlation. 26 islet 
clones from n=2 mice (2 litters) were quantified for E9.5 induction, and 68 islet 
clones from n=3 mice (3 litters) for E12.5 induction. 
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6.6 Mode of proliferation of islet precursors 
Having gained insight into the cellular mechanism of endocrine delamination 
and aggregation into clusters, I was interested in understanding the dynamics 
of endocrine precursor proliferation within the maturing islets. In order to find 
out about the number and mode of cellular divisions, I studied the structure of 
islet compartment containing clones and in particular the size of the islet 
component. I found that the islet compartment size distribution from the E12.5 
tracing data is broad and well-fitted by a single exponential. This observation, 
by analogy with multiple other systems (Klein and Simons 2011), indicates 
that islet precursors do not have a fixed and well-defined proliferative 
potential, but rather they undergo a pattern of stochastic growth, where islet 
progenitors choose stochastically between symmetric division into two islet 
progenitors and entry into quiescence. The E9.5 data fit an exponential curve 
but to a lesser degree than the E12.5 data (Fig. 44). This could be due to 
multiple independent delamination events from large ductal clones, which are 
more likely to arise in early development. 
Altogether, our data indicate, that following the merging of endocrine 
precursors, the cells proliferate stochastically. Whether this could contribute to 
the variability in islet size described previously (Jo et al. 2011; Jo et al. 2007; 
Jo et al. 2012) is not clear. Others have previously suggested that stochastic 
proliferation is an unlikely mechanism driving islet size variability and it is 
more likely to arise from islet fission (Jo et al. 2011). My data, and in particular 
the lack of correlation between the islet clone and islet sizes (described 
above, Section 6.5), seems to confirm this hypothesis. This requires further 
investigation.  
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Figure 44. Islet clone size distributions for E9.5 (pink) and E12.5 (blue) 
induction timepoints showing an exponential size dependence indicative of 
stochastic fate choices during proliferative expansion. Bars indicate mean and 
SD. 26 islet clones from n=2 mice (2 litters) were quantified for E9.5 induction, 
and 68 islet clones from n=3 mice (3 litters) for E12.5 induction. 
 
Figure 45. Model of the formation of islets of Langerhans. The size of islets is 
determined by the number of precursors merging in an islet, which then 
proliferate stochastically upon populating an islet.  
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6.7 Discussion  
Previous studies have focused on the analysis of distribution of pancreatic 
islets to infer their mode of islet growth. These have shown that islets follow 
an exponential distribution (Jo et al. 2011), which has been explained by islet 
fission (Jo et al. 2011; Seymour et al. 2004), and local aggregation of islet 
cells (Herrera et al. 1991; Bouwens and De Blay 1996). In this study, for the 
first time, I have carried out lineage tracing from the ubiquitous R26 promoter 
to focus on the dynamic contribution of cells - their proliferation and migration 
- to islet development.  
My results suggest that islet size is regulated by the merging of precursors 
(Section 6.3, Fig. 41c-e), confirming previous report of polyclonality (Deltour et 
al. 1991), and follows from rare delamination from the ducts. On average, 
there are 20-30 lineage-restricted precursors that delaminate from ducts and 
aggregate into clusters of widely varying sizes. Islet cells then undergo a 
phase of independent stochastic expansion, randomly deciding between 
proliferation and quiescence/differentiation within islets (Fig. 45). This 
contradicts a previous study, which has suggested that islet cells proliferate 
homogenously (Brennand et al. 2007). However, the analysis was performed 
on β-cells exclusively with the MADM (mosaic analysis with double markers) 
system (Brennand et al. 2007), hence it may not be representative of all the 
islet lineages. In my analysis, I observed a wide range of clone sizes at the 
collection timepoint, including large clones of about 45 cells. This contrasts 
with the previous lineage tracing study, which revealed small clone sizes 
when traced using non-inducible Cre system, Ngn3-Cre (Desgraz and Herrera 
2009). The apparent discrepancy between the two studies may arise from the 
fact that high levels of Ngn3 promoter activity may have been required to 
activate the MADM reporter construct leading to the tracing of already highly 
committed endocrine precursors (Desgraz and Herrera 2009).  
Altogether, my results reveal a novel and comprehensive model of islet 
morphogenesis, which was possible due to multicolour non-biased lineage 
tracing in the pancreas, combined with quantitative analysis. This is in 
contrast to previous studies, which focused on the anatomy of islet sizes (Jo 
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et al. 2007; Jo et al. 2011; Jo et al. 2012). The improved understanding of islet 
morphogenesis is of great importance for regenerative medicine, in the 
treatment of diabetes, especially in the fast developing era of tissue 
engineering.   
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Chapter 7 
Discussion 
7.1 Contribution to the field 
The findings of my PhD project reveal that pancreas growth is controlled and 
driven by proliferative ductal-end cells, which stochastically balance 
bifurcation and branch termination, while carrying multipotent as well as ductal 
and acinar-committed precursors. This provides insight into how the 
specification and growth of the three pancreatic lineages, i.e. ductal, acinar 
and islet, may be coordinated. No model that explains the cellular mechanism 
of parallel pancreatic compartment morphogenesis exists in the relevant 
literature, despite there being keen interest in understanding the control 
mechanisms regulating tissue size and composition (Stanger et al. 2007; Iber 
& Menshykau 2013; Shih et al. 2013; Pan & Wright 2011).  
The research of this project also suggests that the tissue is vastly lineage 
restricted at early stages of development, with rapid cell fate commitment of 
cells taking place already in primary transition phase of pancreatic 
development, in contrast to previous reports claiming multipotency at these 
stages (Zhou et al. 2007; Solar et al. 2009; Kopp et al. 2011; Furuyama et al. 
2011). 
Furthermore, I elucidate a cellular mechanism of islet morphogenesis, 
whereby single ductal cells delaminate from ducts and coalesce together to 
form islets and, subsequently, proliferate stochastically. I also find that islet 
size is independent of the proliferative capacity of endocrine precursors. 
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Importantly, this study brings methodological advancements to the field of 
pancreatic development. Firstly, it is the first clonal lineage tracing study with 
the multicolour confetti-reporter system that has been performed in the 
pancreas. To reliably infer the fate potential of pancreatic precursors, it is 
essential to recover clonal information in a situation in which there is potential 
for large-scale cellular migration leading to clonal fragmentation. Until now, 
this problem has prevented the acquisition of clonal information, thereby 
significantly limiting our ability to understand the behaviour of individual cells 
during pancreatic development. Hence, the clonal study presented here is 
important for the correct interpretation of potency results and morphological 
behaviours.  
In addition, I carry out an unbiased lineage tracing with R26-CreT2 promoter, 
which enables one to look at random populations of pancreatic cells and 
therefore infer the dynamics of all lineages. This has been supported by 
tracing from a pancreas-specific Sox9 promoter, serving as a control for the 
ubiquitous lineage tracing and a comparison with the current literature, which 
focuses primarily on Sox9 lineage tracing (Kopp et al. 2011; Furuyama et al. 
2011). 
I also carry out clearing protocols and reconstructions of images, which 
enables the visualisation of whole clones in 3D. This is very important for the 
interpretation of potency in the context of development, where cell migration is 
very active, as well as for the analysis of morphological processes such as 
branching morphogenesis of organs. This approach of 3D clonal analysis has 
not been applied previously in pancreas development studies; mainly thin 
serial sections have been analysed (Kopp et al. 2011; Furuyama et al. 2011).  
Moreover, this study is the first extensively quantitative study of pancreas 
development in vivo up to date, and contains advanced computational 
modelling enabling the analysis of tissue dynamics. 
Lastly, my PhD research involves a comprehensive combination of techniques 
such as whole-mount immunostaining of clonal lineage traced samples 
combined with proliferation assay and single cell sequencing. None of these 
approaches have been applied before, neither alone nor in combination, in the 
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context of pancreatic development, and therefore give rise to novel findings. 
The specific contributions of my research and the novel insight to the field are 
outlined in the sections below. 
7.1.1 Cell fate restriction 
Previous lineage tracing studies have been very useful in establishing the 
relationship between the cellular lineages in the developing pancreas. In 
particular, the fate of Pdx1+ early pancreatic progenitors, Ngn3+ endocrine 
precursors, Cpa1+ acinar precursors and Sox9 ductal precursors has been 
previously determined (Gu et al. 2002; Kawaguchi et al. 2002; Furuyama et al. 
2011; Kopp et al. 2011).  Furthermore, the method has been used to study the 
potency of cells at different developmental stages. In particular, tracing of 
Cpa1+ tip cells have shown tripotency until E14.5 (Zhou et al. 2007), similarly 
to the Hnf1B+ traced cells (Solar et al. 2009). Sox9+ cells, on the other hand, 
have been reported to be tripotent until E18.5 with rare tripotency persisting 
even within few weeks after birth (Kopp et al. 2011; Furuyama et al. 2011). 
Hence the Sox9+ compartment has long been believed to be the potential 
host site of multipotent progenitors, despite the failed attempts to find de novo 
islet precursor neogenesis from Sox9+ precursors in the adult pancreas 
(Kopp et al. 2011; Furuyama et al. 2011). However, the mentioned studies 
have been performed at non-clonal levels of induction and with a use of 
biased promoters. Therefore, I aimed to re-evaluate the question of pancreas 
potency and lineage relationship by studying the potency of individually 
labelled random pancreatic cells.  
The results of R26-CreT2 lineage tracing suggest that the embryonic 
pancreas undergoes a rapid shift towards unipotency in the primary transition 
phase of development, and by E12.5 the majority of cells are unipotent. This 
contrasts with to the literature outlined above (Kopp et al. 2011; Furuyama et 
al. 2011, Zhou et al. 2007, Solar et al. 2009). The difference may be due to 
the fact that in the previous studies the apparent tripotency could arise from 
the merging of independent lineage restricted precursors. Furthermore, the 
aforementioned studies did not attempt to look at individual clones, but rather 
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quantified the total percentage of islet, ductal and acinar lineage labelling 
within thin sections, which were not serially re-constructed.  
In comparison, I observed that at E9.5 the tissue showed a much higher 
extent of tripotency than at E12.5. However, already at this early stage, a 
quarter of cells were unipotent. This further emphasises that lineage 
restriction may be taking place much earlier than previously reported, when 
cells are thought to be morphologically and functionally identical (reviewed in 
Benitez et al. 2012; Shih et al. 2013; Pan & Wright 2011). One previous study 
confirms this finding, whereby genes associated with specific lineage 
maturation were shown to be enriched in certain cells already at this stage 
(Chiang & Melton 2003).  
In order to further verify my hypothesis, I performed a single cell sequencing 
analysis. Ensuring non-biased investigation of pancreatic cells without 
enrichment for any early-committed lineages, I observed signs of early 
heterogeneity, with markers of acinar, ductal and endocrine lineage detected 
in individual cells. Hence, the functional results of lineage tracing were 
confirmed with the analysis of gene expression, in line with the previous 
microarray analysis (Chiang & Melton 2003) 
7.1.2 Mode of pancreatic growth 
The cellular mechanism of pancreas morphogenesis has been the focus of 
numerous studies. Enhanced proliferation of cells in the tip area at E12.5 has 
been observed (Zhou et al. 2007; Dahl-Jensen et al. 2016; Petzold et al. 
2013). The proposed mechanism of pancreas expansion involves the 
extension of the proliferative tip domain, followed by lateral appearance of 
side branches (Villasenor et al. 2010).  However, in this study the focus lies 
on the early tip domain rather than ductal ends at the tips of branches. 
Another study, in ex vivo pancreatic explants, has suggested that 76% of 
bifurcations during ductal branching occur via lateral branching, while 13% 
appear as a result of terminal bifurcation (Puri & Hebrok 2007). Another ex 
vivo explant study has confirmed enhanced tip proliferation (Dahl-Jensen et 
al. 2016), but contradicting evidence has been provided recently (Marty-
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Santos & Cleaver 2016). Altogether, it appears that the mode of pancreatic 
growth and branching morphogenesis of the ducts is poorly understood.  
My study confirms the previous findings of enhanced proliferation of cells at 
peripheral regions of the pancreas. While the previous in vivo study (Zhou et 
al. 2007; Petzold et al. 2013) suggested proliferation in the tip domain, I show 
that this peripheral proliferation is maintained at later stages at ductal ends of 
subsequent branches. I also propose that the mechanism of tissue growth is 
based on this ductal-end driven proliferation and bifurcation rather than ductal 
end extension followed by lateral branching, in contrast to previous 
suggestions (Villasenor et al. 2010; Puri & Hebrok 2007). Indeed, I observe 
conversion of single labelled confetti+ cells within ducts into monoclonal 
labelling of ducts at the peripheral regions of the tissue, which is only possible 
in the case of proliferation, bifurcation and extension of ductal ends. If the 
alternative, i.e. the lateral branching, were the case, then I would observe 
labelling of “main” and side branches without a gradual conversion from single 
cell labelling to covering the whole area of ducts in confetti+ colour. As this is 
not the case, therefore the unbiased lineage tracing suggests that branching 
morphogenesis is tip-bifurcation driven. 
Why is there a discrepancy between this study and the previous reports 
(Villasenor et al. 2010; Puri & Hebrok 2007)? Villasenor and colleagues have 
looked at anatomical snapshots of the ducts in development and based on 
geometry they concluded the mode of ductal branching. However, the 
symmetrical appearance of branches at an approximately right angle from the 
“leading” branch is not sufficient evidence for lateral branching. More dynamic 
evidence, such as live imaging, would be required, however, this is 
technologically implausible to carry out in the embryos. The few live imaging 
studies that have been conducted for pancreas development (Puri & Hebrok 
2007; Dahl-Jensen et al. 2016) were carried out in tissue explants, and 
therefore do not reliably recapitulate the in vivo conditions. Hence, my study, 
which presents snapshots of in vivo traced cells may be used as a proxy to 
live imaging. Indeed, approaches based on static pulse-chase assays can 
also give indirect insight into the dynamics of cell fate decisions by studying 
the evolution of timepoint snapshots, as emphasized by quantitative studies, 
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particularly in adult tissues (Snippert et al. 2010; Mascré et al. 2012; Visvader 
& Clevers 2016; Roy et al 2014), as well as in developmental contexts such 
as mammary gland (Scheele et al. 2017). 
Another question, which has been related to the mode of pancreas growth, 
pertains to the contribution of central plexus remodelling in determining 
pancreatic size. It has been suggested that plexus remodelling by means of 
physical pressure may lead to the origin of first protrusions, i.e. tips, at the 
onset of secondary transition (Pan & Wright 2011). This suggests that plexus 
remodelling could play an important role in determining the final pancreas 
size. Indeed, deletion of pancreatic cells between E9.5 and E12.5, when 
plexus remodelling is taking place (Pan & Wright 2011), results in a 
significantly decreased adult pancreas size, while ablation of cells at later 
stages results in a more compensated tissue growth (Stanger et al. 2007). 
However, the reduced tissue growth as a result of cell deletion at E9.5-E12.5 
might be the outcome of depletion of early progenitors, rather than the plexus 
remodelling itself. Furthermore, the role of plexus remodelling at later stages 
of development is not understood (Bankaitis et al. 2015). 
My study has shown that the primary mechanism of tissue growth in 
secondary transition arises due to ductal-end driven proliferation of 
progenitors rather than plexus remodelling. I hypothesised that if plexus 
remodelling were vastly contributing to tissue growth, then I would observe 
disconnected clusters of labelled ducts during lineage tracing. However, I 
observed stretches of monoclonally labelled ducts indicating ductal-end driven 
growth being the main contributor to branching morphogenesis. Even though 
it has been suggested that plexus remodelling might persist beyond E12.5 
until E15.5 (Bankaitis et al. 2015), it might be a “background” process of 
remodelling and nucleation of ducts rather than expansion. However, my 
findings do not contradict the suggestions of the role of pancreas remodelling 
on pancreas growth in primary transition, between E9.5 and E12.5 (Pan & 
Wright 2011).  
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7.1.3 Multipotent and restricted progenitors at ductal ends 
It has been previously reported that tip cells may host multipotent, proliferative 
Cpa+ cells until E14.5 in vivo (Zhou et al. 2007). In ex vivo explant settings 
proliferative cells have been shown to exist at the ductal ends of branches 
(Puri & Hebrok 2007), however, this has not been demonstrated in vivo. One 
study has suggested that multipotent tip domains may be guiding pancreatic 
growth (Zhou et al. 2007). 
Using clonal density ubiquitous promoter lineage tracing, I observed ductal-
end proliferative cells in vivo, complementing the findings of the previous ex 
vivo study (Puri & Hebrok 2007). I showed that ductal ends carry acinar and 
ductal-committed precursors together with rare tripotent precursors, in 
contrast to the multipotent domain previously suggested (Zhou et al. 2007). 
By E15.5 the tripotent cells are completely depleted. The discrepancy 
between my own and the published study (Zhou et al. 2007) may arise from 
the clonal versus non-clonal levels of induction, as well as the fact that 
previous study looked at the Cpa1+ lineage rather than random cells within 
the ductal-end/tip domain.  
The findings of this thesis offer an explanation as to how all the pancreatic 
lineages can develop in concert, whereby in a vastly lineage restricted tissue 
the early-committed precursors, together with some rare tripotent cells, are 
being carried together at ductal-ends. The ductal-ends bifurcate or terminate 
in a near-balanced stochastic process, resulting in a range of subtrees of 
variable size (different branch number), and the corresponding labelling of 
ductal and acinar branch-associated clones shifting towards monoclonallity 
over subsequent branches. Where a given branch terminates, the acinar and 
ductal committed precursors differentiate into mature acinar and ductal cells, 
respectively, while the islet cells delaminate from the trailing ductal bipotent or 
tripotent precursors.  
It is not clear how the creation of proliferative niche environment at the ductal-
ends is related to the early generation of tip-trunk polarity around E12.5. My 
sequencing data, whereby the cells at E13.25 and E15.25 show uniform and 
similar gene expression between the two timepoints suggests that the tip-
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trunk polarity established at the onset of secondary transition may indeed be 
conveyed via the growing ductal-ends. It is plausible that the initially 
established tip domain proliferates and pushes the outgrowths, leaving behind 
the cells, which terminate proliferation, while the proliferative cells are 
conveyed at ductal-end bifurcation points.  
7.1.4 Branch number regulation 
Pancreatic ductal structure shows some conserved as well as some non-
stereotypical features. The primary ductal frame is conserved between 
individuals and gives the pancreas its specific shape and anatomical features 
such as head, heal and ridge (Villasenor et al. 2010). At the same time, there 
is a significant amount of variability within the number of branches of 
individual ductal subtrees diverging from the main duct (Dahl-Jensen et al. 
2016). What factors could account for this variability in subtree size is not 
clear. It is plausible that the main conserved ductal framework is brought 
about by plexus remodelling, while the side branches of variable size arise 
due to ductal end/tip-driven growth.  
Indeed, my lineage tracing experiment with the induction at E12.5 shows that 
the growth of side branches appears to be tip driven and that plexus 
remodelling does not seem to play a role in the growth of the pancreas during 
secondary transition. I propose a model of stochastic near balanced ductal 
end bifurcation versus termination as a cellular mechanism of branch size 
regulation. This model fits well for my data of the ductal subtree size 
cumulative distribution. Hence, this process could account for the huge 
variability in the subtree sizes between individual pancreata and explain the 
relative composition of pancreatic sub-compartments. 
The mechanism of stochastic bifurcation and termination of ductal ends has 
been shown to play a role in other organs, such as the mammary gland 
(Scheele et al. 2017). Importantly, since branching morphogenesis is a 
process taking place in a number of glandular organs and serves to maximise 
the surface area over constraint volumes within organisms, it is plausible that 
it may follow some conserved features (Iber & Menshykau 2013). Therefore, 
the mechanism of tip driven growth and stochastic branch bifurcation versus 
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termination could be present in more organs. This could be the focus of future 
studies.  
The simulations of the model involve the assumption of branching occurring in 
2D, and random proliferation and bifurcation of ductal-ends until another 
ductal end is encountered. The resulting ductal network contains a ductal 
density equivalent to that resulting from stochastic near-50% probability of 
ductal bifurcation versus termination. However, based on the premises of the 
model, the actual nature of regulation of bifurcation and termination is not 
purely stochastic but results from proximity of other ductal ends, which may 
affect physical and biochemical local environment. The factors involved in this 
local ‘neighbour’ regulation should be investigated. Furthermore, the extent of 
randomness of the ductal end ‘collisions’ themselves is not understood. For 
instance, it is not clear whether there are some internal factors secreted in the 
pancreas or external factors produced by surrounding tissue, which could 
attract the growth of branches in a particular direction. These could involve a 
biochemical or mechanical pressure gradient. ECM and mesenchyme could 
serve this function by posing physical resistance to elongation of ductal-ends 
and by expressing molecules such as laminin-1 in ECM (Li et al. 2004); Fgf10, 
Bmp4 in mesenchyme (Bhushan et al. 2001). In sum, it is not clear if ductal-
end ‘collisions’, and therefore the process of near balanced stochastic 
bifurcation and termination, is purely random. Elucidation of the factors 
affecting local ductal-end bifurcation versus termination, and, in particular, the 
physical and biochemical cues involved, should be carefully investigated in 
the future.  
Focusing on biomolecular regulation, among the likely candidate molecules 
involved would be the inhibitors of signalling pathways shown to play a role in 
regulation of pancreatic branching in mouse models (Bhushan et al. 2001; 
Miettinen et al. 2000; Villasenor et al. 2010; Petzold et al. 2013). To start with, 
Fgf signalling provided by the mesenchyme is a key pathway thought to play 
an important role in branching morphogenesis. Ex vivo organoids fail to grow 
without Fgf10 (Bhushan et al. 2001), while sustaining it uniformly in the 
medium maintains the branching (Miralles et al. 1999). However, it is plausible 
that mesenchyme is necessary for pancreatic bud growth induction but not 
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branching per se (Dahl-Jensen et al. 2016). Indeed, SU5402 inhibition of Fgf 
signalling prevents organoid formation and expansion, but does not affect the 
expansion in the branching phase (Greggio et al. 2013). This is consistent 
with the fact that FGFR2IIIb inactivation leads to hypoplasia at E12.5 and the 
hypoplasia is maintained but does not worsen as development proceeds 
(Pulkkinen et al 2003). Therefore, it is not clear if inhibition of Fgf signalling 
could affect the variability of subtree branch size, and should be the focus of 
future studies.  
Another target pathway could be BMP signalling, which is induced by 
mesenchyme. Its inhibition via either Noggin overexpression of expression of 
dominant-negative BMP receptor causes pancreatic hypoplasia in mice, 
combined with reduced branching and excessive endocrine differentiation 
(Ahnfelt-Rønne et al. 2010).  
ECM has been also shown to play a significant role in regulating branching 
morphogenesis. In addition to its effect via ECM-integrin signalling regulating 
cell adhesion in the cap region of the pancreas, possibly enabling local 
protrusion of tips (Shih et al. 2016), it also secretes molecules such as 
Laminin-1. Blocking laminin-1 in pancreatic explant cultures, impaired 
branching and reduced the expression of acinar markers (Li et al. 2004).  
EphB and EGF signalling pathways have also been shown to play a role in 
regulating branch number in pancreata. EphB3-null/EphB2-dominant negative 
mice develop hypobranched pancreas with less and shorter branches, and 
overall lower exocrine mass (Villasenor et al. 2010). Branching 
morphogenesis is also impaired in EGFR (-/-) mice (Miettinen et al. 2000). 
Therefore, the search for EphB and EGF inhibitors expressed in the 
epithelium might be an important focus for future studies, as it could explain 
localised inhibition of branching, and the resulting stochastic variability of 
subtree branch number within different regions of the pancreas.  
Ephrin and EGF could act by affecting the Rho GTPase activity in the 
pancreas as in other organs it has been shown that Rho GTPases are 
regulated by Ephrin, EGF and ECM integrin signalling (Heasman & Ridley 
2008; Huveneers & Danen 2009; Poliakov et al. 2004). GTPases are believed 
Discussion 
 
 
221 
to be important in tubulogenesis (Heasman & Ridley 2008). It has been 
reported that tubulogenesis of pancreas is prematurely arrested in the 
absence of RhoA GTPase inhibitor Stard13 (Petzold et al. 2013) and that it 
acts via regulation of cytoskeleton organisation and ERK signalling.  
Another signalling molecule, which could control the ductal branch formation 
in the pancreas is the hepatocyte growth factor (HGF), as it controls 
branching of prostate through the Hedgehog pathway (Lim et al. 2014). Both 
the Hedgehog and HGF are expressed during pancreatic development; 
however, conditional inactivation of HGF receptor has not been associated 
with any defect in pancreas morphogenesis (Sonnenberg et al. 1993; 
Mellado-Gil et al. 2011). On the other hand, HGF mediated migration of 
progenitors has been observed and this process could contribute to correct 
morphogenesis in mouse pancreas, as shown in zebrafish (Anderson et al. 
2013).  
The other candidate pathways, which could be involved in local regulation of 
branch bifurcation and termination, include Wnt/β-catenin and Notch 
pathways (Murtaugh et al. 2003; Baumgartner et al. 2014) due to their short-
range activity. Some Wnt inhibitors, such as SRFPs and DKK, are expressed 
in the pancreas, with usually higher levels in the early pancreatic bud (Gauger 
et al. 2012; Dahl-Jensen et al. 2016). Notch has been previously shown to 
promote pancreatic progenitor proliferation (Greggio et al. 2013; Ahnfelt-
Ronne et al. 2012). Candidate inhibitor molecules, which could be involved in 
the regulation of local branch termination, could include Jag1, which has been 
found to be expressed and inhibit Notch signaling in the pancreas (Golson et 
al. 2009a; Golson et al. 2009b). Other inhibitors could include Fringes and 
Dlk1, as they are expressed in the pancreas and have been shown to inhibit 
Notch signaling in other organs. Importantly, Dlk1 has been shown to inhibit 
branching morphogenesis in the salivary gland by repressing Notch signaling 
(García-Gallastegui et al. 2014). Therefore, the study of Notch inhibitors 
should be the focus of future research concerning the control of branching 
morphogenesis (described in Dahl-Jensen et al. 2016). 
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7.1.5 Pancreatic size control 
Understanding of the factors controlling the regulation of pancreatic size is 
currently very limited. This thesis shows that pancreatic growth is tip driven 
during the secondary transition, with ductal ends stochastically ‘deciding’ 
between bifurcation and branch termination, and that plexus remodelling does 
not play a significant role in pancreatic expansion at these stages. These 
findings do not oppose the suggestion of the role of plexus formation on 
establishing the correct pancreatic size (Pan & Wright 2011). Indeed, towards 
the end of plexus remodelling short protrusions emerge on the peripheral 
parts of plexus (Bankaitis et al. 2015), from which the tip driven growth is 
likely to originate. Incorrect or decreased size of plexus could set an incorrect 
framework for pancreas branch formation. Indeed, previous research has 
suggested that deletion of cells until E12.5, when the plexus is remodelled 
(Pan & Wright 2011; Bankaitis et al. 2015), results in a highly decreased 
pancreatic growth to only 6% of the wild type pancreas size (Stanger et al. 
2007). Consistently, a higher extent of growth compensation was observed for 
progenitor depletion at later developmental stages (Stanger et al. 2007). 
However, the study by Stanger et al. also implies that the initial pool of 
progenitors might contain cells which are already highly committed, and 
therefore cannot compensate the ablation by enhanced proliferation, as is the 
case in the liver (Stanger et al. 2007). This is consistent with the findings of 
my thesis, whereby early and rapid cell fate restriction has been observed.  
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7.1.6 Re-evaluating lineage hierarchy 
A lineage hierarchy hypothesis has been established based on lineage tracing 
studies performed at a high density of induction (Gu et al. 2002; Kawaguchi et 
al. 2002; Furuyama et al. 2011; Kopp et al. 2011; Zhou et al. 2007; Solar et al. 
2009). The current model involves multipotent progenitor cells separating their 
domain into tip and trunk, mediated by Nkx6.1-Ptf1a cross-repression 
(Schaffer et al. 2010). The tip domain then gives rise to acinar precursors, 
while the trunk domain gives rise to ductal-islet bipotent progenitors (Fig. 46, 
reviewed in Shih et al. 2013). 
 
 
 
Figure 46. Lineage hierarchy model based on previous lineage tracing 
studies (on the left; Gu et al. 2002; Kawaguchi et al. 2002; Furuyama et al. 
2011; Kopp et al. 2011; Zhou et al. 2007; Solar et al. 2009) juxtaposed with a 
schematic of pancreatic morphological changes (on the right; see Fig. 2 in 
Chapter 1.1). Adapted from Shih et al. 2013. 
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The non-biased ubiquitous promoter lineage tracing study of this thesis 
partially confirms this hierarchy. Importantly, however, the findings enrich the 
current understanding by showing that ductal-ends might be the proliferation-
supportive niche environment for multipotent progenitors as well as cell fate-
restricted progenitors. Single cell RNA sequencing results, and, in particular, 
the diffusion pseudotime plots (DPT), show that the Sox9+ ductal precursor 
cells are at the apex of the hierarchy, and separate into acinar and islet 
branches. Furthermore, the functional results of lineage tracing confirm this 
finding, as most of the tripotent clones are ductal-end associated, and, 
additionally, I observe an abundance of ductal-islet and ductal-acinar bipotent 
clones. This confirms that the ductal compartment might, indeed, be at apex 
of hierarchy. The lineage relationship inferred based on these findings is 
presented in Figure 47. 
 
 
Figure 47. Schematic of the lineage relationship based on ubiquitous R26-
CreT2; R26-Confetti lineage tracing presented in Chapter 4 of this thesis. 
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The analysis of diffusion pseudotime plots (DPT) of single cell RNA data has 
enabled me to identify genes associated with progenitor-like state as well as 
those correlated with progressive differentiation. The genes anti-correlated 
with the direction of DPT would be those expressed at high levels in the 
progenitor cells. On the other side, the genes correlated with the direction of 
DPT would be associated with differentiation of pancreatic lineages. 
Interestingly, I found that Sox9 showed a very significant anti-correlation with 
the direction of DPT, supporting my hypothesis based on lineage tracing 
results of progenitor cells being localised at ductal-ends. This is also 
consistent with literature, whereby Sox9+ cells may be the source of 
multipotent cells until E14.5 or until birth (Furuyama et al. 2011; Kopp et al. 
2011). 
On the other hand, among the genes highly correlated with the direction of 
DPT was Cpa. This is a surprising finding, as previous studies suggest that 
“multipotent Cpa cells might be guiding pancreas morphogenesis” (Zhou et al. 
2007). 
In addition to looking at the genes known for their role in mouse pancreatic 
development, in collaboration with Dr. Steffen Rulands, we carried out an 
unbiased approach of searching for all genes, which show high anti-
correlation with direction of DPT. In this way, I could identify potential novel 
markers of the multipotent pancreatic cells. The list of genes was numerous; 
however, in order to narrow it down to those which could actually perform a 
functional role in pancreas development, I compared it with a previously 
published list of genes with conserved expression between pancreata of 
different species (Tarifeño-Saldivia et al. 2017). Surprisingly, the majority of 
the genes identified in DPT correlation list also appeared in the list of 
Tarifeño-Saldivia et al. (Tarifeño-Saldivia et al. 2017).  These genes are 
available in my thesis in Chapter 5.6 and could be used in the future to test 
various potential ductal-end niche markers.  
Finally, I show that the relationship between the ductal and acinar lineage 
may be closer than previously suggested. Based on the previous hypothesis, 
the ductal lineage separates from the acinar lineage early on during the tip-
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trunk domain separation (reviewed in Shih et al. 2013). However, the 
abundance of acinar-ductal bipotent clones at E12.5 observed with our 
analysis, and their persistence at later stages (E15.5 and E18.5) suggests 
that the separation of these two domains is not as sharp and symmetrical as 
previously suggested (Schaffer et al. 2010). This suggests that besides the 
canonical Ptf1a-Nkx6.1 cross-repression, other factors could be involved. In 
particular, it has been shown that Prox1 deficient mice lack the second phase 
of endocrine production and the pancreata display enhanced acinar 
specification (Wang et al. 2005; Westmoreland et al. 2012). This could arise 
due to imbalanced tip-trunk separation. Therefore, Prox1 could have an 
impact on the separation of domains and play a role in determining the 
sharpness of the boundary, perhaps leaving a more plastic zone in between 
the tip and trunk domains. 
7.1.7 Stem cell niche in developing pancreas 
Previous studies have suggested that there may be a niche site of multipotent 
progenitors during pancreatic development, and it may perhaps persist after 
birth. Tip cells until E14. 5 have been shown to be multipotent (Zhou et al. 
2007). On the other hand, some studies have implied that centroacinar cells, 
at the interface between ducts and acini, might be the host sites of multipotent 
progenitors even in the adult pancreas (Rovira et al. 2010). Furthermore, the 
Sox9+ lineage has also been associated with tripotency (Kopp et al. 2011; 
Furuyama et al. 2011).  
The results of this thesis suggest that ductal-ends might serve as a 
proliferation-supportive niche for both the multipotent precursors as well as 
lineage restricted cells. The signals, which provide the proliferation-stimulating 
environment for the cells in the niche, should be examined in the future. The 
findings of this thesis serve as a comprehensive and integrative model 
explaining the previous, apparently contradictory, results (Zhou et al. 2007, 
Rovira et al. 2010, Kopp et al. 2011, Furuyama et al. 2011). At the early 
stages of development ductal-ends could coincide with the Cpa1+ tip domain 
(Zhou et al. 2007), later on the multipotent progenitors would appear at the 
interface of ductal and acinar compartment (centroacinar cells) (Rovira et al. 
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2010) and within the Sox9+ ductal-end domain (Kopp et al. 2011; Furuyama 
et al. 2011).  
7.1.8 Islet morphogenesis 
The control of islet growth and morphogenesis is not well understood. It has 
been shown that in embryos and in neonates the endocrine cells proliferate 
contiguously, forming branched cord-like structures (Miller et al. 2009). 
Aggregation of cell clusters, i.e. fusion, is another, probably coexistent, 
mechanism of islet formation in the embryonic pancreas, considering the 
polyclonal origin of islets and the significant variability in islet size (Deltour et 
al. 1991; Ma et al. 2010; Jo et al. 2011).  
How islets of correct size are formed is not fully understood, and it is not clear 
whether the islet size is determined by the proliferative capacity of endocrine 
precursors. My study has shed light on the cellular mechanism of the islet 
formation. On average 26 precursors, which have delaminated from the ducts, 
migrate and coalesce together into endocrine clusters. However, islet size is 
independent of the proliferative capacity of the constituent endocrine 
progenitors. The endocrine precursors proliferate stochastically. Furthermore, 
islet fusion appears to be a rare event considering that multiple confetti 
colours appear rarely within the same islet. These findings provide a novel 
insight into the cellular dynamics of islet formation, which has been previously 
based on static analysis of islet size distributions (Jo et al. 2007; Kilimnik et al. 
2009; Jo et al. 2012; Jo et al. 2011).  
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7.2 Limitations 
Despite providing important advancements to the understanding of pancreatic 
development, there were certain limitations implicated in the current study. 
These were mainly related to technological limitations rather than 
experimental design. However, upon optimisation and improvement of the 
currently available technology, the following issues could be resolved.  
7.2.1 Tissue markers 
Firstly, I was limited in the number of tissue markers used to study the 
potency of cells due to the use of the multi-colour confetti-reporter system. Its 
importance, however, needs to be re-emphasised. To reliably infer the fate 
potential of pancreatic precursors, it is essential to recover clonal information 
in a situation in which there is potential for large-scale cellular migration 
leading to clonal fragmentation. This problem has prevented the acquisition of 
clonal information until now, significantly limiting our ability to understand the 
behaviour of individual cells during pancreatic development (Zhou et al. 2007; 
Solar et al. 2009; Kopp et al. 2011; Kopinke et al. 2011; Furuyama et al. 2011; 
Schaffer et al. 2010; Pan et al. 2013). It is only through the use of confetti 
labelling that I could achieve a statistically-defined level of confidence in the 
assignment of clones while still working with an acceptable number of 
embryos.  
However, in using the confetti-labelling system, I was left with only one 
channel, which I used for imaging of both ducts and islets. Fortunately, since 
ducts and islets adopt a separate and distinct morphology, I could 
unambiguously infer the cell composition of clones (Fig. 13, Chapter 3.3.5). 
However, there was no channel left for imaging the acinar markers in the 
initial analysis, and I assumed that the acinar cells were the DBA-, 
Chromogranin A- cells from the dissected pancreata.  
Importantly, I further confirmed the validity of this cell-type assignment by 
performing a set of control immunostainings using different channels for DBA, 
amylase and Chromogranin A to make sure that the ductal and endocrine 
compartments were indeed discernible (DBA and Chromogranin A; DBA, 
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amylase and Chromogranin A; Chromogranin A and amylase, Fig. 13). 
Indeed, the bulk of the tissue which was DBA- Chromogranin A- was indeed 
amylase+, hence given the number of clones quantified (244 for E12.5 to P14 
tracing and 50 for E9.5 to P14 tracing), the assumption holds true. 
The use of multiple staining markers in lineage traced samples has already 
been an issue in literature studying the potency of pancreas progenitors, as 
only 2 markers corresponding to 2 out of 3 pancreatic compartments (islet, 
ductal or acinar) were stained simultaneously, even when only one reporter 
colour was used for tracing (see, e.g., Zhou et al. 2007, Solar et al. 2009, 
Kopp et al. 2011, Kopinke et al. 2011, and Pan et al. 2013). Nevertheless, this 
issue should be optimised in the future by careful staining and improvement of 
imaging methods avoiding bleed-through between closely spaced imaging 
channels. 
However, since correct potency assignment was vital for this study, I re-
quantified the potency of a random subset of clones traced from E12.5 to P14 
after co-staining for amylase, DBA and Chromogranin A (Fig. 23, Chapter 
4.5), controlling for the risk of channels bleeding through and affecting the 
readout of other markers and clones. Crucially, I found that the potency 
distribution of the re-quantified clones was very similar to those initially 
reported (no statistically significant difference, see Fig. 24, Chapter 4.5). 
Finally, I confirmed my conclusion about the morphology and potency of the 
R26-Cre;R26-Confetti clones through an additional Sox9-CreERT2 lineage 
tracing experiment from E12.5 to P14, demonstrating that clones are of 
pancreatic (and not extra-pancreatic) origin (Fig. 22, Chapter 4.4).  
In summary, the simultaneous co-staining of multiple pancreatic markers has 
been a limitation of my study due to available technology. I managed to 
overcome it with a set of additional controls. Nevertheless, the current 
microscopy technology available does not allow me to image more than 3-4 
pancreatic markers simultaneously. In the future, the field would benefit from 
looking at various markers of ductal cells and islet maturation markers, in 
order to gain additional insight into heterogeneity of cellular dynamics 
between different sub-compartments. 
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7.2.2 Region-specific single cell RNA sequencing  
The single cell RNA sequencing experiments were very useful in shedding 
light on the molecular confirmation of early lineage commitment shown by the 
functional lineage tracing experiments, as well as the understanding of 
lineage relationship during development. However, in order to interpret the 
molecular mechanism guiding the branching behaviour and the potency of 
cells at ductal-ends specifically, laser capture would be an illuminating 
experiment to undertake, given the precision with which ductal regions could 
be studied. Unfortunately, there is currently no established method/protocol 
that would enable me to study the transcripts of single cells obtained from the 
laser-dissected area. Evidence from other organs (Scheele et al. 2017) 
suggests that cellular heterogeneity within ductal-ends may be vast, hence 
the sequencing of the bulk area without discrimination into individual could be 
uninformative. Therefore, the question of gene expression by single cells at 
ductal-ends should be re-addressed in the future, when appropriate methods 
and technology are available.  
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7.3 Future directions 
Despite the advancements of the study, certain aspects following on from this 
research would benefit from further investigation, as they are key to 
understanding the development of the pancreas. These areas are outlined 
below. 
7.3.1 Factors regulating local branch expansion 
Firstly, my findings suggest that branching morphogenesis is guided by a 
near-balanced ductal bifurcation and termination, and that the distribution of 
subtree sizes matches a distribution of subtree branch number, where, on 
average, a newly arising branch has nearly 50% probability of termination. 
Despite the statistically stochastic nature of the process some factors could 
be involved in reregulating the proliferation versus termination decision of 
cells at ductal-ends and these potential extrinsic and intrinsic cues should be 
studied in the future, as explained below.  
7.3.1.1 Biophysical factors 
The pressure exerted by ECM and mesenchyme surrounding the pancreatic 
bud and its effect on the growth of individual subtrees within the tissue could 
be examined with microfluidics. 
Additionally, the amount of ECM around various branches could be 
determined from imaging with second harmonics generation (Weigelin et al. 
2016; Wu et al. 2015) in parallel to confetti reporter tracing and the use of 
tissue markers. This would enable one to gain an additional assessment 
marker, besides the ductal, acinar and islet stainings, without the sacrifice of 
any of the previously used imaging channels. In this way, one could infer 
whether there is any relationship between the amount of ECM surrounding the 
subtree and the subtree size itself. This would provide one with an 
understanding of how ECM regulates the local branch expansion. 
7.3.1.2 Biochemical factors 
The expression of inhibitors of major signalling pathways shown to regulate 
global branching patters in vivo (Miettinen et al. 2000; Villasenor et al. 2010; 
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Petzold et al. 2013; Bhushan et al. 2001; Ahnfelt-Rønne et al. 2010) within the 
pancreatic epithelium should be studied (as outlined in Chapter 7.1.4), 
including the effect of their deletion or local inhibition on individual branch 
size. This would allow one to identify pathways responsible for the local 
regulation of pancreas branching. 
7.3.2 Ductal-end niche factors 
My findings suggest that ductal-ends serve as a proliferation-supporting niche 
and a site for rare multipotent progenitors in a vastly lineage restricted tissue, 
until around E12.5. Understanding which factors are expressed by the ductal-
end cells and the local environment cells would be key to elucidating the 
mechanism of branching morphogenesis and coordinated growth of acinar, 
ductal and islet lineages. There are several methodological approaches, with 
which the understanding of ductal-end niche factors could be improved, and 
these are outlined below. 
7.3.2.1 Laser capture optimisation 
Firstly, laser caption of specific ductal areas would enable the study of factors, 
which are enriched around ductal-ends as compared to the more central 
areas. However, up to date, no effective methods for single cell RNA 
sequencing of laser-captured cells have been developed. From the studies of 
ductal cells in branching morphogenesis in other organs it follows that the 
cellular heterogeneity plays a significant role (Scheele et al. 2017), calling for 
the study of individual cells within such processes. Therefore, optimising laser 
capture experiments whilst retaining cells at sufficient condition for single cell 
RNA sequencing could be the focus of future studies.  
7.3.2.2 Testing genes identified from diffusion pseudotime correlations 
The analysis of genes anti-correlated with the direction of the diffusion plot 
provided me with a list of potential novel candidate genes, which could be 
expressed in multipotent progenitors at ductal-ends. Subsequently, the list 
was narrowed down to the genes, which are expressed in pancreata of 
various species (Tarifeño-Saldivia et al. 2017), as these could be part of the 
core regulatory mechanisms in the development of the pancreas. It would be 
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key to verify some of these factors by co-immunostaining of the lineage traced 
tissue samples containing multipotent clones against those factors in order to 
find out if any of them are enriched at ductal-ends. 
7.3.3 Potency analysis 
I have studied the potency of single cell-derived clones and based on that I 
inferred a rapid cell fate restriction already in the primary phase of 
development. However, my analysis was restricted in the number of 
differentiation markers due to the use of multi-colour reporter cassette for 
lineage tracing (reasons for its use outlined in the previous section 7.2.1). If 
this technological limitation was overcome, then the understanding of the 
extent of tissue maturation and clone cellular heterogeneity could be 
enhanced by staining of multiple lineage-associated markers. The future 
analysis could include more extended analysis of islet maturation markers, 
such as the expression profile of various hormones. Furthermore, the analysis 
of ductal branching clones, indicative of tip-driven growth mode, would be 
enriched by simultaneous analysis of several ductal markers, such as DBA, 
CK19 and mucin. This would allow one to characterise the heterogeneity of 
the expanding ducts during intense tissue morphogenesis. 
7.3.4 Ductal abnormality model 
In this project, I have examined how branching morphogenesis controls 
pancreas growth in secondary transition and how it is essential for the 
coordination of the simultaneous development and expansion of three major 
pancreatic compartments. Given the crucial role of branching morphogenesis, 
it would be useful to turn to ductal abnormality models such as EGFR-/- and 
EphB2/3 mutant mice (Miettinen et al. 2000; Villasenor et al. 2010) and study 
the effect of these mutations on the relative composition of pancreas and the 
branch structure – globally and locally. These models have been shown to 
result in the development of abnormal pancreas with abnormal development 
of the pancreatic lineages (Miettinen et al. 2000; Villasenor et al. 2010). 
However, whether this arises due to an effect on early bud emergence and 
proliferation, or whether indeed it has an impact on the branch formation itself 
is not clear. Therefore, these model systems would first need to be verified by 
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an in vivo time course analysis and comparison to wild type mice in order to 
point to the specific stages and processes which are affected in these mutant 
mouse lines.  
7.4 Summary 
Pancreas development involves a coordinated process in which an early 
phase of cell segregation and patterning is proceeded by a longer phase of 
lineage restriction, expansion, and extensive tissue remodelling. By combining 
quantitative clonal lineage tracing and whole-mount reconstruction with 
proliferation kinetics and single-cell transcriptional profiling, I define the 
functional basis of pancreas morphogenesis. My results show that the large-
scale organization of tissue can be traced to the activity of self-renewing 
precursors that localize at the termini of growing ductal branches and act 
collectively to drive serial rounds of stochastic ductal bifurcation balanced by 
termination. During this process, multipotent precursors give rise to self-
renewing acinar-committed precursors, which are conveyed with growing 
ducts, as well as fate-restricted ductal progenitors that expand the trailing 
ducts and give rise to delaminating endocrine cells. These endocrine 
precursors merge together, resulting in variable islet size, while their 
proliferation is stochastic and independent of islet size. Together, these 
findings define quantitatively how the functional behaviour and lineage 
progression of precursor pools serve to define the organization of pancreatic 
sub-compartments. 
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